VAERS Reports GJ6742

VAERS 2728584

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 29.12.2023
Impfdatum: 15.12.2022
Beginn: 21.11.2023
Tage bis Beginn: 341,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Agitation Angiogram pulmonary abnormal Atelectasis Atrial fibrillation Bacterial infection Bladder cancer Blood culture negative Blood lactic acid Blood pH normal Blood potassium decreased Blood sodium decreased Bradycardia COVID-19 COVID-19 pneumonia Cardiac failure chronic Cardiac telemetry abnormal Chronic obstructive pulmonary disease

Symptomtext

Patient is a 64 y.o. male patient of MD with history of COPD, CHF with LVEF 45 to 50%, seizure disorder, A-fib on Xarelto, bladder cancer status post cystectomy with ileal conduit, ongoing tobacco dependence presented to Hospital with AMS, hypoxemia. Encephalopathy- improving Delirium Agitation Per wife this has been ongoing since his recent admission. Suspect secondary to COVID-19 versus other infectious etiology Placed no AMA MRI brain during recent hospitalization was negative for any acute findings. Afebrile, vital stable. VBG pH 7.4, PCO2 52, PO2<30. Sodium 134, potassium 3.3, lactic acid 0.8, WBC 8.8, hemoglobin 11.8. Troponin 16, 16. CT head, CT cervical spine with no acute injuries. CT pulmonary angiographic study showed bilateral pleural effusions, infiltrative changes in bilateral lower lobes as well as atelectasis or infiltrative process involving the lateral segment of the right middle lobe which is new since previous imaging with probably reactive lymph nodes in mediastinum, hilar and subcarinal location which are new. EKG with no acute ST-T changes. UA positive for nitrite, urine culture with 3 more morphotypes suggesting possible contamination. Prelim blood cultures negative 5 days Initiated on broad-spectrum antibiotics with vancomycin, cefepime, then DC'd as pro-calcitonin 0.13. Fall precautions. Consulted behavioral health as patient noted to be agitated, trying to get out of bed and leave the hospital. 11/23?recommendation for olanzapine 2.5 mg twice a day. Could increase dose if needed otherwise would start with increasing evening dose to 5 mg if needed. Monitor thrombocytopenia which could be a side effect of valproic acid. Platelet count up to 192 on 11/27 Evaluated by PT/OT on 11/27. Updated recommendations for 2-3 days. Case management setting up home health care with spouse to transport home on discharge Acute hypoxemic respiratory failure Abnormal CT COPD VBG, chest imaging as above. Continue broad-spectrum antibiotics, steroids. Had to be increased to 5 L of oxygen via NC wean oxygen as able. Pulmonary consulted given abnormal CT chest findings. Appreciate input. Recommend to continue Trelegy and albuterol at home, Dulera and Spiriva whilst inpatient. Recommend follow-up CT chest in 6 to 8 weeks to ensure resolution of mediastinal lymphadenopathy. Was stable on RA with one desat. Home O2 eval ordered. Qualified for 2 L nasal cannula continuously on 11/28 Bradycardia resolving On 11/22, patient was noted to be bradycardic on telemetry EKG with sinus bradycardia Avoid rate lowering medications Monitor Covid-19 virus Infection Date of onset of symptoms: Unsure Symptoms present on admission: Yes Date of covid positive test: 11/12 Imaging: CT pulmonary angiogram. Results as above. Oxygen requirements on admission: Yes 4 L nasal cannula. Current oxygen requirements: RA < 2 L nasal cannula. Medical therapy: steroids Consultants following: ID. Anticipated special isolation end date: 11/22 GERD Resumed home Tums as needed History of hospital delirium Likely secondary to multiple etiologies, such as pneumonia from COVID versus other bacterial, viral etiology, COVID encephalopathy, secondary to hypoxemia, severe protein calorie malnutrition. Seen by behavioral health team during recent hospitalization. Was discharged home with olanzapine 2.5 mg twice daily. Continue olanzapine, will use Haldol 1 mg every 6 hours as needed. BH consulted as above. Appreciate input. Nonischemic cardiomyopathy Chronic HFrEF, POA Nonobstructive coronary artery disease LHC 2014 LVEF of 45-50% 09/18 Continue home aspirin and statin, not on any beta-blocker due to bradycardia. Bladder cancer s/p radical cystoprostatectomy 3/2023 Diagnosed- 10/2022, follows with Dr. Pathology showed high grad erothelial carcinoma with squamous differentiation, muscularis propria involved by invasvie carcinoma Unable to tolerate chemo, no further neoadjuvant chemotherapy recommended per urology S/p radical cystoprostatectomy 3/2023 Currently on tecentriq q28 days, most recently treated 10/13 No plans for inpatient treatment Repeat surveillance scans per oncology team during inpatient stay, MRI brain negative. Seizure disorder Continue home Depakote 500 3 times daily Paroxysmal atrial fibrillation, POA Continue Eliquis Severe protein calorie malnutrition, POA BMI- 18 Nutrition consulted. Appreciate input. Hypokalemia K 3.4 Klor con ordered 11/27. Potassium up to 4.1 on day of discharge Patient seen and examined. Denies any major complaints. Was on room air at the time and had been tolerating. Had desaturation after evaluation. Home O2 evaluation ordered. Qualified for 2 L nasal cannula continuously. Case management assist with setting up home O2

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2728547

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 79,0
Geschlecht: F
Eingang: 29.12.2023
Impfdatum: 20.12.2022
Beginn: 24.10.2023
Tage bis Beginn: 308,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Atrial fibrillation Blood culture negative Blood lactic acid Blood pressure abnormal Constipation Culture urine negative Diuretic therapy Echocardiogram abnormal Ejection fraction normal COVID-19 Cardiac failure acute Chronic kidney disease Computerised tomogram thorax abnormal Condition aggravated Gout Hyperglycaemia Hypervolaemia

Symptomtext

Patient is a 80 y.o. female patient of MD with history of diastolic heart failure with severe TR and chronic pericardial effusion presented with lower extremity edema Sepsis, 10/30 possibly due to COVID-19, resolved Lactic acidemia, resolved MRSA swab negative. sputum urine and blood cultures. Negative CT CAP reviewed?no acute etiology identified. Status post 3 L bolus with some improvement in blood pressure. Lactic acid improved Consult ID for comanagement recommendation continue steroids, and remdesivir started on 11/1, patient finished remdesivir course on 11/5, patient had empirical cefepime course finished on 11/5 Cleared by ID from isolation on day of discharge Acute decompensation of diastolic heart failure. Bilateral extremity edema worse on the left side Severe pulmonary hypertension Severe tricuspid valve regurgitation Right-sided systolic dysfunction Pulmonary vascular congestion Echo 10/25 reviewed?EF 65%, diastolic function normal, RV severely enlarged and moderate systolic dysfunction, RV volume and pressure overload, severe TR and significant pulm hypertension. DVT ultrasound with no acute DVT Diuresed with IV Bumex and switched to torsemide. Patient required dobutamine drip this hospitalization Seen by cardiology no further recommendations at this time. Bumex 1mg BID Acute on Chronic hypoxic respiratory failure On 2 L at home. On 4L at discharge Wean off oxygen for saturation greater than 90 Chronic Afib with RVR On admission was rate controlled. Went into RVR 10/30 when she spiked a fever. Was on Cardizem drip briefly now discontinued due to low blood pressure. On metoprolol (at reduced dose) for Afib with additional midodrine due to hypotension Xarelto. Echo limited. Section fraction 60 to 65%, lung pressure 85 diabetes type 2 Hyperglycemia this hospitalization due to steroids Discharge insulin as below gout Continue on allopurinol. Ankle x-ray without any fracture. Moderate degeneration of the midfoot. CKD stage III 1.29 on discharge, at baseline Obstructive sleep apnea Resume home CPAP at 9 mmHg Constipation Laxatives as needed Stool softener

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 16,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2726830

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 22.12.2023
Impfdatum: 17.01.2023
Beginn: 01.10.2023
Tage bis Beginn: 257,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Bronchial secretion retention C-reactive protein increased COVID-19 Chest X-ray abnormal Computerised tomogram thorax abnormal Dyspnoea Endotracheal intubation Fibrin D dimer Hypoxia Impaired healing Insomnia Lung consolidation Lung infiltration Malaise Malnutrition Physical deconditioning Pleural effusion

Symptomtext

Patient is a 64 y.o. male patient of, MD with history of esophageal cancer s/p stent ( metastaic to liver, follows with dr), COPD, HTN, HLD, PAD, prostate cancer, DM2 and OSA ( on 2L o2 at home) , hx of Right ankle fracture ( s/p ORIF), and chronic pain ( on polypharmacy) with recurrent admissions for hypoxia and shortness of breath was brought to hospital rom home by family for another episode of shortness of breath and increased oxygen need. Of note, he was just admitted here from 9/20/23 to 9/29/23 for acute on chronic respiratory failure when he was intubated and was treated for Pseudomonas pneumonia and mucus plug. Acute on Chronic Hypoxemic Respiratory Failure Patient stated when he uses 2 L NC nightly And on and off 1 L during the day On admission was somnolent and hypoxic Somewhat improved with IV Narcan CT showed bibasilar infiltrates, concerning for aspiration Had a recent hospitalization for Pseudomonas PNA, completed 7-day course Was able to wean to 2 L NC ATC, based on predischarge O2 eval COVID-19 infection Covid-19 Virus Infection Date of onset of symptoms: 10/1/2023 Symptoms present on admission: Dyspnea, hypoxia Date of covid positive test: 10/1/2023 Vaccination status: vaccinated Imaging: CT chest - right lung and LLL consolidation, CXR-interstitial edema vs pneumonia, stable right pleural effusion Oxygen requirements on admission: 4 L Current oxygen requirements: 4 L Medical therapy: remdesivir and steroids Consultants following: Infectious disease Anticipated special isolation end date: 10/11/2023 CRP 109, D-dimer 2.79, ferritin 586 ID was consulted, DC to oral antibiotics Will complete 10 days of dexamethasone course COPD with continued tobacco use No evidence of exacerbation Continue nebulizer Reinforced smoking cessation DM2 Continue home medications Metastatic Adenocarcinoma of Esophagus Follows with Hem/onc Dr. He has hx of esophageal stenting at facility, denies dysphagia symptoms S/p hx of cycle 6 of FOLFOX therapy completion Resume OP f/u with dr as needed Prostate Cancer Follows with Urology On abiraterone and prednisone >change prednisone to stress doe, hold abiraterone while here Resume OP urology f/u Chronic pain Peripheral neuropathy Polypharmacy Continue home medications after discharge HLD Continue statin PAD Continue cilostazil, plavix and statin OSA Uses nocturnal 2L NC, Hx of R Ankle Fracture Follows with Dr. Hx of bimalleolar fx in May 2023, s/p ORIF with delayed healing and wound dehiscence C/w local care Physical deconditioning Insomnia Continue home medications after discharge Severe malnutrition POA Consult dietitian

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2716201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: MN
Alter: 81,0
Geschlecht: M
Eingang: 21.11.2023
Impfdatum: 04.02.2023
Beginn: 17.10.2023
Tage bis Beginn: 255,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Fall Pneumonia bacterial Pyrexia SARS-CoV-2 test positive Superinfection

Symptomtext

The patient was brought to the ED by EMS on 10/17/23 for evaluation of weakness and after a fall. In the ED he had a fever of 101.4 F. O2 sats were at 87% so patient was placed supplemental O2. A COVID PCR test resulted positive while the patient was in the ED. Ultimately, the patient was admitted 10/17/23 - 10/20/23 with discharge diagnoses including acute hypoxic respiratory failure due to COVID 19 pneumonia and suspected superimposed bacterial pneumonia, among other diagnoses. During admission, the patient was able to be weaned off oxygen. The patient has received the Pfizer Monovalent COVID vaccine (given 2/19/21; 3/11/21; 12/6/21) and the Pfizer Bivalent COVID vaccine (given 2/4/23).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2678234

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

kritisch

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 31.08.2023
Impfdatum: 24.01.2023
Beginn: 09.04.2023
Tage bis Beginn: 75,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/9/2023 ACUTE HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2663645

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: MN
Alter: 85,0
Geschlecht: M
Eingang: 31.07.2023
Impfdatum: 06.01.2023
Beginn: 05.06.2023
Tage bis Beginn: 150,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Cough Lethargy Pneumonia bacterial Pyrexia SARS-CoV-2 test positive Sepsis Superinfection

Symptomtext

The patient has a history of Parkinson's. He was seen in the ED on 6/5/23 after increasing cough, lethargy, weakness, and fever of 101 at home for the past few days. A COVID PCR test performed in the ED resulted positive. Ultimately, the patient was admitted 6/5/23 - 6/13/23. Discharge diagnosis include sepsis secondary to acute bacterial superimposed pneumonia and acute hypoxemic respiratory failure secondary to COVID-19 pneumonitis, among other diagnoses. During admission, he was started on dexamethasone and did require several liters of nasal cannula which was eventually weaned to room air. Of note, the patient has received the primary COVID-19 vaccine series and three boosters.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2659372

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 87,0
Geschlecht: M
Eingang: 21.07.2023
Impfdatum: 26.09.2022
Beginn: 11.02.2023
Tage bis Beginn: 138,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction

Symptomtext

ACUTE NON ST ELEVATION MI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2654339

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 10.07.2023
Impfdatum: 12.12.2022
Beginn: 14.03.2023
Tage bis Beginn: 92,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Depressed level of consciousness Encephalopathy Endotracheal intubation Essential hypertension Hypoxia Intensive care Pneumonia aspiration Pneumonia bacterial SARS-CoV-2 test positive Sepsis Septic shock Superinfection

Symptomtext

Patient is a 72 y.o. female with history of Lewy body dementia who presented from home on 3/14/2023 with acute hypoxemic respiratory failure and found to be COVID-positive with superimposed bacterial pneumonia. Patient had a prolonged hospital course due to acute on chronic encephalopathy, severe sepsis and aspiration pneumonia. She was intubated while in ICU, unable to wean. Family opted for DNR CC after GOC discussions with Palliative team. Patient was discharged to the inpatient hospice team at a local HCF. Acute hypoxic respiratory failure COVID infection Aspiration pneumonia Septic shock -Patient was admitted for hypoxemia and found to have COVID-positive infection. -Transferred to ICU, intubated. Hospital course was prolonged due to inability to wean, acute on chronic encephalopathy -Patient was extubated after extensive goals of care discussion with palliative team. Patient is currently DNR CC Lewy body dementia Acute on chronic encephalopathy -Known history, she is currently obtunded -Comfort meds in place Essential hypertension -She needed vasopressor support for septic shock while in ICU -Home Coreg held

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 24,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2651985

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 03.07.2023
Impfdatum: 05.12.2022
Beginn: 07.01.2023
Tage bis Beginn: 33,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Pulmonary embolism

Symptomtext

ACUTE PULMONARY EMBOLISM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2651570

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 81,0
Geschlecht: F
Eingang: 30.06.2023
Impfdatum: 06.12.2022
Beginn: 22.02.2023
Tage bis Beginn: 78,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Acute respiratory failure Symptom recurrence

Symptomtext

ACUTE ST ELEVATION MI, ANTERIOR WALL ACUTE NON ST ELEVATION MI ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/9/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2651468

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 63,0
Geschlecht: F
Eingang: 30.06.2023
Impfdatum: 07.12.2022
Beginn: 04.02.2023
Tage bis Beginn: 59,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction

Symptomtext

ACUTE NON ST ELEVATION MI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2651334

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 58,0
Geschlecht: M
Eingang: 30.06.2023
Impfdatum: 09.12.2022
Beginn: 09.02.2023
Tage bis Beginn: 62,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Deep vein thrombosis Obstructive sleep apnoea syndrome Pulmonary embolism

Symptomtext

ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE PULMONARY EMBOLISM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2650811

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 79,0
Geschlecht: F
Eingang: 29.06.2023
Impfdatum: 23.01.2023
Beginn: 10.03.2023
Tage bis Beginn: 46,0
Dosis: 5
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure

Symptomtext

ACUTE RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2650794

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 29.06.2023
Impfdatum: 27.01.2023
Beginn: 06.03.2023
Tage bis Beginn: 38,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Cerebrovascular accident

Symptomtext

ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2642841

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 08.06.2023
Impfdatum: 05.10.2022
Beginn: 04.12.2022
Tage bis Beginn: 60,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Cardiac failure End stage renal disease Glomerular filtration rate Hypertensive heart disease Hypertensive nephropathy Lower gastrointestinal haemorrhage

Symptomtext

J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/2/2023 HYPERTENSIVE HEART AND CKD, STAGE 5 (GFR < 15), W HEART FAILURE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 5/2/2023 LOWER GI HEMORRHAGE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2641724

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

kritisch

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 06.06.2023
Impfdatum: 11.01.2023
Beginn: 20.02.2023
Tage bis Beginn: 40,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Organ failure Pyrexia Sepsis

Symptomtext

ACUTE RESPIRATORY FAILURE 2/28/2023 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION ACUTE RESPIRATORY FAILURE 2/28/2023 HX OF ACUTE KIDNEY INJURY ACUTE RESPIRATORY FAILURE 2/28/2023 FEVER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2634526

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: SD
Alter: 65,0
Geschlecht: F
Eingang: 19.05.2023
Impfdatum: 08.12.2022
Beginn: 02.01.2023
Tage bis Beginn: 25,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Abscess drainage Ataxia Carotid artery stenosis Cerebral disorder Cerebral ischaemia Cerebral small vessel ischaemic disease Cerebrovascular accident Cognitive disorder Dizziness Echocardiogram abnormal Ejection fraction decreased Endocarditis Extradural abscess Impaired work ability Left atrial dilatation Left ventricular hypertrophy Loss of personal independence in daily activities Magnetic resonance imaging

Symptomtext

She had reported 3-4 weeks of dizziness and ataxia following her bivalent booster injection and she was having difficulty functioning and concerned she may lose her job. She presented to ED finally on Jan 26, 2023 with refractory neurologic symptoms and was found to have subacute stroke on MRI imaging. Subsequent in May 2023, she has now been admitted with refractory severe MSSA sepsis with endocarditis, meningitis, epidural abscess and persistently positive blood cx with new multifocal strokes. She has required epidural abscess drainage, long term antibiotics, vasopressor support, ventilatory support and will require heart valve replacement. Her long term prognosis is grimm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: EXAM: MRI BRAIN LIMITED WITHOUT CONTRAST INDICATION:Neuro deficit, acute, stroke suspected, Lightheadedness, ataxia ADDITIONAL INDICATION: none COMPARISON(S): None Available FINDING: There is tiny focus of restricted diffusion involving the dorsal right pontomedullary junction with corresponding decreased signal on the ADC map. This may represent a small acute infarct without hemorrhage or mass effect. There is mild chronic small vessel ischemic high signal on FLAIR imaging within the cerebral hemispheric white matter as well as within the pons. IMPRESSION: Small focus of restricted diffusion involving the dorsal right pontomedullary junction with corresponding decreased signal on the ADC map may represent a small acute infarct without hemorrhage or mass effect. Carotid duplex: 1. Bilateral internal carotid arteries demonstrate mild (less than 50%) stenosis. 2. Bilateral vertebral arteries are antegrade. Echo: Left Ventricle The left ventricle appears normal in size. There is mild concentric left ventricular hypertrophy. Normal left ventricular systolic function. The EF is visually estimated to be 60-65%. There are no wall motion abnormalities. Indeterminate diastolic function. Right Ventricle The right ventricle is mildly dilated. Systolic function is normal. Wall thickness is normal. The RVSP measures 41 mmHg. Left Atrium The left atrium is moderately dilated. Interatrial Septum No evidence of an atrial shunt by color Doppler or agitated saline. Right Atrium The right atrium is mildly dilated. Aortic Valve The aortic valve is tricuspid. Restricted valve cusp mobility. The cusps are thickened. The cusps are calcified. There is no regurgitation. There is moderate stenosis. Mitral Valve There is severe annular calcification. There is mild regurgitation. There is no evidence of mitral valve stenosis. Tricuspid Valve Tricuspid valve structure is normal. There is mild regurgitation. There is no evidence of tricuspid valve stenosis. Pulmonic Valve Pulmonic valve structure is normal. There is no regurgitation or stenosis. Aorta The sinus of Valsalva is normal. The ascending aorta is normal. IVC/SVC Normal IVC size with normal respirophasic changes. Pericardium There is no pericardial effusion.
Aktuelle Erkrankungen: None known.
Vorgeschichte: Hypothyroidism post thyroidectomy for thyroid cancer, Type 2 DM, colonic carcinoid tumor resection.
Andere Medikamente: Synthroid, glucotrol, glucophage, zocor, zyrtec, flonase, losartan, cymbalta, invokana.
Allergien: Keflex, peas, tree nuts, INH, pet dander.
Vorherige Impfungen: -

VAERS 2627523

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

kritisch

Staat: -
Alter: 62,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 13.05.2022
Beginn: 25.08.2022
Tage bis Beginn: 104,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Hypoxia

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624829

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

kritisch

Staat: -
Alter: 61,0
Geschlecht: M
Eingang: 02.05.2023
Impfdatum: 20.01.2022
Beginn: 24.04.2022
Tage bis Beginn: 94,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Symptom recurrence

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/24/2022 -- RECURRENCE OF SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2579640

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: CO
Alter: 83,0
Geschlecht: F
Eingang: 10.02.2023
Impfdatum: 03.02.2023
Beginn: 06.02.2023
Tage bis Beginn: 3,0
Dosis: 3
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Cyanosis Death Unresponsive to stimuli

Symptomtext

Received vaccine on 2/3/23 and then on 2/6/23 in am when up for breakfast was noted to cyanotic and unresponsive, was assisted into bed and passed away. There is no evidence that her death is related to vaccine other than timing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Left frontoparietal CVA on 12/27/22 with right sided hemiplegia
Vorgeschichte: Dementia, Depression, Hypertension, Hyperlipidemia, Coronary artery disease, chronic kidney disease, Anxiety, Macular degeneration
Andere Medikamente: Acetaminophen, Amlodipine, Artificial tears eye drops, Aspirin, Atorvastatin, Senna Plus
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2564473

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

kritisch

Staat: MA
Alter: 65,0
Geschlecht: F
Eingang: 24.01.2023
Impfdatum: 06.01.2023
Beginn: 07.01.2023
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Blood test Body temperature Chest X-ray Computerised tomogram Chest pain Headache Laboratory test abnormal Pain Electrocardiogram Laboratory test Pulmonary embolism Pyrexia SARS-CoV-2 test

Symptomtext

pain in my stomach area as well as chest area; two pulmonary embolism's in my right lung/ pain in my chest area; I developed a fever of 104 degrees along with a headache and body aches; I developed a fever of 104 degrees along with a headache and body aches; I developed a fever of 104 degrees along with a headache and body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 65-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Jan2023 at 11:55 as dose 4 (booster), single (Lot number: GJ6742) at the age of 65 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Single, Batch/lot number: Lot # FF2593, Anatomical Location: Arm Left), for COVID-19 Immunization; Bnt162b2 (DOSE 2, Single, Batch/lot number: Lot # ER8731 , Anatomical Location: Arm Left), for COVID-19 Immunization; Bnt162b2 (DOSE 3, Single, Batch/lot number: Lot # FF2593, Anatomical Location: Arm Left), for COVID-19 Immunization. The following information was reported: PYREXIA (hospitalization, medically significant, life threatening), HEADACHE (hospitalization, medically significant, life threatening), PAIN (hospitalization, medically significant, life threatening) all with onset 07Jan2023, outcome "unknown" and all described as "I developed a fever of 104 degrees along with a headache and body aches"; PULMONARY EMBOLISM (hospitalization, medically significant, life threatening) with onset 07Jan2023 at 20:00, outcome "recovering", described as "two pulmonary embolism's in my right lung/ pain in my chest area"; ABDOMINAL PAIN UPPER (hospitalization, medically significant, life threatening) with onset 09Jan2023, outcome "unknown", described as "pain in my stomach area as well as chest area". The patient was hospitalized for pulmonary embolism, pyrexia, headache, pain, abdominal pain upper (start date: 07Jan2023, discharge date: 09Jan2023, hospitalization duration: 3 day(s)). The events "two pulmonary embolism's in my right lung/ pain in my chest area" and "i developed a fever of 104 degrees along with a headache and body aches" required emergency room visit. The patient underwent the following laboratory tests and procedures: Blood test: (Jan2023) Unknown result; Body temperature: (07Jan2023) 104 Centigrade; Body temperature: (08Jan2023) 102; (09Jan2023) 102; (09Jan2023) 105, notes: Late afternoon my fever spiked to 105; Chest X-ray: (Jan2023) Unknown result; Computerised tomogram: (Jan2023) pulmonary embolism's in my right lung, notes: I had two pulmonary embolism's in my right lung; Electrocardiogram: (Jan2023) Unknown result; Tests: (Jan2023) Unknown result; SARS-CoV-2 test: (07Jan2023) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of pulmonary embolism, pyrexia, headache, pain. Clinical course: On 06Jan2023 at 11:55AM patient received her 4th Pfizer vaccine Bival booster Lot GJ6742 at the Withheld. On Saturday evening 07Jan2023 she developed a fever of 104 degrees along with a headache and body aches. She took some Advil and went to bed. On Sunday morning 08Jan2023 she had a fever of 102 with headache and body aches and continued with Advil. This continued. On Monday morning 09Jan2023 she had pain in my stomach area as well as chest area with a 102 fever and continued with Advil. Late afternoon her fever spiked to 105 and her husband took her to emergency room. She went through a series of tests, blood work, EKG, chest X-rays and a Catscan. Her Catscan found that she had two pulmonary embolisms in her right lung. She was admitted to the hospital for 3 days and treated, then discharged and put on medication for 6 months. She believed this last booster on 06Jan2023 was the cause of these blood clots and her hospitalization. Patient was treated with blood thinners and critical care. Patient had Nasal Swab COVID test type post vaccination, test name post vaccination. No known allergies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Test Date: 202301; Test Name: Blood work; Result Unstructured Data: Test Result:Unknown result; Test Date: 20230107; Test Name: Body temperature; Result Unstructured Data: Test Result:104 Centigrade; Test Date: 20230108; Test Name: Fever; Result Unstructured Data: Test Result:102; Test Date: 20230109; Test Name: Fever; Result Unstructured Data: Test Result:102; Test Date: 20230109; Test Name: Fever; Result Unstructured Data: Test Result:105; Comments: Late afternoon my fever spiked to 105; Test Date: 202301; Test Name: Chest X-rays; Result Unstructured Data: Test Result:Unknown result; Test Date: 202301; Test Name: Cat scan; Result Unstructured Data: Test Result:pulmonary embolism's in my right lung; Comments: I had two pulmonary embolism's in my right lung; Test Date: 202301; Test Name: EKG; Result Unstructured Data: Test Result:Unknown result; Test Date: 202301; Test Name: Tests; Result Unstructured Data: Test Result:Unknown result; Test Date: 20230107; Test Name: Test Result: Negative ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: other medical history: None known allergies: No
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2564473

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: MA
Alter: 65,0
Geschlecht: F
Eingang: 24.01.2023
Impfdatum: 06.01.2023
Beginn: 07.01.2023
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Blood test Body temperature Chest X-ray Computerised tomogram Chest pain Headache Laboratory test abnormal Pain Electrocardiogram Laboratory test Pulmonary embolism Pyrexia SARS-CoV-2 test

Symptomtext

pain in my stomach area as well as chest area; two pulmonary embolism's in my right lung/ pain in my chest area; I developed a fever of 104 degrees along with a headache and body aches; I developed a fever of 104 degrees along with a headache and body aches; I developed a fever of 104 degrees along with a headache and body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 65-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Jan2023 at 11:55 as dose 4 (booster), single (Lot number: GJ6742) at the age of 65 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Single, Batch/lot number: Lot # FF2593, Anatomical Location: Arm Left), for COVID-19 Immunization; Bnt162b2 (DOSE 2, Single, Batch/lot number: Lot # ER8731 , Anatomical Location: Arm Left), for COVID-19 Immunization; Bnt162b2 (DOSE 3, Single, Batch/lot number: Lot # FF2593, Anatomical Location: Arm Left), for COVID-19 Immunization. The following information was reported: PYREXIA (hospitalization, medically significant, life threatening), HEADACHE (hospitalization, medically significant, life threatening), PAIN (hospitalization, medically significant, life threatening) all with onset 07Jan2023, outcome "unknown" and all described as "I developed a fever of 104 degrees along with a headache and body aches"; PULMONARY EMBOLISM (hospitalization, medically significant, life threatening) with onset 07Jan2023 at 20:00, outcome "recovering", described as "two pulmonary embolism's in my right lung/ pain in my chest area"; ABDOMINAL PAIN UPPER (hospitalization, medically significant, life threatening) with onset 09Jan2023, outcome "unknown", described as "pain in my stomach area as well as chest area". The patient was hospitalized for pulmonary embolism, pyrexia, headache, pain, abdominal pain upper (start date: 07Jan2023, discharge date: 09Jan2023, hospitalization duration: 3 day(s)). The events "two pulmonary embolism's in my right lung/ pain in my chest area" and "i developed a fever of 104 degrees along with a headache and body aches" required emergency room visit. The patient underwent the following laboratory tests and procedures: Blood test: (Jan2023) Unknown result; Body temperature: (07Jan2023) 104 Centigrade; Body temperature: (08Jan2023) 102; (09Jan2023) 102; (09Jan2023) 105, notes: Late afternoon my fever spiked to 105; Chest X-ray: (Jan2023) Unknown result; Computerised tomogram: (Jan2023) pulmonary embolism's in my right lung, notes: I had two pulmonary embolism's in my right lung; Electrocardiogram: (Jan2023) Unknown result; Tests: (Jan2023) Unknown result; SARS-CoV-2 test: (07Jan2023) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of pulmonary embolism, pyrexia, headache, pain. Clinical course: On 06Jan2023 at 11:55AM patient received her 4th Pfizer vaccine Bival booster Lot GJ6742 at the Withheld. On Saturday evening 07Jan2023 she developed a fever of 104 degrees along with a headache and body aches. She took some Advil and went to bed. On Sunday morning 08Jan2023 she had a fever of 102 with headache and body aches and continued with Advil. This continued. On Monday morning 09Jan2023 she had pain in my stomach area as well as chest area with a 102 fever and continued with Advil. Late afternoon her fever spiked to 105 and her husband took her to emergency room. She went through a series of tests, blood work, EKG, chest X-rays and a Catscan. Her Catscan found that she had two pulmonary embolisms in her right lung. She was admitted to the hospital for 3 days and treated, then discharged and put on medication for 6 months. She believed this last booster on 06Jan2023 was the cause of these blood clots and her hospitalization. Patient was treated with blood thinners and critical care. Patient had Nasal Swab COVID test type post vaccination, test name post vaccination. No known allergies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Test Date: 202301; Test Name: Blood work; Result Unstructured Data: Test Result:Unknown result; Test Date: 20230107; Test Name: Body temperature; Result Unstructured Data: Test Result:104 Centigrade; Test Date: 20230108; Test Name: Fever; Result Unstructured Data: Test Result:102; Test Date: 20230109; Test Name: Fever; Result Unstructured Data: Test Result:102; Test Date: 20230109; Test Name: Fever; Result Unstructured Data: Test Result:105; Comments: Late afternoon my fever spiked to 105; Test Date: 202301; Test Name: Chest X-rays; Result Unstructured Data: Test Result:Unknown result; Test Date: 202301; Test Name: Cat scan; Result Unstructured Data: Test Result:pulmonary embolism's in my right lung; Comments: I had two pulmonary embolism's in my right lung; Test Date: 202301; Test Name: EKG; Result Unstructured Data: Test Result:Unknown result; Test Date: 202301; Test Name: Tests; Result Unstructured Data: Test Result:Unknown result; Test Date: 20230107; Test Name: Test Result: Negative ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: other medical history: None known allergies: No
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2560287

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: -
Alter: 37,0
Geschlecht: M
Eingang: 19.01.2023
Impfdatum: 04.01.2023
Beginn: 07.01.2023
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Angiogram Blood test Cerebrovascular accident Computerised tomogram Echocardiogram Aphasia Atrial septal defect Cerebral infarction Hypoaesthesia Magnetic resonance imaging head abnormal Intensive care Magnetic resonance imaging Neurological examination Scan with contrast Ultrasound Doppler Muscular weakness Neurological symptom Thrombolysis

Symptomtext

I saw this patient in consultation today, I am a hematologist. He is a young healthy firefighter with no comorbidities who had a viral type illness in late December 2022. Is likely influenza A as his children tested positive for this at the same time. On 1/4/2023 he underwent bivalent COVID booster vaccination(I do not know which one he received) at a different facility. 3 days later he presented to the local hospital with strokelike symptoms of aphasia right arm weakness and numbness. He underwent thrombolytic therapy with improvement in his symptoms. MRI of the brain done after thrombolytics was consistent with cerebral infarction. There was no obvious precipitating event. He was found to have a PFO. He was discharged from the hospital after unrevealing extensive hematologic work-up. He continues to improve in his symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: Possible influenza A 1-2 weeks prior.
Vorgeschichte: None.
Andere Medikamente: None.
Allergien: None.
Vorherige Impfungen: -

VAERS 2557783

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: WA
Alter: 89,0
Geschlecht: M
Eingang: 11.01.2023
Impfdatum: 09.12.2022
Beginn: 19.12.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death General physical health deterioration

Symptomtext

Decline in condition 12/11/2022 followed by death on 12/19/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: 11/18 P. mirabilis, E. faecalis detected in urine. Received fluoroquinolone ciprofloxacin for 5 days beginning 11/23-11/27. Rapid decline in weight occurred after this treatment.
Vorgeschichte: complete a/v block with pacemaker, vascular dementia, history of COVID-19 infection 8/23/2022, repeated falls, CKD Stage III, major depressive, disorder, paroxysmal tachycardia, hyperlipedemia, history of pulmonary embolism, histroy of remnal cancer with nephrectomy, asthma, chronic gout, BPH, anxiety disorder, obstructive sleep apnea, polyosteoarthritis
Andere Medikamente: latanoprost, rivaroxaban, zoloft, depakote, dorzololamide/timolol, NaCl tabs, cannabinoid liquid, halperidol, gatorade, trazodone, tylenol 3 grams daily, senna
Allergien: allopurinol, brimonidine, cephalexin, diclonefenac, etodolac, penicillin, piroxicam, prednisone, chocolate
Vorherige Impfungen: -

VAERS 2544257

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

kritisch

Staat: PA
Alter: 56,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 06.10.2022
Beginn: 01.11.2022
Tage bis Beginn: 26,0
Dosis: 4
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arterial occlusive disease B-cell lymphoma Disease recurrence Myocardial infarction SARS-CoV-2 test Scan

Symptomtext

heart attack on 16Dec2022; 2 blocked arteries; Diffuse B-Cell Lymphoma in Nov2022; Diffuse B-Cell Lymphoma in Nov2022; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient. A 56-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 56 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "B-Cell Lymphoma" (unspecified if ongoing); "Never smoked" (unspecified if ongoing). Concomitant medications included: ACCURETIC; TRINTELLIX; ADDERALL. Vaccination history included: BNT162b2 (dose number: 3, lot number: FC3180, in Right arm), administration date: 29Aug2021, when the patient was 55-year-old, for COVID-19 Immunization; BNT162b2 (dose number: 2, lot number: EN6203, in Left leg), administration date: 17Mar2021, when the patient was 54-year-old, for COVID-19 Immunization; BNT162b2 (dose number: 1, lot number: EN6203, in Left leg), administration date: 25Feb2021, when the patient was 54-year-old, for COVID-19 Immunization. The following information was reported: B-CELL LYMPHOMA (hospitalization, medically significant, life threatening), DISEASE RECURRENCE (hospitalization, medically significant, life threatening) all with onset Nov2022, outcome "recovered with sequelae" (Dec2022) and all described as "Diffuse B-Cell Lymphoma in Nov2022"; ARTERIAL OCCLUSIVE DISEASE (hospitalization, medically significant, life threatening) with onset 16Dec2022, outcome "recovered with sequelae" (Dec2022), described as "2 blocked arteries"; MYOCARDIAL INFARCTION (hospitalization, medically significant, life threatening) with onset 16Dec2022, outcome "recovered with sequelae" (Dec2022), described as "heart attack on 16Dec2022". The patient was hospitalized for b-cell lymphoma, disease recurrence, myocardial infarction, arterial occlusive disease (start date: 2022, discharge date: 2022, hospitalization duration: 3 days). The events "diffuse b-cell lymphoma in nov2022", "heart attack on 16dec2022" and "2 blocked arteries" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Negative; Scan: (2015) no calcifications were present at that time. Therapeutic measures were taken as a result of b-cell lymphoma, disease recurrence, myocardial infarction, arterial occlusive disease. Clinical course: The patient did not receive other vaccine in four weeks. The patient reported, "Diagnosed with Diffuse B-Cell Lymphoma in Nov2022. Then I had a heart attack on 16Dec2022. No previous history of heart disease. In 2015, had full body scan and no calcifications were present at that time. No problems with cholesterol, never smoked, blood pressure under control. Cardiologist cannot explain why this happened and in such a short time, I had 2 blocked arteries. I had two stents put in." Adverse event start date was on 16Dec2022 (as reported). Adverse event treatment included catheterization and stents, medication. The patient had no COVID prior vaccination and was tested for COVID post vaccination via nasal swab with negative result. The patient had no known allergies.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201393472 same patient/vaccine, different dose/event;US-PFIZER INC-202201393473 same patient/vaccine, different dose/event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 3,0
Labordaten: Test Name: Covid test; Test Result: Negative ; Test Date: 2015; Test Name: Body scan; Result Unstructured Data: Test Result:no calcifications were present at that time
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: B-cell lymphoma; Non-smoker
Andere Medikamente: ACCURETIC; TRINTELLIX; ADDERALL
Allergien: -
Vorherige Impfungen: -

VAERS 2543266

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

kritisch

Staat: OH
Alter: 73,0
Geschlecht: F
Eingang: 26.12.2022
Impfdatum: 11.12.2022
Beginn: 19.12.2022
Tage bis Beginn: 8,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Cerebrovascular accident

Symptomtext

Caregiver called and stated that patient had a stroke on 12/19/22 and was concerned it could be related to the vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2540783

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

kritisch

Staat: MA
Alter: 60,0
Geschlecht: M
Eingang: 22.12.2022
Impfdatum: 12.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

pt passed away on 12/13/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: neuropathy, hiv, hypertension, bph, anxiery
Andere Medikamente: elavil,biktarvy, buspar, clonidine, vit , duloxetine, hydroxyzine, lisinopril/hctz
Allergien: penicillin
Vorherige Impfungen: -

VAERS 2651976

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 03.07.2023
Impfdatum: 05.12.2022
Beginn: 20.02.2023
Tage bis Beginn: 77,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Epilepsy Obstructive sleep apnoea syndrome Partial seizures

Symptomtext

SIMPLE PARTIAL EPILEPSY, INTRACTABLE EPILEPSY, UNSPECIFIED OBSTRUCTIVE SLEEP APNEA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Partial seizures
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2651549

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: -
Alter: 78,0
Geschlecht: F
Eingang: 30.06.2023
Impfdatum: 06.12.2022
Beginn: 13.01.2023
Tage bis Beginn: 38,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Ischaemic stroke

Symptomtext

ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2598613

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: CO
Alter: 71,0
Geschlecht: F
Eingang: 17.03.2023
Impfdatum: 01.01.2023
Beginn: 02.03.2023
Tage bis Beginn: 60,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood pressure decreased Blood test COVID-19 Computerised tomogram Cough Dehydration Electrocardiogram Fatigue Insomnia Respiratory tract congestion SARS-CoV-2 test positive Syncope

Symptomtext

Started feeling a dry scratchy cough. Took a home COVID-19 test and was positive. Started getting better, then on March 6, 2023 I fainted and was taken to the emergency room as my blood pressure dropped. Was given a CT scan, EKG, blood panel, all inconclusive. Doctors thought it was either a symptom of COVID-19 or was dehydrated. Was released 5 hours later. Still have extreme fatigue, congested and insomnia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 03MAR2023 home COVID-19 test, positive; 06MAR2023 EKG inconclusive; CT scan inconclusive; 06MAR2023 Blood panel inconclusive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Past Diverticulitis
Andere Medikamente: SYNTHROID; multivitamin.
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2590565

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: ID
Alter: 19,0
Geschlecht: M
Eingang: 02.03.2023
Impfdatum: 24.02.2023
Beginn: 01.03.2023
Tage bis Beginn: 5,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time Bell's palsy Blood glucose Differential white blood cell count Discomfort Electrocardiogram abnormal Facial paralysis Full blood count Magnetic resonance imaging head normal Metabolic function test NIH stroke scale Prothrombin time SARS-CoV-2 test Sinus arrhythmia Sinus bradycardia Troponin I Urine analysis

Symptomtext

Patient presented to clinic on 24FEB2023 to receive vaccination of Encephalitis and Covid-19 Bivalent Booster (Pfizer BioNTech). Patient awoke on 01MAR2023 stating that he feels like the right side of his face was "heavy" and noted some facial droop on the right side. Patient was evaluated at the ER for tests and diagnosis to rule out other causes of symptoms. Patient was discharged with Bell's Palsy diagnosis after being evaluated by a neurologist and was instructed to follow up with his Primary Care Manager and have a referral to a neurologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Comprehensive Metabolic, PT-APTT, CBC with Differential, Troponin I, Covid-19 Test, Urinalysis (Macroscopic w/Microscopic if indicated) POCT Blood Glucose - All conducted and resulted on 03/01/2023 - no outstanding results. EKG Obtained - sinus bradycardia w/ marked sinus arrhythmia at 54 bpm. No STEMI criteria. MRI Brain Code Stroke without IV contrast - normal findings. NIH Stroke Score - 1 due to mild facial droop.
Aktuelle Erkrankungen: None Reported
Vorgeschichte: None reported
Andere Medikamente: None reported
Allergien: Tree Nuts
Vorherige Impfungen: -

VAERS 2588110

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: CA
Alter: 52,0
Geschlecht: F
Eingang: 28.02.2023
Impfdatum: 05.01.2023
Beginn: 07.01.2023
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Alopecia Balance disorder Blood pressure measurement Blood test Blood thyroid stimulating hormone Blood thyroid stimulating hormone increased Chest X-ray Decreased appetite Electric shock sensation Hypertension Hypoaesthesia Investigation Muscle discomfort Ocular hyperaemia Palpitations Paraesthesia Renal pain Swelling

Symptomtext

Pfizer Bivalent, Dose Number: 1; Right side swelling; Thyroid felt tight; TSH levels at 6.0; Heart racing Palpitations; High blood pressure; Kidney area felt weird; Electric type zaps; Muscles felt weird; Numbness toes; Loss of appetite; Thirsty; Off balance; Red eyes; Loosing hair; Vibrating feeling In arms and legs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 52-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Jan2023 at 16:00 as dose 1, single (Lot number: GJ6742) at the age of 52 years, in right arm for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history included: "Hashimotos" (unspecified if ongoing). There were no concomitant medications. The following information was reported: ELECTRIC SHOCK SENSATION (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Electric type zaps"; PALPITATIONS (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Heart racing Palpitations"; HYPERTENSION (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "High blood pressure"; RENAL PAIN (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Kidney area felt weird"; ALOPECIA (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Loosing hair"; DECREASED APPETITE (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Loss of appetite"; MUSCLE DISCOMFORT (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Muscles felt weird"; HYPOAESTHESIA (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Numbness toes"; BALANCE DISORDER (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Off balance"; OCULAR HYPERAEMIA (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Red eyes"; SWELLING (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Right side swelling"; BLOOD THYROID STIMULATING HORMONE INCREASED (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "TSH levels at 6.0"; THIRST (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Thirsty"; THYROID PAIN (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Thyroid felt tight"; PARAESTHESIA (non-serious) with onset 07Jan2023 at 12:00, outcome "recovering", described as "Vibrating feeling In arms and legs"; WRONG PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "Pfizer Bivalent, Dose Number: 1". The events "right side swelling", "thyroid felt tight", "tsh levels at 6.0", "heart racing palpitations", "high blood pressure", "kidney area felt weird", "electric type zaps", "muscles felt weird", "numbness toes", "loss of appetite", "thirsty", "off balance", "red eyes", "loosing hair" and "vibrating feeling in arms and legs" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of swelling, thyroid pain, blood thyroid stimulating hormone increased, palpitations, hypertension, renal pain, electric shock sensation, muscle discomfort, hypoaesthesia, decreased appetite, thirst, balance disorder, ocular hyperaemia, alopecia, paraesthesia. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Test Name: Blood pressure; Result Unstructured Data: Test Result:High; Test Name: bloodwork; Result Unstructured Data: Test Result:Unknown result; Test Name: TSH; Result Unstructured Data: Test Result:6.0; Test Name: Chest X-rays; Result Unstructured Data: Test Result:Unknown result; Test Name: monitor; Result Unstructured Data: Test Result:Unknown result; Test Name: ultrasound; Result Unstructured Data: Test Result:Unknown result
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hashimoto's disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2586992

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: CT
Alter: 47,0
Geschlecht: M
Eingang: 24.02.2023
Impfdatum: 19.01.2023
Beginn: 19.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Hypotension Loss of consciousness

Symptomtext

Patient became severe hypotensive and lightheaded and basically passed out

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Asked prior to vaccine if he was feeling sick today and was denied. Soon after reaction he did mention that he had a temp earlier in the week and was nauseous and vomiting. When looking at his lab results during apt. His pcp said he did appear dehydrated.
Vorgeschichte: HTN, NASH, OSA, Gout, fatty liver
Andere Medikamente: atorvastatin, irbesartan, metoprolol, Vit D
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2580715

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: PA
Alter: 36,0
Geschlecht: M
Eingang: 13.02.2023
Impfdatum: 06.02.2023
Beginn: 06.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Fatigue Loss of consciousness Syncope Tooth loss

Symptomtext

Patient fainted or passed out less than a minute after receiving vaccine. Heard him asking to get help. Verified patient was not having an anaphylactic reaction. Patient had lost some teeth when he hit the floor. Technician called emergency response number. Pharmacist sat with patient until they arrived. Patient stated he still felt dizzy and tired. When paramedics arrived they evaluated him, but he refused to go with them. His fiance came and they were going to the hospital on their own. Pharmacist called patient two days later, and he stated he felt much better, and that he went to the hospital that day to get evaluated and was told he was ok.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2567861

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

schwer

Staat: NJ
Alter: 50,0
Geschlecht: M
Eingang: 01.02.2023
Impfdatum: 24.01.2023
Beginn: 25.01.2023
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Body height Loss of consciousness Syncope Weight Head injury

Symptomtext

Passed out; fainting; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 50-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 24Jan2023 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 50 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Primary immunization complete; Manufacturer unknown), for Covid-19 Immunization. The following information was reported: LOSS OF CONSCIOUSNESS (medically significant) with onset 25Jan2023, outcome "recovered", described as "Passed out"; SYNCOPE (medically significant) with onset 25Jan2023, outcome "recovered", described as "fainting". The patient underwent the following laboratory tests and procedures: Body height: About 5 feet 8 inches, notes: Patient Height: About 5 feet 8 inches; Weight: About 160, notes: Patient Weight: About 160 pounds. Clinical course: Caller wants to know if passing out after receiving the Vaccine has been reported. No information on how long after receiving the vaccine, the patients have been fainting was found. Had the vaccine two days ago. Two nights ago he woke up and was going to the bathroom and passed out in the bathroom. Never passed out before. Passed Out and it only happened once. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Test Name: Height; Result Unstructured Data: Test Result:About 5 feet 8 inches; Comments: Patient Height: About 5 feet 8 inches; Test Name: Weight; Result Unstructured Data: Test Result:About 160 lbs; Comments: Patient Weight: About 160 pounds
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other Conditions: No
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2570006

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: MN
Alter: 67,0
Geschlecht: M
Eingang: 29.01.2023
Impfdatum: 23.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 4,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram cerebral abnormal Anticoagulant therapy Arteriogram carotid abnormal Arteriosclerosis Blood creatinine normal Blood fibrinogen normal Blood thyroid stimulating hormone normal Carotid arteriosclerosis Coagulation test normal Computerised tomogram Computerised tomogram head normal Echocardiogram Electrocardiogram normal Electrophoresis protein normal Gait disturbance Glycosylated haemoglobin normal Haemoglobin normal Hypoaesthesia

Symptomtext

Admitted to the hospital with symptoms consistent with an acute ischemic stroke on 1/28/23. On 1/25 or 1/26 he noticed intermittent blurry vision, primarily with near vision (did not have difficulty driving to the HCF on 1/28). On 1/27 at 8pm, he developed acute onset tongue numbness, a feeling that his L face was rubbery, and L UE/LE weakness and numbness, primarily in his hand and leg. Noticed it was harder to lift his L leg to walk but was still able to. Looked on the internet 1/28 and was concerned about a stroke, so he drove to the ED and walked unassisted inside. On admission on 1/28, reported that his weakness/numbness is improving but not resolved. Exam notable for tongue protrusion w/ R deviation, SILT in all extremities but decreased on L UE/LE, strength 5/5 R UE/LE and 4/5 L UE/LE, no pronator drift, FNF wnl. ASA and plavix loaded in the ED, seen by neuro and discussed with cardiology. Remains admitted undergoing stroke work-up, including ICD interrogation, TTE, and repeat CT. Unfortunately, this HCF does not do MRIs in patients with ICDs. Currently on a heparin drip and home medications except aspirin, with final plan to be decided 1/30.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: -
Labordaten: Labs in ED and from 1/23 notable for TSH wnl, LDL 58, A1c 5.3, PSA 0.75, SPEP wnl, Hb 14.8 (b/l 14s-14s), Cr 0.8 (b/l 0.8), trop neg, coags/fibrinogen wnl, and COVID/flu/RSV PCRs neg. CTH unremarkable, CTA head/neck w/ calcified prox ICAs and R intracranial vertebral artery but no hemodynamically significant stenosis or LVO. EKG w/ NSR, QTc 424.
Aktuelle Erkrankungen: None
Vorgeschichte: Coronary artery disease with multiple stents, history of myocardial infarction complicated by ventricular fibrillation cardiac arrest in 2004, COPD, HFrEF with recovered EF, MGUS, h/o prostate cancer in remission after XR therapy, h/o paroxsymal afib
Andere Medikamente: Albuterol inhaler, aspirin, atorvastatin, carvedilol, lisinopril, mirtazapine, olodaterol/tiotropium inhaler
Allergien: No allergies
Vorherige Impfungen: Causative agent: PNEUMOCOCCAL VACCINE Nature of Reaction: Unknown Signs/symptoms: INFLUENZA-LIKE ILLNESS Drug C

VAERS 2566318

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: OR
Alter: 50,0
Geschlecht: F
Eingang: 23.01.2023
Impfdatum: 19.01.2023
Beginn: 20.01.2023
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Feeling hot Hypoaesthesia oral Immunisation reaction Impaired driving ability Seizure

Symptomtext

PATIENT REPORTED TO PHARMACY ON 1/23/2023 STATING SHE HAD A REACTION TO HER THIRD BOOSTER WHICH SHE RECEIVED THURSDAY. SHE REPORTS FEELING DIZZY WHILE DRYING HER CAR AT A CAR WASH AND THEN WOKE UP IN THE ER. SHE REPORTS THAT A BYSTANDER SAW HER AND SHE HAD A SEIZURE FOR ~ 6 MINUTES. SHE REPORTS HER BOTTOM LIP BEING NUMB (AND STILL IS). SHE REPORTED A WARM SENSATION TO TOUCH ON THE ARM AFTER ADMINISTRATION.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: PATIENT WENT TO THE ER. UNSURE WHAT WAS DONE THERE.
Aktuelle Erkrankungen: STATES NONE
Vorgeschichte: NOTHING NOTED ON PRESCRIPTION FILE OR GIVEN AT TIME OF VACCINATION WHEN PROMPTED
Andere Medikamente: RECENT USE OF OXYCODONE/APAP 7.5MG/325MG (~75 DAYS), RECENT USE OF DULOXETINE 60MG (~75 DAYS), RECENT USE OF HYDROXYZINE HCL 25MG (~75 DAYS). NOTHING ELSE DISCLOSED TO PHARMACY
Allergien: NSAIDS
Vorherige Impfungen: -

VAERS 2565180

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: IN
Alter: 18,0
Geschlecht: M
Eingang: 22.01.2023
Impfdatum: 22.01.2023
Beginn: 22.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Fall Hyperhidrosis Immediate post-injection reaction Loss of consciousness Skin discolouration

Symptomtext

Almost immediately after receiving both vaccinations, patient stayed seated and put his head in his hands. He said he was feeling dizzy. I told him to stay seated. About 30 seconds later he fell back against the wall. He woke up after about 10 seconds and I had him lie down. He was gray looking and very sweaty. I gave him water and put a cold towel on his head. He started feeling better after about 10 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: No test or labs were taken
Aktuelle Erkrankungen: No known
Vorgeschichte: No
Andere Medikamente: Unknown
Allergien: No known
Vorherige Impfungen: dizziness/lightheadedness

VAERS 2562336

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: NE
Alter: 76,0
Geschlecht: M
Eingang: 18.01.2023
Impfdatum: 17.12.2022
Beginn: 07.01.2023
Tage bis Beginn: 21,0
Dosis: 4
Route/Site: - / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Computerised tomogram Echocardiogram Ischaemic stroke Magnetic resonance imaging

Symptomtext

ischemic stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: 5,0
Labordaten: mri ecco ct scan
Aktuelle Erkrankungen: nonehypeten
Vorgeschichte: hypertension copd pancreatitis
Andere Medikamente: simvastatin meloxicam doxazosin aspirin lisinopril metoprolol tartrate fish oil
Allergien: none
Vorherige Impfungen: -

VAERS 2560632

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

schwer

Staat: NC
Alter: -
Geschlecht: F
Eingang: 18.01.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood pressure measurement Body temperature Dizziness Electrocardiogram Fall Chills Diarrhoea Hypotension Heart rate Heart rate increased Investigation Lymphadenopathy Pain Presyncope Pyrexia

Symptomtext

dizziness; low Blood pressure; elevated heart rate; fever; diarrhea; chills; swollen lymph glands; achy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: DIZZINESS (hospitalization, medically significant), outcome "unknown"; HYPOTENSION (hospitalization, medically significant), outcome "unknown", described as "low Blood pressure"; HEART RATE INCREASED (hospitalization, medically significant), outcome "unknown", described as "elevated heart rate"; PYREXIA (non-serious), outcome "not recovered", described as "fever"; DIARRHOEA (non-serious), outcome "not recovered", described as "diarrhea"; CHILLS (non-serious), outcome "not recovered"; LYMPHADENOPATHY (non-serious), outcome "not recovered", described as "swollen lymph glands"; PAIN (non-serious), outcome "not recovered", described as "achy". The events "dizziness", "low blood pressure" and "elevated heart rate" required emergency room visit. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: Low, notes: low Blood pressure; Electrocardiogram: Unknown results, notes: EKG performed in ambulance and at hospital; Heart rate: elevated. Clinical course: Received a Pfizer bivalent booster after 3 previous doses of Comirnaty. 17 minutes later had dizziness, low Blood pressure, and elevated heart rate. Walked back to pharmacist and laid down. Pharmacist took blood pressure and heart rate and called ambulance and taken to Hospital. EKG performed in ambulance and at hospital. Patient was sent home and then had fever chills swollen lymph glands achy and diarrhea. Event took place after use of product. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Test Name: blood pressure; Result Unstructured Data: Test Result:Low; Comments: low Blood pressure; Test Name: EKG; Result Unstructured Data: Test Result:Unknown results; Comments: EKG performed in ambulance and at hospital.; Test Name: heart rate; Result Unstructured Data: Test Result:elevated
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2561135

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: IN
Alter: 44,0
Geschlecht: M
Eingang: 16.01.2023
Impfdatum: 15.12.2022
Beginn: 06.01.2023
Tage bis Beginn: 22,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram abnormal Angiogram cerebral abnormal Aphasia Carotid artery dissection Cerebral artery occlusion Cerebral artery stent insertion Cerebral artery thrombosis Computerised tomogram head abnormal Computerised tomogram neck Hemiparesis Thromboembolectomy

Symptomtext

Jan 6th 230 am awoke with new onset right sided weakness from foot through right arm. Also, developed partial aphasia. After arriving to er, CT?s showed high Lt internal carotid dissection and complete Lt M1 branch thrombus occlusion. Neurosurgeon started emergent stent placement to fix the dissection and embolectomy of thrombus from M1 to distal M2 branch. All this was completed by 630 to 7 am. Fortunately, once I recovered from anesthetic I felt like most prior symptoms were completely gone. I was discharged from the hospital on 1-8-23 light duty for the next 4.5 weeks until f/u with neuro.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral artery thrombosis
Hospital-Tage: 3,0
Labordaten: Cta head and neck Cerebral angiogram
Aktuelle Erkrankungen: Sinus infection Slight muscle strain
Vorgeschichte: None
Andere Medikamente: Melatonin 5mg qd Lexipro 10mg qd Cialis 20mg as needed Medral dose pack
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2560123

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

schwer

Staat: SC
Alter: 79,0
Geschlecht: M
Eingang: 14.01.2023
Impfdatum: 04.01.2023
Beginn: 05.01.2023
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Chills Head injury Loss of consciousness Vomiting

Symptomtext

27 hours later developed chills. around 30 hours after vaccination vomiting. headed to urgent care and passed out and hit head. went to hospital and admitted thursday and left sunday. no significant findings other that reaction to vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: none known
Vorgeschichte: diabetes
Andere Medikamente: -
Allergien: penicillins
Vorherige Impfungen: -

VAERS 2557972

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: -
Alter: 31,0
Geschlecht: F
Eingang: 11.01.2023
Impfdatum: 03.12.2022
Beginn: 03.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Headache Syncope

Symptomtext

Pt had a syncopal event. Vitals:123/82,92,16, O2 Sat 100% When sitting, pt denies dizziness. 14:05 108/68,78,18,100% no unusual symptoms or sensation. 14:10 c/o of having slight dizziness. Pt remains sitting in bed 123/72,106,18,100% 14:17 122/74,99,18, 100%. Claims HA is almost gone. Pt stable and released from vaccination site to home w/ husband

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: PMH: Hx of Chemotherapy for Breast CA -Last treatment 6mos prior to vaccination
Andere Medikamente: None KNown
Allergien: Egg
Vorherige Impfungen: -

VAERS 2557582

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: IL
Alter: 49,0
Geschlecht: M
Eingang: 11.01.2023
Impfdatum: 07.01.2023
Beginn: 07.01.2023
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bradycardia Dizziness Flushing Hyperhidrosis Hypotension Presyncope

Symptomtext

Systemic: Dizziness / Lightheadness-Medium, Systemic: Bradycardia-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Additional Details: After receiving vaccine, pt was sitting in waiting room; then family member alerted nurse that pt was feeling dizzy. Nurse & NP assessed pt; pt was alert, awake, conversant, diaphoretic, pulse in 40-50s, with low BP. Pt had vasovagal response, without syncope. Pt recovered after a few minutes & reported that he always has anxiety with needles/vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2556226

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

schwer

Staat: WA
Alter: 27,0
Geschlecht: F
Eingang: 10.01.2023
Impfdatum: 04.01.2023
Beginn: 05.01.2023
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Discomfort Feeling hot Loss of consciousness Middle insomnia Presyncope Stress Syncope

Symptomtext

Felt very hot and fainted shortly after waking in the night, lost consciousness for several minutes, and struggled to get back up without help for about 20 minutes after regaining consciousness. Was able to stand again after resting, cooling, and consuming water. Voluntarily visited an urgent care facility for evaluation as no other walk-in clinic was open. Nearly fainted again while sitting in waiting area and needed to lie down. Vitals and other test results were normal. Diagnosed as vasovagal syncope potentially relating to stress and discomfort from more typical vaccine side effects and instructed to hydrate and rest. Left clinic and suffered no further events after 8-9am.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Estradiol Valerate Progesterone
Allergien: Acetaminophen
Vorherige Impfungen: -

VAERS 2553374

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: MI
Alter: 20,0
Geschlecht: F
Eingang: 08.01.2023
Impfdatum: 04.01.2023
Beginn: 04.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Immediate post-injection reaction Loss of consciousness Unresponsive to stimuli

Symptomtext

Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient passed out 30 seconds after vaccine while walking away. 911 called and first responders took her to hospital. Patient in early 20's. Parents were notified or incident and trip to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2553057

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: -
Alter: 72,0
Geschlecht: F
Eingang: 07.01.2023
Impfdatum: 07.12.2022
Beginn: 07.01.2023
Tage bis Beginn: 31,0
Dosis: 6
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram normal Computerised tomogram abdomen normal Computerised tomogram head abnormal Computerised tomogram thorax normal Ischaemic stroke Mechanical ventilation Somnolence Weaning failure

Symptomtext

Patient was found down by neighbor. Brought to hospital and found to have ischemic stroke of left thalamus and basal ganglia per Head CT. CTA was performed and did not show any evidence of occlusion. CT chest/abd/pelvis was performed and negative for any metastases. Patient is still drowsy and unable to be taken off the ventilator.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2551432

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: WA
Alter: 64,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 28.12.2022
Beginn: 29.12.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Aphasia Dysphagia Dyspnoea Ear pain Facial pain Fatigue Glossodynia Headache Lymphadenopathy Musculoskeletal stiffness Obstructive airways disorder Oesophageal disorder Oropharyngeal pain Pain SARS-CoV-2 test negative Streptococcus test negative Symptom recurrence Throat tightness

Symptomtext

29DEC2022 I woke up with a sore throat. Progressively got really really bad. I was tired, had difficulty breathing, throat tightness, tongue paralyzed, and I couldn't talk. I went to urgent care on 31DEC2022 and was given 2 tablets of dexamethasone 8mg. I was feeling like I was on the mend and then when the drug wore off about 24 hours later and then I started to get tired again and in a lot of pain. The symptoms came back like 10 times worse with extremely stiff neck, extremely swollen lymph nodes, very sore throat, very painful tongue, pain in my teeth, face, inner ears, and headache on left side. My airway was only 50%. My esophagus was barely open and I could barely swallow a tiny bit of water. The pain was very great and throbbing. I wasn't able to talk for like two days. Most all of symptoms were on my left side. Then I was taken to the emergency room on 02JAN2023. The doctor's name and number is reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tongue paralysis
Hospital-Tage: -
Labordaten: 31DEC2022 COVID-19 negative; 31DEC2022 Strep throat negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Vitamin D; fish oil; magnesium; MSM
Allergien: Penicillin; morphine; tramadol; gluten; dairy
Vorherige Impfungen: -

VAERS 2548775

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

schwer

Staat: CA
Alter: 41,0
Geschlecht: M
Eingang: 03.01.2023
Impfdatum: 30.12.2022
Beginn: 30.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Fall Flushing Hyperhidrosis Loss of consciousness Syncope Tremor Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild, Additional Details: Patient states he got dizzy and suddenly blacked out. He fell over from his chair, shaking, and sweating. We helped him up and he being responsive again immediately. Had patient sit at the pharmacy for 30-40 minutes to monitor patient. Had him drink water and cranberry juice and he states that it helped his lightheadedness go away. He became fine after 30-40 mins of observation. I will be calling patient back the next day to check up on him

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2547271

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: CA
Alter: 22,0
Geschlecht: M
Eingang: 30.12.2022
Impfdatum: 07.12.2022
Beginn: 07.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Syncope

Symptomtext

Pt had a TBI 4 months ago playing football. He also gave a history of syncope with previous injections, as he had received multiple Metamizole injections in the past with syncope. After vaccination patient experienced syncope in few mints. We helped the patient to be stable and send him out emergency department for further evaluation and care. At ED his diagnosis was vasovagal syncope. No further workup. No meds. In follow-up by a provider for vaccination site staff the next day, he was stable and was advised to establish primary care , to have a full assessment. Also, advised to seek medical attention if he experience any concerning symptoms. patient was released from the emergency department in stable condition with no adverse reaction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: history of syncope with previous injections,

VAERS 2546341

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: WV
Alter: 26,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 29.12.2022
Beginn: 29.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Adverse Event: patient fainted after receiving third vaccination. She received adacel and fluzone quad in left arm and then pfizer bivalent in right arm. Treatment: Caught patient when she was falling out of chair and gently laid her on the floor. She came back to consciousness within about 5-10 seconds. We provided her with water and orange juice and also gave her an ice pack. We had her remain at the pharmacy until she was feeling better. Outcome: patient recovered and said she was feeling ok within about 15 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2541111

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: CA
Alter: 16,0
Geschlecht: M
Eingang: 22.12.2022
Impfdatum: 22.12.2022
Beginn: 22.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncopal episode

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: None
Vorgeschichte: Generalized Anxiety Disorder
Andere Medikamente: Sertraline
Allergien: None
Vorherige Impfungen: -

VAERS 2540744

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: GA
Alter: 49,0
Geschlecht: M
Eingang: 22.12.2022
Impfdatum: 07.12.2022
Beginn: 17.12.2022
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anion gap Blood calcium decreased Blood creatine phosphokinase normal Blood lactic acid Carbon dioxide decreased Condition aggravated Endotracheal intubation Laboratory test abnormal Seizure White blood cell count increased

Symptomtext

Resident had seizure activity on 12/17/22 with several seizures during the day. at 4 pm he had a seizure that wouldn't stop and was given Ativan IM and seizure stopped. At 1700 he had another seizure and Ativan was given IM but seizure continued. EMS was called and they started an IV, intubated him and gave meds and took him to the hospital . He has had a seizure 2 days after getting his 1st Pfizer COVID vaccine on 3/25 LOT # fm0698 and was sent to the ED and came back the same day. His 2nd COVID vaccine was given on 6/29/22 lot# FP7135 and didn't have a seizure until 7/28/22. He was sent to the ED and came back within 24 hours. He was given Flu vaccine afluria lot # as3615b on 11/4 and had a seizure on 11/7/22. He was not sent out the the ED at that time. He does have a history of breakthrough seizures but it seems that every time he has gotten a vaccine, he had a seizure. Our MD wanted me to report this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 6,0
Labordaten: Test done in hospital on 12/17 (Adnomral results) WBC 20.5, lactic acid 3.7, CPK 70, CO2 11, Calcium 7.9, Annon gap 23.0.
Aktuelle Erkrankungen: Upper Respiratory Infection 11/14/22 Augmentin 875/125mg BID x 7 days and Cetirizine 10 mg QD x 7 days
Vorgeschichte: Epilepsy, Dysphagia, Seizures, Autistic
Andere Medikamente: Keppra 1000 mg BID, lamotrigine 150 Q PM, Lamotrigine 200 mg Q AM, Multivitamin QD, Ativan IM PRN for seizures, zonisamide 400 mg Q HS, trazadone 25 mg Q AM, acetaminophen 650 mg PRN
Allergien: NKA
Vorherige Impfungen: See note in section 18

VAERS 2536094

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

schwer

Staat: CA
Alter: 82,0
Geschlecht: F
Eingang: 17.12.2022
Impfdatum: 12.12.2022
Beginn: 12.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Balance disorder Chest pain Dizziness Fatigue Loss of consciousness Malaise Nausea Nervousness Pain in jaw Vomiting

Symptomtext

Four hours after getting the shot on 12/12/22 I felt unwell and upon awakening the following morning was desperately unwell with jaw and chest pain, and unsteadiness, which culminated in dizziness and passing out on the floor. While coming-to I was nauseous and vomiting. The Person who found me called for help and by the time the nurse arrived I was able to get up and into a chair though weak and shaky. I am still somewhat weak today with heavy fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: heart failure, trigeminal neuralgia
Andere Medikamente: metoprolol, lasix, gabapentin
Allergien: Nsaids
Vorherige Impfungen: 3/5/2021 Moderna Covid

VAERS 2533454

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

schwer

Staat: CO
Alter: 18,0
Geschlecht: M
Eingang: 15.12.2022
Impfdatum: 15.12.2022
Beginn: 15.12.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blindness Heart rate decreased Hyperhidrosis Pallor Syncope

Symptomtext

pt fainted for less than 30 seconds and then came to. he was diaphoretic, pale and reported a complete loss of vision. I was having a hard time getting a blood pressure and pulse was very faint. Pt was alert after fainting episode and answered all questions appropriately. 911 called for pt to be evaluated, pt declined ambulance. Father came to pick him up

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: none
Allergien: hazel nuts
Vorherige Impfungen: -

VAERS 2522231

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

schwer

Staat: WV
Alter: 71,0
Geschlecht: F
Eingang: 02.12.2022
Impfdatum: 02.12.2022
Beginn: 02.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Loss of consciousness

Symptomtext

patient passed out after receiving the flu shot and covid booster. we moved her to the floor and bent her knees, and she started to come to

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2727374

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: -
Alter: 70,0
Geschlecht: M
Eingang: 26.12.2023
Impfdatum: 13.12.2022
Beginn: 16.10.2023
Tage bis Beginn: 307,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia Blood lactic acid increased COVID-19 Cerebral atrophy Cerebral small vessel ischaemic disease Chest X-ray normal Cognitive disorder Condition aggravated Diabetic neuropathy Gait disturbance Glycosylated haemoglobin increased Hypophagia Hypovolaemia Lactic acidosis Magnetic resonance imaging head abnormal Memory impairment Nausea SARS-CoV-2 test positive

Symptomtext

Patient is a 71 y.o. male with a history of T2DM, HTN, depression, who presented to hospital on 10/16/2023 for nausea/vomiting, severe generalized weakness. Found COVID+ without respiratory distress or hypoxia, symptoms improved with supportive care and Paxlovid initiated given high-risk with age/co-morbidities. 1. COVID-19 infection: Test positive 10/16/23, with symptoms starting 10/14/23. High-risk with age and co-morbidities. Last bivalent booster 12/2022. Not hypoxic. CXR on admit without significant infiltrates. ID followed via e-consult: recommended Paxlovid course initiated 10/17/23 (held atorvastatin for now, restart when Paxlovid complete). Rest of course prescribed at discharge. 2. Nausea/vomiting: Suspect related to COVID infection as reportedly similar to prior presentation in 2020. Gastroparesis could be considered. Improved with PRN anti-emetics and supportive care. Tolerated diet prior to discharge. 3. Generalized weakness: Likely due to COVID and poor PO. PT/OT evaluated. 4. Lactic acidosis: Lactate 2.7 on admit. Suspect from hypovolemia due to N/V. Resolved. 5. T2DM: Last A1C 7.5% in 7/2023. Home regimen Lantus alone at 50 units at bedtime. Continued reduced basal dose while acutely ill with poor PO intake, plus SSI. Back to home regimen at discharge with reduced basal insulin dosing until back to regular PO intake. 6. HTN: Reports on home amlodipine, lisinopril, Toprol (fill history without amlodipine or lisinopril). Continued home meds. 7. Peripheral neuropathy: Suspected due to diabetes. Saw Neuro 8/29/23, felt that neuropathy was contributing to his ongoing gait imbalance. 8. Cognitive impairment: Recently also saw Neuro for memory issues. MRI brain 9/2/2023 showed global cerebral volume loss, chronic microvascular changes. Pending outpatient Neuropsych eval.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2700545

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: AZ
Alter: 61,0
Geschlecht: F
Eingang: 23.10.2023
Impfdatum: 08.12.2022
Beginn: 15.10.2023
Tage bis Beginn: 311,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

COVID-19 Chest X-ray normal Diarrhoea Dyspnoea Haematology test normal Hypoxia Metabolic function test normal Nausea SARS-CoV-2 test positive Vomiting

Symptomtext

no adverse event related to the vaccine, but patient was admitted to the Adult Care Unit for COVID-related issues on 10/15/2023. Presented to the ED the same day for chief complaints of nausea, vomiting, diarrhea that began the night before. From ED physician note: This is a 62-year-old female with a history of borderline diabetes and obesity who is presenting with nausea, vomiting and diarrhea starting last night, as well as shortness of breath which she states is actually more of a chronic issue. She was found to be hypoxic to the mid 80s on room air, COVID-positive. X-ray shows no evidence of lobar pneumonia. She does not appear to be systemically ill or toxic. She has a completely benign abdominal examination with no major metabolic or hematologic abnormalities. I do not suspect an acute intra-abdominal process that would warrant a CT scan at this time. Likewise I do not suspect an alternative acute cardiac or pulmonary process. As mentioned above she was placed on 2 L nasal cannula, with oxygen saturations now in the mid 90s. Given her COVID?19 and hypoxia she will need to be admitted to the hospital for further care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 3,0
Labordaten: see above
Aktuelle Erkrankungen: unknown
Vorgeschichte: cerebellar degeneration unsteady gait HPV infection incontinence spinal stenosis hyperopia with regular astigmatism and presbyopia, bilateral ASCUS of cervix with negative high risk HPV ophthalmoplegia borderline type 2 diabetes obesity
Andere Medikamente: unknown
Allergien: NKA listed in medical record
Vorherige Impfungen: -

VAERS 2684622

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

moderat

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 21.09.2023
Impfdatum: 06.12.2022
Beginn: 05.04.2023
Tage bis Beginn: 120,0
Dosis: 4
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Dependence on respirator End stage renal disease Hydronephrosis Hypotension Respiratory failure Sepsis

Symptomtext

I95.9 HYPOTENSION 6/24/2023 ESRD (END STAGE RENAL DISEASE) J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 ESRD (END STAGE RENAL DISEASE) I95.9 HYPOTENSION 6/24/2023 ESRD (END STAGE RENAL DISEASE) J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 ESRD (END STAGE RENAL DISEASE) I95.9 HYPOTENSION 6/24/2023 SEPSIS WO ACUTE ORGAN DYSFUNCTION J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 SEPSIS WO ACUTE ORGAN DYSFUNCTION I95.9 HYPOTENSION 6/24/2023 RESPIRATOR DEPENDENCE J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 RESPIRATOR DEPENDENCE I95.9 HYPOTENSION 6/24/2023 HYDRONEPHROSIS J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 HYDRONEPHROSIS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2677556

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

moderat

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 29.08.2023
Impfdatum: 06.10.2022
Beginn: 25.03.2023
Tage bis Beginn: 170,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Aortic arteriosclerosis Hypotension

Symptomtext

I95.9 HYPOTENSION 3/26/2023 ATHEROSCLEROSIS OF AORTA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2673013

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

moderat

Staat: -
Alter: 53,0
Geschlecht: M
Eingang: 17.08.2023
Impfdatum: 04.04.2023
Beginn: 06.04.2023
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Hypotension

Symptomtext

I95.9 HYPOTENSION 4/27/2023 CHEST PAIN.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2647884

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

moderat

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 21.06.2023
Impfdatum: 17.06.2022
Beginn: 25.03.2023
Tage bis Beginn: 281,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Hypertension Obstructive sleep apnoea syndrome Transient ischaemic attack

Symptomtext

G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/25/2023 HTN (HYPERTENSION) G47.33 ADULT OBSTRUCTIVE SLEEP APNEA 4/17/2023 HTN (HYPERTENSION)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2639032

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: IN
Alter: 83,0
Geschlecht: F
Eingang: 31.05.2023
Impfdatum: 29.11.2022
Beginn: 25.05.2023
Tage bis Beginn: 177,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chills Cough Dyspnoea Fatigue Headache Malaise Nausea Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I tested positive for COVID-19 on 5/25/23. I had fever, sore throat, cough, nausea, chills, headache, fatigue, shortness of breath and body aches. I didn't go to the doctor at the time and just took Tylenol for the fever. I ended up going to the Emergency Room, but they did not give me medication because of my Kidney problems. They offered Remdesivir, but I declined that too. This has lasted for about a week, and I am still not feeling well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 25MAY2023 COVID-19 Test - Positive; 27MAY2023 Chest X-Ray - Normal
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Cholesterol; High Blood Pressure; Kidney Failure
Andere Medikamente: Aspirin; Atorvastatin; Vitamin D3; Lexapro; Magnesium; Metoprolol; Fish Oil; Omeprazole; Probiotic
Allergien: Cipro; Flagyl
Vorherige Impfungen: -

VAERS 2635596

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: AZ
Alter: 78,0
Geschlecht: F
Eingang: 23.05.2023
Impfdatum: 19.12.2022
Beginn: 26.12.2022
Tage bis Beginn: 7,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Chest pain Cough Fatigue Nausea Respiratory tract congestion SARS-CoV-2 test positive Vomiting

Symptomtext

In late December 2022, she was nauseous and vomiting. She had terrible head congestion and coughed so much her chest hurt. She thought she had broken a rib. She visited the urgent care on December 31, 2022, and received Paxlovid and took half doses as prescribed. She felt better. It took her an additional two weeks to completely recover. She was extremely fatigued.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: COVID-19, positive, 12302022
Aktuelle Erkrankungen: Sinus infection
Vorgeschichte: Sinus problems
Andere Medikamente: Tylenol as needed
Allergien: N/A
Vorherige Impfungen: -

VAERS 2621600

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: IN
Alter: 34,0
Geschlecht: F
Eingang: 26.04.2023
Impfdatum: 26.01.2023
Beginn: 01.03.2023
Tage bis Beginn: 34,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthma Computerised tomogram Condition aggravated Magnetic resonance imaging whole body

Symptomtext

I experienced an Asthma flairs that lasted a couple of weeks. Saw my PCP for this condition. Testing, Full Body Scan MRI and CT, is ongoing at time of reporting.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Full Body Scan MRI and CT
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes; Anemia
Andere Medikamente: Amlodipine; Losartan; Lurasidone; Albuterol; Iron Capsule; Trazadone; Metoprolol; Metformin; Hydroxyzine
Allergien: Mandarin Oranges; Latex; Adhesive
Vorherige Impfungen: -

VAERS 2610006

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: WI
Alter: 91,0
Geschlecht: M
Eingang: 05.04.2023
Impfdatum: 18.12.2022
Beginn: 12.02.2023
Tage bis Beginn: 56,0
Dosis: 3
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 COVID-19 pneumonia Cardiac failure acute Chest X-ray abnormal Cough Dyspnoea Hypoxia Lung opacity Pleural effusion SARS-CoV-2 test positive Tachycardia

Symptomtext

On 2/12/2023, patient presented to the emergency department for evaluation of cough and progressively worsening shortness of breath. He was given a COVID-19 NAA test which resulted positive; His chest x-ray showed opacities and small bilateral pleural effusions. Patient had tachycardia and was found to be hypoxic at 88% on room air; He was treated with oxygen supplementation and Decadron. Patient was diagnosed with Covid-19 pneumonitis, hypoxia, and acute on chronic heart failure. He was admitted to the hospital for further evaluation and treatment. Submitter does not have access to further medical information on this case including discharge date. If more information is needed, please contact the admitting hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: 2/12/2023 - positive COVID-19 NAA test; Chest x-ray showed opacities and small bilateral pleural effusions.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Severe aortic stenosis, severe chronic heart failure, paroxysmal atrial fibrillation, coronary artery disease, hypertension, chronic kidney disease.
Andere Medikamente: Unknown
Allergien: No known drug allergies.
Vorherige Impfungen: -

VAERS 2599687

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: MI
Alter: 68,0
Geschlecht: M
Eingang: 20.03.2023
Impfdatum: 17.12.2022
Beginn: 02.02.2023
Tage bis Beginn: 47,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Bradycardia Chest X-ray Chills Electrocardiogram Headache Ophthalmic migraine Palpitations Tremor Visual impairment

Symptomtext

February 2, 2023, my vision turned into a kaleidoscope. The doctor advised me to go to the ER. I was told I was having an ocular migraine. On February 14, 2023, I could feel my heart beating very heavy. I had another ocular migraine the next day. I got a chill over me and getting a headache and was feeling shaky. I tried to take my blood pressure. I called the ambulance and went to the emergency department. They found bradycardia. My heart rate was down to 46 beats per minute. I was given a monitor for a week on my heart. It showed I am having heart palpitations. I have an appointment with a cardiologist at the end of April.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ophthalmic migraine
Hospital-Tage: -
Labordaten: ECG; Blood panel; Chest X-Ray
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: FLOMAX; atenolol
Allergien: N/A
Vorherige Impfungen: -

VAERS 2592942

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

moderat

Staat: NE
Alter: 73,0
Geschlecht: F
Eingang: 07.03.2023
Impfdatum: 12.01.2023
Beginn: 01.02.2023
Tage bis Beginn: 20,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Mobility decreased Muscular weakness Myalgia Pain Pain in extremity

Symptomtext

My left outer bicep has become weak and tender. I have difficulty completing tasks with left arm. Pain increases when my arm is raised above shoulder.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Neuropathy
Andere Medikamente: Lisinopril, Pregabalin, Bupropion, Buprenorphin
Allergien: Medications: Keflex
Vorherige Impfungen: -

VAERS 2592370

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: NY
Alter: 86,0
Geschlecht: M
Eingang: 07.03.2023
Impfdatum: 28.12.2022
Beginn: 07.01.2023
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Computerised tomogram head Hypoacusis Migraine Speech disorder Transient ischaemic attack Vomiting

Symptomtext

Onset of Migraine headache followed by a TIA and 3 rounds of vomiting . Patient had difficulty hearing and speaking . Symptoms resolved the next day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: Head CT on 1/19/2023
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension, Parkinsons, previous TIA that had been resolved by repair of PFO in May 2022
Andere Medikamente: Sinemet, Dorzalanide, Losartan, Eliquis, Loratadine, Amlodipine, Rivastigmine, Fluticasone Nasal, Rocklatan, Atorvastatin, Floma,
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2590886

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: AZ
Alter: 47,0
Geschlecht: M
Eingang: 03.03.2023
Impfdatum: 19.01.2023
Beginn: 02.02.2023
Tage bis Beginn: 14,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Post-traumatic stress disorder

Symptomtext

2/2/23 I have an exiting condition, PTSD, starting in 2001. I had boxes packed and had someone help me go through the boxes and had to expose myself to memories I was not expecting. My symptoms of PTSD began to worsen and exacerbate. I had to seek mental health help and am continuing in treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: PTSD; Anxiety; Depression; Osteoarthritis
Andere Medikamente: Gabapentin; hydroxyzine; medical marijuana; capsaicin cream; diclofenac; lidocaine; naproxen; tadalafil; omeprazole
Allergien: Oxycodone; hydrocodone
Vorherige Impfungen: -

VAERS 2587819

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: MI
Alter: 78,0
Geschlecht: F
Eingang: 27.02.2023
Impfdatum: 01.12.2022
Beginn: 18.02.2023
Tage bis Beginn: 79,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain Adrenal insufficiency Aortic arteriosclerosis Blood cortisol Blood glucose Bronchial secretion retention COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Computerised tomogram thorax abnormal Condition aggravated Cough Dyspnoea Fungal test negative Gastritis erosive Gastrointestinal tract biopsy Gastrointestinal tube insertion

Symptomtext

Discharge Provider: MD Primary Care Provider: DO Admission Date: 2/18/2023 Discharge Date: Feb 24, 2023 PRESENTING PROBLEM: Community acquired bilateral lower lobe pneumonia HOSPITAL COURSE: Patient is a 78 y.o. female with a past medical history of Billroth 1 surgery for PUD in the past who presented with shortness of breath, hypoxia, nausea, vomiting, poor oral intake. Patient came as a direct admit from inpatient. She was admitted there on 02/19/2023 with nausea, vomiting, abdominal pain, foubd to be positive for COVID-19 infection. Over the next few days she started developing cough, shortness of breath, hypoxia and had to be put on supplemental oxygen which not taking at home for chronic obstructive pulmonary disease although she is on chronic prednisone. Due to the nausea and 1 she has had very poor po intake. GI and General surgery had been consulted given her previous history and upper GI series showed small hiatal hernia but otherwise unremarkable except for postsurgical anatomy. She transferred here for further care including artificial nutrition. Chest x-ray and CT thorax showed bilateral ground-glass opacities consistent with likely COVID-19 pneumonia, scattered mucous plugging and there was also noted on aortic arch plaque at high risk for embolization. She was also found to have of procalcitonin of 18.5 and was started on Rocephin and doxycycline and completed course and was weaned to room air. GI was consulted and took her for EGD on 2/18 showing ulcerative esophagitis and erosive gastritis biopsies were negative for H pylori. Negative for fungal organisms. She continued on ppi and carafate. She had GI place corepak on 2/20 since oral intake remainted poor. Unfortunately patient continued to have intractable nausea with dry heaving. Did tolerate the jejunal tube feeds. Reviewing past medical history patient had very similar episodes of intractable nausea and vomiting in the past including 2021 during which she saw Gastroenterology and had a thorough workup performed. Essentially the thought was she may have some hypomotility related to her previous Billroth surgery but no other definitive cause was found. In-hospital patient was continued on p.r.n. Zofran Compazine and Tigan. GI reconsulted but did not have significant additional recommendations. Additional issue brought to light during this hospitalization is patient has chronic prednisone use. Patient was started on prednisone for nausea in 2021. No labs are available previous to the start of prednisone in epic. Cortisols levels in system were drawn after patient was already on steroids. No clear previous diagnosis of adrenal insufficiency. Patient gave history of PCP adjusting prednisone dosing up and down based on her nausea symptoms. On admission patient had been placed on increased prednisone dose 40 mg daily for chronic obstructive pulmonary disease component with pneumonia. This did not improve her nausea or vomiting. Also trialed IV dose of Decadron with no improvement. Patient did not have hypotension. Blood sugars stable. Endocrinology consulted but declined consult. Did place recommendations in chart. Recommendations: "In the interest of safety given her long term use of steroids would: - continue steroids and wean to no less than 5mg of prednisone OR 10mg in am and 5mg in afternoon of hydrocortisone. -needs instructions to double dose for 3-5 days during times of acute illness. -Will also need to always wear a medical alert for adrenal insufficiency -provide Rx at discharge for injection steroids for times when unable to take oral steroids for >24h. If wean is desired still would: -check 21 hydroxylase antibodies for addisons disease, if positive, then pt will never be allowed to wean off. -wean down to 5mg prednisone daily and then drop by 1mg every 3-4 weeks until off then have 8am cortisol/ACTH testing. If acute illness develops then still needs to stress dose for 3 days before dropping back to prior dose." Patient decreased back to baseline prednisone dosing and then on discharge transitioned to hydrocortisone after discussion with pharmacy regarding dosing 30 mg in a.m. 20 mg afternoon. Have given instructions to care facility regarding possible future need for stress dosing and emergency injectable hydrocortisone if unable to take po. Discussed with patient and with son and recommended outpatient endocrinology consult for further management. Twenty-one hydroxylase pending at time of discharge. Finally despite continued nausea discussed with patient and son as no further workup recommended in-hospital patient stable on Corpak to jejunal feeds will discharge to rehab with p.r.n. Zofran and Compazine as well as PT OT. Patient to return to ER if symptoms worsen or new issues arise.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Osteoporosis, post-menopausal Hyperlipidemia Chronic allergic rhinitis Familial tremor Depression, unspecified depression type Herpes simplex labialis GAD (generalized anxiety disorder) Adrenal insufficiency Primary osteoarthritis of right hip Idiopathic acute pancreatitis Intractable nausea and vomiting History of total right hip replacement Bronchiectasis without acute exacerbation Abnormal CT scan of lung COPD (chronic obstructive pulmonary disease) IBS (irritable bowel syndrome) Kidney mass Lung nodule Left upper quadrant abdominal pain Preoperative clearance Sinusitis SOB (shortness of breath) Upper respiratory infection with cough and congestion Parkinson's disease
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol (PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 20 MG tablet carbidopa-levodopa (SINEMET) 25-100 MG per tablet famotidine (PEPCID) 20 MG table
Allergien: PenicillinsHives, Rash Azithromycin CodeineNausea and Vomiting TramadolNausea and Vomiting Tramadol-acetaminophenNausea and Vomiting Troleandomycin
Vorherige Impfungen: -

VAERS 2584040

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: MN
Alter: 63,0
Geschlecht: F
Eingang: 19.02.2023
Impfdatum: 26.01.2023
Beginn: 04.02.2023
Tage bis Beginn: 9,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram Condition aggravated Coronary arterial stent insertion Dyspnoea Echocardiogram abnormal Ejection fraction decreased Electrocardiogram Exercise tolerance decreased Fibrin D dimer Haemoglobin increased N-terminal prohormone brain natriuretic peptide increased Troponin increased Wall motion score index abnormal White blood cell count increased

Symptomtext

On 2/4/23 patient stated that her shortness of breath (SOB) was worse than her normal SOB. She was unable to tolerate walking distances.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 3,0
Labordaten: Hgb: 16.2, WBC: 10.6, D-dimer 460, NT proBNP: 601, Trop 45, 149, 136. ECG; Echocardiogram: New reduction in EF: 40% with new regional wall abnormalities (Recent ECHO done 10/13/22 57% with no RWMA). On 2/17 pt was taken to angiogram, 1 stent placed in patient's distal circumflex.
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic illnesses: COPD, Hypertension, Hyperlipidemia,
Andere Medikamente: Advair diskus inhaler, albuterol 90mcg inhaler, aspirin 81mg daily, atorvastatin 80 mg daily, duoneb PRN, Lisinopril 5mg daily, Metformin XR 500mg daily, singulair 10 mg daily, nicotine polacrilex 4mg gum, prednisone 10mg daily, nasal spray
Allergien: carvedilol
Vorherige Impfungen: (Yes/unknown) Patient received first covid vaccines (3/30/21 PFR ER8733 IM/Left deltoid .3ml & 4/20/21 PFR EW0169 IM/Left deltoi

VAERS 2582588

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: PA
Alter: 43,0
Geschlecht: M
Eingang: 15.02.2023
Impfdatum: 24.01.2023
Beginn: 07.02.2023
Tage bis Beginn: 14,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Cough Discomfort Headache Impaired work ability Migraine Nasal congestion Oropharyngeal pain Parosmia Photophobia Rhinorrhoea SARS-CoV-2 test negative Upper respiratory tract infection

Symptomtext

I had a splitting headache on January 7, 2023. I had photophobia and could not get comfortable. I was sensitive to smells. It was more severe than my usual migraine and didn't respond to ibuprofen as usual. I called my dad; he is a neurologist. He advised me to go to the emergency department, but I declined. I finally went to sleep. The headache went away after I woke up. Now, I have an upper respiratory infection and I have tested negative for COVID-19. I have not had a fever. I have had a cough that includes pain in my throat and now in my chest. I have a runny nose with nasal congested. I've had to work from home for two days because the symptoms were severe.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: COVID-19, negative, 02/12/23 and 02/13/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Mild Asthma
Andere Medikamente: N/A
Allergien: Seasonal; cats; dogs
Vorherige Impfungen: -

VAERS 2581522

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: MO
Alter: 70,0
Geschlecht: F
Eingang: 14.02.2023
Impfdatum: 23.01.2023
Beginn: 06.02.2023
Tage bis Beginn: 14,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Cough Dyspnoea Headache Influenza virus test negative Respiratory tract congestion SARS-CoV-2 test negative Sneezing Viral test

Symptomtext

I started coughing, having congestion, sneezing, and short of breath. I also experienced head and chest pain. I decided to make my doctors on Wednesday February 8, 2023, where he prescribed me prednisone for five days, and amoxicillin for seven days. I still am not better yet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 08FEB2023 Influenza test negative; 08FEB2023 COVID-19 test negative; 08FEB2023 Blood test, viral
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD
Andere Medikamente: BREZTRI; meloxicam; D-3; azithromycin; famotidine; montelukast; calcium; OSTEO BY-FLEX; furosemide; fluticasone; potassium; omeprazole; daily vitamin; letrozole
Allergien: Nickel
Vorherige Impfungen: -

VAERS 2580012

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: NY
Alter: 40,0
Geschlecht: M
Eingang: 12.02.2023
Impfdatum: 30.12.2021
Beginn: 03.01.2023
Tage bis Beginn: 369,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Electrocardiogram

Symptomtext

Almost one month of left side chest pain to varying degrees starting after the 4th shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKG
Aktuelle Erkrankungen: None
Vorgeschichte: High BP Episodes of Afib High cholesterol
Andere Medikamente: Zoloft Clonazepam Metoprolol Lipitor Aspirin
Allergien: Sulfur IVR Dye
Vorherige Impfungen: -

VAERS 2569951

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: NC
Alter: 17,0
Geschlecht: M
Eingang: 28.01.2023
Impfdatum: 14.01.2023
Beginn: 14.01.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anxiety Crying Nervousness Tremor

Symptomtext

Systemic: Dizziness / Lightheadness-Medium, Systemic: Shakiness-Medium, Additional Details: PATIENT WAITED IN THE WAITING AREA FOR 10 MIN AND LEFT TO REST ROOM. MOM REACHED OUT TO RPH REPORTING THAT HER SON SAT DOWN OUT SIDE OT THE BATH ROOM DOOR AND IS SHAKING AND NERVOUS. RPH ATTENDED CHECKED PULSE AND PATIENT WAS RESPONSIVE AND BREATHING. HE WAS ANXIOUS AND CRYING. CALLED 911 , PARAMEDICS CHECKED AND REPORTED NORMAL BP. MOM REFUSED FURTHER EVALUATION AND MENTIONED TO PARAMEDICS THAT HER SON HAVE ANXIETY AND IT HAS NOTHING TO DO WITH VACCINE. SHE REFUSED TO GO TO HOSPITAL.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2569243

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: IL
Alter: 56,0
Geschlecht: F
Eingang: 27.01.2023
Impfdatum: 09.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 18,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Electrocardiogram Feeling abnormal Feeling jittery Full blood count Metabolic function test Palpitations Troponin

Symptomtext

Developed increasing palpitations, jittery sensation, and increasing anxiety. Feels like "I'm withdrawing from something"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: ECG, CBC, CMP, troponin -- ER visit 1/13/23 and 2 clinic visits 1/10/23 and 1/19/23
Aktuelle Erkrankungen: Chronic constipation
Vorgeschichte: Bipolar 2, Slow transit constipation, HTN
Andere Medikamente: Vitamin D3, calcium, MVI, miralax, senna, benefiber, zyprexa
Allergien: Risperidone
Vorherige Impfungen: -

VAERS 2567706

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: NE
Alter: 63,0
Geschlecht: F
Eingang: 25.01.2023
Impfdatum: 20.01.2023
Beginn: 20.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypoaesthesia Paraesthesia

Symptomtext

New onset numbness and tingling in her right arm and leg shortly after getting her COVID shot. Patient advised to seek evaluation in the ED but denied recommendation. Resolved without treatment. Unknown duration of symptoms but can confirm no residual symptoms when patient was contacted for follow up 1/24/23.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: hypertension, gastric ulcers, depression, chronic back pain, chronic leg pain, GERD, and hypothyroidism.
Andere Medikamente: acetaminophen PRN albuterol sulfate 90 mcg/actuation 2 puffs Inhalation Every 4 hours PRN alprazolam 0.5 mg Take 0.5 mg by mouth 3 (three) times a day as needed for anxiety. amitriptyline HCl 75 mg Oral Nightly amlodipine besylate 10 mg Ora
Allergien: tramadol (history unknown)
Vorherige Impfungen: -

VAERS 2564548

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: WI
Alter: 42,0
Geschlecht: F
Eingang: 20.01.2023
Impfdatum: 19.01.2023
Beginn: 19.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Paraesthesia oral Throat tightness

Symptomtext

WITHIN 5 MINUTES FOLLOWING RECEIPT OF PFIZER BIVALENT BOOSTER DOSE, CLIENT COMPLAINED OF SENSATION OF HER THROAT CLOSING, TINGLING OF HER LIPS, AND FEELING LIGHTHEADED. CLIENT DENIED DIFFICULTY BREATHING OR HEADACHE; RASH/HIVES, CLAMMY SKIN, OR LOCAL SITE REACTION WERE NOT OBSERVED BY NURSES PRESENT, NOR DID CLIENT LOSE CONSCIOUSNESS. CLIENT WAS GIVEN 50mg PO BENADRYL (2 TABLETS) AND PLACED IN A RECUMBENT POSITION WITH FEET ELEVATED. A COLD COMPRESS WAS APPLIED TO HER FOREHEAD. ABOVE SYMPTOMS IMPROVED AND APPEARED TO SUBSIDE WITHIN 20 MINUTES. VITALS OBTAINED (BP 102/70, PULSE 70). CLIENT REPORTED SHE FELT GOOD AND WISHED TO GO HOME. CLIENT PROVIDED FURTHER INSTRUCTIONS AND RELEASED TO HOME.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2561428

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: CA
Alter: 79,0
Geschlecht: F
Eingang: 17.01.2023
Impfdatum: 30.12.2022
Beginn: 02.01.2023
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Cardiac monitoring Chest pain Dyspnoea Electrocardiogram Headache Pain in extremity

Symptomtext

She got her vaccine Pfizer Bivalent vaccine, bad news reaction. Not immediate, but had sore arm that was normal. Within a couple of days she had an extremely bad headache. She had some shortness of breath and some chest pains. When she called her PCP they referred her to more immediate care. She does not drive and her pastors wife took her and at that point they did an EKG and wasn?t quite sure what was going on. Immediately she suggested to call an ambulance to take her to a local hospital, enough concern that she was taken to the ER closer to where she lives. She did not have a heart attack, they were busy there, but the ER nurse told her that she has seen cases where people have a reaction to the booster vaccine. She had the J&J, then she had two boosters of Pfizer and that was nothing major. Then she had this one that something went wrong and she will not get another booster again. While in the ER they said she needed to be assessed for heart issues for the chest pains, and they immediate did another EKG/blood work and put her on a monitor. If there would have been an issue she felt they would have kept her. She was told to investigate with her own doctor and was sent home. She is doing OK now, did not like that experience. She is not a heart patient at all. In the past she has had a work up for heart issues when she had a stroke, and no heart condition that she is aware of. She believes she may have had the flu vaccine within 30 days of this one, but did have a COVID and flu vaccine in the past at the same time and did not have any problems with them. She had an ischemic stroke. She is wanting to know if there is an added risk for getting vaccines with an ischemic stroke.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: EKG and blood work while in the ER.
Aktuelle Erkrankungen: None.
Vorgeschichte: History of stroke, Lynch syndrome, vision issues from birth and age.
Andere Medikamente: Advil. Atorvastatin, Lipitor 10 mg a day, Amlodipine 5 mg, 81 mg aspirin, cranberry pills.
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2560192

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: OR
Alter: 66,0
Geschlecht: M
Eingang: 14.01.2023
Impfdatum: 16.12.2022
Beginn: 29.12.2022
Tage bis Beginn: 13,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Ophthalmic migraine Visual impairment

Symptomtext

Ocular migraine - jagged and color spectrum rings of vision, 2 rings that moved outward radially (got larger from the center), and then disappeared. About 30 minutes total duration, no recurrence since first event. No treatment or medication attempted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ophthalmic migraine
Hospital-Tage: -
Labordaten: None initiated.
Aktuelle Erkrankungen: None
Vorgeschichte: Slightly high cholesterol (215-220)
Andere Medikamente: Levothyroxine, 100 mg Omega-3 fish oil,2200 mg, 1400 mg EPA, 480 mg DHA Blood Sugar Support: Biotin, Chromium, American Ginseng root, Holy Basil Leaf extract, Fenugreek seed fiber, Gymnema Silvestre leaf extract, Cinnamon bark, Vanadium Phy
Allergien: None
Vorherige Impfungen: -

VAERS 2558715

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: MN
Alter: 66,0
Geschlecht: F
Eingang: 12.01.2023
Impfdatum: 10.01.2023
Beginn: 12.01.2023
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Dyspnoea Fatigue Hypoaesthesia

Symptomtext

patient experinced flushing and rapid heart beat about 15 min after first covid booster in 2021. She was asked to wait 30 min after covid booster with bivalent on 1-10-23, she did not report any side effects. On 1/12/23 she reported she did have chest pressure while waiting for 30 min in the pharmacy, but choose not to report it. It resolved after she arrived home. On 1/11/23 about 1pm she began feeling chest pressure, shortness of breath, numbness in right leg and fatigue and she was currently experiencing these symptms. She was taken to the clinic for triage

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: cymbalta,lexparo,omeprazole,buspar,codeine,effexor,latex,niacin,triamcinolone,ventolin,benadryl,melatonin,paxil,promethasine
Vorherige Impfungen: flushing, rapid heart beat

VAERS 2557778

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: MI
Alter: 33,0
Geschlecht: F
Eingang: 11.01.2023
Impfdatum: 20.12.2022
Beginn: 29.12.2022
Tage bis Beginn: 9,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Arthralgia Blood test normal Hypoaesthesia Impaired work ability Insomnia Mobility decreased Pain Pain in extremity

Symptomtext

On 12/29/2022, I started experiencing some leg pain. I thought it was due to extensive walking. On 12/30/2022, I rested all day. On 12/31/2022, I also stayed home. By the evening of 01/02/2023, the pain was getting bad, but I still thought it was due to extra walking. From 01/01/2023- 01/03/2023, I was completely resting. I treated with Tylenol twice. The pain slowly started to wear off. When I took the Tylenol, I could feel the leg pain going away, but still had joint pain. By 01/05/2023, I was still having terrible joint pain. It was to the point that I could feel pain in each and every toenail and other joints. By 01/07/2023, the pain spread to my elbow and my hands. I am unable to lift anything with my left hand due to the pain in my hand and elbow. By Saturday evening, my right hand was feeling the same way. When I take over the counter medication, it eases for two to three hours, but once it wears off, the pain comes back. The pain is way worse in the night. I can't sleep or turn over. Mid-day is the best time of day, but I'm still feeling pain. By Tuesday evening, I had taken lots of Tylenol. I was taking it every six hours. I was able to feel my right hand again by that point. Today is the first day I have been able to return to work from the pain and I was only able to work partially due to the pain in my left hand. Today is better than the last four days. My dad provided me a medication for joint pain that he brought from another country, and it helped me a lot for three to four hours. However, now again, it's evening time and the pain is returning. I went to my doctor on Monday. She recommended some blood work and advised that I take only Tylenol until the blood work is back. She also explained some exercises that should help. They are helping but the pain is still there. I called my doctor's office when I saw that my results should have been in. The nurse in her office stated that the blood results looked alright and there was nothing she could do. She believes the pain is vaccine related and advised that I take no more COVID-19 vaccines and continue with the Tylenol and exercising. However, I am in terrible pain and cannot do my daily activity.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: 09JAN2023 - Blood Work - Nothing Abnormal Found
Aktuelle Erkrankungen: None
Vorgeschichte: Migraines
Andere Medikamente: Metformin XR
Allergien: Doxycycline
Vorherige Impfungen: Third Dose of Pfizer 12/14/2021 - Similar joint pain localized to fingers.

VAERS 2557734

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: GA
Alter: 75,0
Geschlecht: M
Eingang: 11.01.2023
Impfdatum: 06.01.2023
Beginn: 07.01.2023
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain lower Abdominal rigidity Activated partial thromboplastin time Blood gases Blood glucose increased Blood magnesium Bradycardia Brain natriuretic peptide Cardiac telemetry Chest X-ray Discoloured vomit Disorientation Dyspnoea Echocardiogram Full blood count International normalised ratio Laboratory test Metabolic function test

Symptomtext

Began vomiting yellow/green emesis. Became disoriented x 4. Shortness of Breath. Oxygen saturation 75% room air, Temp-97.5, Pulse-36, BP-70/37. Placed oxygen on at 3liters/minute via nasal canula; oxygen saturation up to 98%. Blood Glucose-295; increased to 368. Complained of pain 8/10 in lower abdomen with guarding. Called emergency medical services to transport to hospital for evaluation. EMS gave Atropine in route to ER. He was admitted to local Health Hospital in for diagnosis of Bradycardia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 5,0
Labordaten: IV Fluids, Oxygen therapy, Telemetry, Echocardiogram, Chest X-Ray, COVID test (PCR and rapid), lab work: Serial cardiac enzymes, BNP, CBC, CMP, Magnesium, PT, APTT, INR, Blood Gas.
Aktuelle Erkrankungen: 10/26/22-UTI with sepsis and Acute Respiratory Failure with Hypoxia 11/25/22-Cellulitis right lower limb with sepsis
Vorgeschichte: Benign Prostatic Hyperplasia, Hypertension, Major Depressive Disorder, Hyperlipidemia, Anxiety Disorder, NSTEMI Myocardial Infarction, STEMI Myocardial Infarction involving left anterior descending coronary artery, legal blindness, Peripheral Vascular Disease, Coronary Artery Disease, Chronic Kidney Disease stage 3, Anemia, Type 2 Diabetes Mellitus with Diabetic Neuropathy, Chronic Congestive Heart Failure, Gastro-Esophageal Reflux Disease
Andere Medikamente: Amiodarone HCl 200mg tab QD, Aspirin 81mg QD, Atorvastatin Calcium 80mg QHS, Clopidogrel Bisulfate 75mg QD, Decubi-Vite QD, Flomax 0.4mg QD, Nifedipine ER 30mg give 2 tabs (60mg) QD, Trazodone HCl 100mg QHS, Venlafaxine HCl 75mg QD, Vitam
Allergien: Metformin and Terazosin
Vorherige Impfungen: -

VAERS 2554777

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 09.01.2023
Impfdatum: 07.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 20,0
Dosis: 5
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Angiogram pulmonary normal Blood potassium abnormal COVID-19 Chest X-ray normal Chronic obstructive pulmonary disease Condition aggravated Dyspnoea Exposure to SARS-CoV-2 Hypokalaemia Hypoxia Influenza virus test negative Respiratory syncytial virus test negative SARS-CoV-2 test positive Ultrasound Doppler normal

Symptomtext

COVID+ 12/30/22. Vaccination Status - Pfizer x4 + Pfizer BIVALENT x1 BRIEF OVERVIEW: Admission Date: 12/27/2022 Discharge Date: 1/7/2023 Active Hospital Problems Diagnosis Date Noted POA ? Statin started by Vascular Surgery with Rx to be taken over by patient's PCP 01/07/2023 Unknown ? Multiple comorbid conditions 01/02/2023 Unknown ? COVID-19 09/13/2022 Yes ? Immunosuppressed status 07/29/2022 Yes ? Moderate pulmonary hypertension on echo from May 2019 01/14/2020 Yes ? OSA (obstructive sleep apnea) 04/09/2018 Yes ? Anxiety 03/11/2018 Yes ? History of tobacco abuse: 30 pack years, quit 1999 06/20/2016 Yes ? COPD with asthma Yes DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxemia [R09.02] COPD exacerbation [J44.1] Chronic obstructive pulmonary disease with (acute) exacerbation [J44.1] HOSPITAL COURSE: Patient is a 75-year-old female who presented to the emergency department with chief complaint of shortness of breath. In the emergency department, she was found to be hypoxemic and required increased O2. In the emergency department chest x-ray with no acute process. Patient had known exposure to COVID-19 prior to admission. On admission COVID-19, influenza and RSV were negative. She was admitted to the Internal Medicine Service with a pulmonology consult. She was started on IV steroids and DuoNebs. She completed a course of azithromycin. CTA chest was obtained which revealed no evidence of PE and no acute thoracic abnormality. Bilateral lower extremity ultrasound was negative for DVT. As patient's symptoms improved, IV steroids were discontinued and she was placed on prednisone Repeat COVID-19 testing was performed due to recent exposure and was positive. Patient completed a course of Remdesivir while inpatient. She was seen by pulmonary medicine who recommended prednisone taper by 10 mg every 5 days until off. They also recommended she follow-up with her pulmonologist on 01/13/2023 as previously scheduled, Patient was seen by PT and OT and recommendation was for home with home health care. Patient with history of anxiety which is worsened by her acute respiratory failure. Palliative Care was consulted for assistance with symptom management. Patient had hypokalemia during her stay and losartan was held. Potassium level did normalize and patient advised to resume losartan at discharge. Care management did arrange for home care. Patient had improvement of her respiratory status, had no other acute issues and was discharged home in stable condition on 1/7/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: Pt in ED on 12/4/22- ED Disposition: DISCHARGE MEDICAL DECISION MAKING: Patient reported several episodes of feeling short of breath similar to what she was having at home, was not having any signs of respiratory distress no hypoxemia on her baseline O2 at 2.5 L, no arrhythmia, no tachycardia. Her workup at this time does not show any obvious explanation for her episodes of dyspnea. She has a normal complete blood count, troponin is negative x2, BNP is normal, D-dimer is normal, complete blood count is normal, chest x-ray is clear. She does report some increased shortness of breath that seems to occur with exertion and physical activity, likely due to her underlying chronic obstructive pulmonary disease may possibly need increased O2 requirements with physical activity. She is scheduled to see her pulmonologist however this appointment is in January. Patient does report she has Xanax prescribed for anxiety however she does not usually take this as she is concerned due to its risk for abuse and dependence. Symptoms may in fact be due to some anxiety.
Vorgeschichte: COPD with asthma OSA (obstructive sleep apnea) Hypoxemia History of tobacco abuse: 30 pack years, quit 1999 Hypertension Hyperlipidemia Hypothyroidism Anxiety Chronic respiratory failure with hypoxia and hypercapnia Coronary artery disease involving native coronary artery of native heart with other form of angina pectoris Moderate pulmonary hypertension on echo from May 2019 Uveitis Left carotid artery stenosis Immunosuppressed status COVID-19
Andere Medikamente: Albuterol Sulfate 2.5 mg Nebulization Every 6 hours PRN 108 (90 Base) MCG/ACT Aers, INHALE 2 PUFFS BY MOUTH EVERY 4 HOURS AS NEEDED PER WHEEZING ALPRAZolam 0.5 MG Take 0.25 mg three times daily as needed for shortness of breath and anxiety.
Allergien: Statins [Hmg-coa-r Inhibitors]Other
Vorherige Impfungen: -

VAERS 2551536

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: MN
Alter: 56,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 09.12.2022
Beginn: 01.12.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Asthenia Mobility decreased Pain in extremity Sleep disorder X-ray

Symptomtext

Patient has had arm pain and shoulder pain since the injection on 12/9/22. Unable to sleep on arm, raise arm above head, or reach backward with that arm. Difficulty lifting objects up with that arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: Xrays taken today, referrals to orthopedics and physical therapy from today's visit, 1/5/23.
Aktuelle Erkrankungen: none that writer is aware of
Vorgeschichte: morbid obesity, adrenal gland dysfunction, acquired hypothyroidism, GERD, menopausal syndrome with hormone replacement therapy, herpes simplex (cold sores), plantar fascitis, OSA, insomnia.
Andere Medikamente: albuterol inhaler PRN, BIEST, vitamin D, levothyroxine, cytomel, meloxicam, omeprazole, potassium, progesterone, tumeric, valtrex prn, zinc.
Allergien: environmental substances & morphine
Vorherige Impfungen: -

VAERS 2551429

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: KY
Alter: 74,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 20.12.2022
Beginn: 21.12.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram normal Fall Mobility decreased Nerve injury Pain in extremity Peripheral swelling X-ray limb normal

Symptomtext

Resident noted to have a fall the next morning while ambulating to the restroom. Resident right upper arm noted to have significant swelling and pain. Resident is not able to use her right extremity at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: X-ray right upper extremity---Results show no fracture.---Performed 12/21/2022 CT scan of right upper extremity---Results show no fracture---Performed 12/27/2022 Hospital states that the resident has a neuropraxia of the right upper extremity
Aktuelle Erkrankungen: none
Vorgeschichte: Generalized anxiety disorder PTSD Unilateral Osteoarthritis resulting from hip dysplasia, left hip Seasonal allergic rhinitis Iron deficiency anemia Constipation Essential Hypertension History Transient Ischemic Attack Personal history Covid 19 Type 2 Diabetes Mellitus without complications Hypothyroidism Primary generalized osteoarthritis GERD Hyperlipidemia Major depressive disorder Polyneuropathy Idiopathic gout Vascular dementia Epilepsy Chronic pain syndrome
Andere Medikamente: Acetaminophen 500mg tablet Allopurinol 100mg tablet Amlodipine 10mg tablet Artificial Tears Solution 0.5-0.6% Atorvastatin 10mg tablet Carafate 1gm tablet Cetirizine 10mg tablet Cholecalciferol 1000 unit tablet Clopidogrel 75 mg tablet Fent
Allergien: Razadyne Penicillin
Vorherige Impfungen: -

VAERS 2549717

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

moderat

Staat: NJ
Alter: 48,0
Geschlecht: M
Eingang: 04.01.2023
Impfdatum: 28.12.2022
Beginn: 28.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chest pain Fatigue

Symptomtext

Chest pain; left side Joint ache; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 48-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Dec2022 at 12:30 as dose 4 (booster), single (Lot number: GJ6742) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "COVID" (unspecified if ongoing), notes: if COVID prior vaccination : Yes. Concomitant medication(s) included: INFLUENZA VACCINE taken for immunisation, on 28Dec2022 as dose 1, single; IBUPROFEN. Vaccination history included: Bnt162b2 (other vaccine same date product=Pfizer,, other vaccine same date lot number=Lot#EL3248,, other vaccine same date vaccine date=28Dec2022,, other vaccine same date dose number=1,), for COVID-19 immunization; Bnt162b2 (other vaccine same date product=Pfizer,, other vaccine same date lot number=Lot#EL3248,, other vaccine same date vaccine date=28Dec2022,, other vaccine same date dose number=2,), for COVID-19 immunization; Bnt162b2 (other vaccine same date product=Pfizer,, other vaccine same date lot number=Lot#FE3594,, other vaccine same date vaccine date=28Dec2022,, other vaccine same date dose number=3,), for COVID-19 immunization. The following information was reported: CHEST PAIN (non-serious) with onset 28Dec2022 at 23:30, outcome "recovering"; FATIGUE (non-serious) with onset 28Dec2022 at 23:30, outcome "recovering"; ARTHRALGIA (non-serious) with onset 28Dec2022 at 23:30, outcome "recovering", described as "left side Joint ache". Therapeutic measures were not taken as a result of chest pain, arthralgia, fatigue. Additional information: The patient had chest pain, left side Joint ache (recovering as of 29Dec2022 20:40) Fatigue (recovering as of 29Dec2022 20:40). Location of injection for vaccine received within 4 weeks PRIOR: Flu - right arm. Patient received ibuprofen within 2 weeks of vaccination. No treatment for Adverse event. Prior to vaccination, patient was diagnosed with COVID-19. It was unknown that since the vaccination, the patient been tested for COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (if COVID prior vaccination : Yes)
Andere Medikamente: INFLUENZA VACCINE; IBUPROFEN
Allergien: -
Vorherige Impfungen: -

VAERS 2542797

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: CA
Alter: 57,0
Geschlecht: F
Eingang: 24.12.2022
Impfdatum: 19.12.2022
Beginn: 19.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Injected limb mobility decreased Injection site pain

Symptomtext

Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Severe, Additional Details: Unable to move her arm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injected limb mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2527766

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

moderat

Staat: OK
Alter: 62,0
Geschlecht: F
Eingang: 09.12.2022
Impfdatum: 03.12.2022
Beginn: 03.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Body temperature increased Feeling cold Pollakiuria Tremor Urinary incontinence

Symptomtext

She got her vaccine, she was doing fine, drank a bunch of water, and then about 8:30 she started having violent shakes and she was freezing. She went to bed, covered up and then about 1:00 AM she had to use the restroom, she unloaded her bladder and had no control her bladder, and kept doing that about every hour. This is what scared her as she couldn't control her bladder function. Then towards morning she was able to get up for the most part to make it to the bathroom before she had an accident, so that started improving. Then she was pretty much lying in bed, felt like she was running a temp which lasted a day. Yesterday she was fine, but still weak. Today, she is feeling like she is halfway normal. She did not call her doctor. She took Tylenol for the temp.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None.
Vorgeschichte: High cholesterol, kidney cancer, ovarian cysts, thyroid disease.
Andere Medikamente: Trazadone, Atorvastatin, Hyzaar, potassium chloride, Levothroid, Norvasc, zinc, Vitamin D.
Allergien: None.
Vorherige Impfungen: All of the COVID vaccines, she felt horrible, felt like she had the flu and was off work for a week from it. The 2nd vaccine s

VAERS 2522760

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

moderat

Staat: MN
Alter: 15,0
Geschlecht: F
Eingang: 05.12.2022
Impfdatum: 01.12.2022
Beginn: 01.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Flushing Hyperhidrosis Hypotension Immediate post-injection reaction Nausea Pulse absent Tremor Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Severe, Systemic: Nausea-Mild, Systemic: Shakiness-Medium, Additional Details: pt went unresponsive soon after vaccine like within 30 seconds, couldnt not feel a pulse, called 911. patient came with it less than 30 sec. EMS came and eventually patient left with mom.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2726681

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: AZ
Alter: 72,0
Geschlecht: M
Eingang: 21.12.2023
Impfdatum: -
Beginn: 08.02.2023
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Arthralgia Myalgia

Symptomtext

Reported Symptoms: 10003239:ARTHRALGIA; 10028411:MYALGIA; Narrative: Other Relevant HX: Other:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2722798

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: MN
Alter: 12,0
Geschlecht: F
Eingang: 11.12.2023
Impfdatum: 28.12.2022
Beginn: 08.12.2023
Tage bis Beginn: 345,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Oropharyngeal pain SARS-CoV-2 test

Symptomtext

Sore throat, headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: IDNOW
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2709944

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

mild

Staat: KS
Alter: 76,0
Geschlecht: F
Eingang: 05.11.2023
Impfdatum: 29.11.2022
Beginn: 29.11.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site bruising Injection site haemorrhage Product administered at inappropriate site

Symptomtext

11/29/22 covid shot: Patient said bruised at the injection site and about a week later, a little bit of blood came out of the bruise. She did not follow up with the doctor. She has frozen shoulder currently and has had in her left arm for about 2 years, where she cannot lift up her arm high. She said that she thought the male pharmacist hit the bone, he was standing while giving the shot, and she thought he did the shot too high.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: frozen shoulder on side of injection
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2656622

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: WA
Alter: 28,0
Geschlecht: F
Eingang: 14.07.2023
Impfdatum: 19.01.2023
Beginn: 20.01.2023
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache

Symptomtext

Constant headache located front/top of the head; This is a spontaneous report received from a contactable reporter (Other HCP). The reporter is the patient. A 28-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Jan2023 as dose 3 (booster), single (Lot number: GJ6742) at the age of 28 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Migraines", start date: 2010 (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: prior to vaccination. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (dose 1, single; lot number: FJ9943; site: left arm), administration date: 29Mar2022, when the patient was 27-year-old, for COVID-19 immunization; BNT162b2 (dose 2, single; lot number: FJ9943; site: left arm), administration date: 26Apr2022, when the patient was 27-year-old, for COVID-19 immunization. The following information was reported: HEADACHE (medically significant) with onset 20Jan2023, outcome "not recovered", described as "Constant headache located front/top of the head". The event "constant headache located front/top of the head" required physician office visit. Therapeutic measures were taken as a result of headache. Clinical course: Constant headache located front/top of the head. No relief even with OTC medications and prescribed medications (3 different medications). Went to the doctor 4 times with the same complaint. Headaches started the day after 3rd dose of the Pfizer COVID shot. The patient has not tested for COVID post-vaccination. She has no known allergies. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the temporal relation, the association between the event headache and the suspect product cannot be completely ruled out. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (prior to vaccination); Migraine
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2648508

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: ID
Alter: 53,0
Geschlecht: F
Eingang: 22.06.2023
Impfdatum: 15.06.2023
Beginn: 15.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Joint range of motion decreased Pain in extremity

Symptomtext

Her arms that ache; can barely move her bangles and it is not normal; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Jun2023 at 14:00 as dose number unknown, single (Lot number: GJ6742) at the age of 53 years intramuscular, in arm for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "need potassium in diet" (unspecified if ongoing). Concomitant medication(s) included: POTASSIUM taken for mineral supplementation; BUSPIRONE taken for anxiety (ongoing). The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 15Jun2023, outcome "unknown", described as "Her arms that ache"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 15Jun2023, outcome "unknown", described as "can barely move her bangles and it is not normal". Additional Information: It was reported that the patient needed to knowif that was standard or normal for her arms that ache like a 'TB time' shot like that was in military. It was reported that they did not put an expiration date. Buspirone should have been taken twice a day but the patient have been taking it once a day. The patient was asked to visit healthcare professional if needed. No investigations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Anxiety; Potassium supplementation
Andere Medikamente: POTASSIUM; BUSPIRONE
Allergien: -
Vorherige Impfungen: -

VAERS 2631981

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: IL
Alter: 33,0
Geschlecht: F
Eingang: 15.05.2023
Impfdatum: 10.05.2023
Beginn: 11.05.2023
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Eye swelling Fatigue Lip swelling Pruritus

Symptomtext

5/11/2023-Upper lip swelling, Swollen eyes, Body itching, itching eyes, and extreme fatigue after waking up the day after her vaccine Given Claritin and told to follow up with Health Dept. if symptoms did not improve 05/12/2023- Now has Diarrhea and continued fatigued, though swelling and itching has ceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Seasonal
Vorherige Impfungen: -

VAERS 2619324

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: CA
Alter: 69,0
Geschlecht: M
Eingang: 21.04.2023
Impfdatum: 19.12.2022
Beginn: 20.02.2023
Tage bis Beginn: 63,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Cough Dysstasia Fatigue Feeling abnormal Gait disturbance Influenza like illness Joint instability Muscle spasms Musculoskeletal stiffness Nasopharyngitis Pain Paranasal sinus hypersecretion Respiratory tract congestion Sensitive skin

Symptomtext

Started with sinus drainage continued for a day or so, fatigue and mild achiness and sensitive skin. Then I started to feel tired. It felt like a cold and mild flu. I coughed because of the drainage, I had some chest congestion, but it was not bad. For the most part it stayed upper respiratory, more so. After 4 or 5 days, I felt fine and then it bounced back the drainage, not the achiness and tiredness. After testing negative, the drainage lingered afterwards, a few days slowly decreasing after 15 days. I tested negative with multiple tests. My son and wife got it a little behind me. None of us were terribly sick. The drainage took a long time to go away. Middle of my back bunch up, knotted up, to stand up straight work with physical therapist. I felt like roaming, stiff neck, stiff shoulders, pain and unstable hips, getting knotted up. It lasted for 4 or 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: N/A
Vorgeschichte: None
Andere Medikamente: Atorvastatin; Testosterone Cypionate Intermuscular Injection; Vitamin C; Multivitamin; Ubiquinol; Vitamin D3; Silymarin; One A Day Multiples; Calcium Citrate
Allergien: Penicillin; Percodan
Vorherige Impfungen: Pfizer Dose 2, I was achy and tired for a day.

VAERS 2618676

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: CA
Alter: 61,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 09.10.2022
Beginn: 13.04.2023
Tage bis Beginn: 186,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Gastric disorder Influenza like illness

Symptomtext

04/13/2023, I was feeling like I had the stomach flu. I was really dizzy, and I thought I was getting bronchitis and I went to the doctor. I was doing really well for a few years. I think my health is declining. It is reacting to the treatment that I take. I am chronic immunocompromised. I saw my doctor 4/19/2023. He just listened to my chest and said I do not have fluid in my lungs. I do not have pneumonia. He prescribed albuterol and said to call him in a few days or if I am feeling any worse.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: N/A
Vorgeschichte: Psoriatic Arthritis; Diabetes; High Blood Pressure; Glaucoma
Andere Medikamente: Metformin; losartan; levothyroxine; EFFEXOR; meloxicam
Allergien: N/A
Vorherige Impfungen: -

VAERS 2613396

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: TN
Alter: 55,0
Geschlecht: F
Eingang: 11.04.2023
Impfdatum: 06.01.2023
Beginn: 01.01.2023
Tage bis Beginn: -
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthropathy Back pain Blood test abnormal Joint space narrowing Magnetic resonance imaging abnormal Nerve block Pain in extremity Vitamin B12 deficiency X-ray abnormal

Symptomtext

I had a sudden dramatic increase of pain in my lower back and right leg. I went to the doctor and had a number of blood tests. MRI, and X-ray. The blood work showed a significant decrease in B-12. I've had B-12 injections, an increase in pain medication, and a nerve blockage. The pain has eased somewhat. I go to a physical therapy and a pain clinic. Last fall I had COVID-19, and the day before I tested positive for COVID-19 I started having pain in my leg which is similar to the pain that I'm feeling now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Back pain
Hospital-Tage: -
Labordaten: 19JAN2023 Blood test B-12 deficiency; 27JAN2023 MRI advanced Arthropathy; 27JAN2023 X-Ray, Joint space narrowing
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Depression; Anxiety; Restless Leg Syndrome; Hyperthyroidism; Arthritis; Sleep Apnea
Andere Medikamente: TYLENOL; amlodipine; bupropion; LEXAPRO; PEPCID; gabapentin; SYNTHROID; HYZAAR
Allergien: N/A
Vorherige Impfungen: -

VAERS 2612595

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: NY
Alter: 76,0
Geschlecht: M
Eingang: 10.04.2023
Impfdatum: 10.12.2022
Beginn: 01.03.2023
Tage bis Beginn: 81,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Asthenia Blood test normal Bronchial disorder Bronchial hyperreactivity Chest X-ray abnormal Conjunctivitis Cough Feeling abnormal Haemoptysis Oropharyngeal pain Pyrexia Viral infection Wheezing X-ray normal

Symptomtext

I had a sore throat and a bad cough in early March. Due to the symptoms, I came down with conjunctivitis. My 03/14/2023, I had very bloody phlegm. I went to my primary doctor who did an x-ray. They didn't find anything there. He prescribed me an antibiotic and something else. They advised, if it got worse, I should go to the emergency room. By the next day, I was feeling very bad with a low energy level. I ran a high fever, and I went to the emergency room and was admitted into the hospital until 03/18/2023. In the hospital, they described the reason I was there as reactive airway disease with wheezing, and it had a viral component. They first had me on Prednisone and an antibiotic for two days and two more after the discharge. Within five or six days, I went back to my primary care physician as they indicated that I should. They put me on a ten-day course of Prednisone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: 3,0
Labordaten: 14MAR2023- X-Ray - Nothing Found; 15MAR2023 - Blood Work - Nothing Found; X-Ray - Bronchial Reductions
Aktuelle Erkrankungen: None
Vorgeschichte: Congenital Heart Condition
Andere Medikamente: Pradaxa; Sotalol; Losartan Potassium; Gabapentin; Atorvastatin; Omeprazole; Alfuzosin; Generic Advair Inhaler; Eplerenone; Furosemide; Centrum Silver; Saw Palmetto; Loratadine; Zinc; Tylenol Time Release; Glucosamine Chondroitin; Vitamin C;
Allergien: Ceclor
Vorherige Impfungen: -

VAERS 2609650

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: WA
Alter: 48,0
Geschlecht: F
Eingang: 04.04.2023
Impfdatum: 29.03.2023
Beginn: 29.03.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Induration Pain Peripheral swelling Swelling Type III immune complex mediated reaction

Symptomtext

Arthus reaction, redness, swelling, induration, warmth, pain. Started at about an inch and grew to over 4x2.5 with whole arm and hand swelling.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: -
Vorgeschichte: Lymphedema s/p axillary lymph node dissection
Andere Medikamente: Premeditated with antihistamine x2 days
Allergien: Taxanes, statins, latex, dexamethasone, aromasin, flu vaccine, tdap vaccine,
Vorherige Impfungen: Experimental tumor vaccine, anaphylaxis, flu and tdap, swelling of throat and respiratory distress

VAERS 2492167

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CA
Alter: 63,0
Geschlecht: M
Eingang: 01.04.2023
Impfdatum: 18.10.2022
Beginn: 01.03.2023
Tage bis Beginn: 134,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective Fatigue Pain in extremity

Symptomtext

COVID-19; COVID-19; This is a spontaneous report received from contactable consumer. The reporter is the patient. A 64-year-old male patient received BNT162b2, BNT162b2 OMI BA.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Oct2022 at 14:45 as dose 5 (booster), single (Lot number: GJ6742) at the age of 63 years, in left arm for COVID-19 immunisation; BNT162b2 (COMIRNATY), on 09Mar2021 at 09:45 as dose 1, single (Lot number: EL3248) and on 30Mar2021 at 09:45 as dose 2, single (Lot number: EN6199) for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Allergies to penicillin" (unspecified if ongoing); "Allergies to some fruits" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL taken for hypertension. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included nirmatrelvir/ ritonavir (PAXLOVID; Lot Number: 660103) from 28Mar2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201256247 Same patient and product; different dose and event;US-PFIZER INC-2021284555 Same patient and product; different dose and event;US-PFIZER INC-2021368447 Same patient and product; different dose and event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Fruit allergy; Hypertension; Penicillin allergy
Andere Medikamente: LISINOPRIL
Allergien: -
Vorherige Impfungen: -

VAERS 2600251

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: MA
Alter: 59,0
Geschlecht: F
Eingang: 21.03.2023
Impfdatum: 17.12.2022
Beginn: 16.02.2023
Tage bis Beginn: 61,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Brain fog Burning sensation COVID-19 Fatigue Headache Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

The first day I had headache, sore throat, fatigue, and mental fogginess. Tested 2/17 with At Home COVID-19 test positive. Televisit with doctor, recommended treating symptomatically. Symptoms were mild in the mornings but as the day progressed, the symptoms got progressively worse. Developed a burning sensation in upper respiratory system later in the day. Symptoms lasted about 10 days, and then got gradually better over days 11 and 12 with fatigue that lingers. During time of fatigue, headache, burning in upper respiratory and mental fogginess reappear. Participant states they did field research and got upper respiratory illnesses every time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 17Feb2023 At Home COVID-19 test positive
Aktuelle Erkrankungen: No
Vorgeschichte: Abnormal copy of Factor V Leiden gene
Andere Medikamente: Multivitamin; Omega 3 oil
Allergien: Demerol
Vorherige Impfungen: -

VAERS 2599701

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: ME
Alter: 35,0
Geschlecht: M
Eingang: 20.03.2023
Impfdatum: 08.03.2023
Beginn: 08.03.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Lethargy Vaccination site discolouration

Symptomtext

Lingering painful headaches; lethargy; exhaustion; discoloration at the injection site where the bandaid was.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 35-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Mar2023 at 12:00 as dose 5 (booster), single (Lot number: GJ6742) at the age of 35 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: WELLBUTRIN; ATORVASTATIN; FLUOXETINE. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE; MANUFACTURER UNKNOWN, lot number and expiration date not provided.), for Covid-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE; MANUFACTURER UNKNOWN, lot number and expiration date not provided.), for Covid-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE; MANUFACTURER UNKNOWN, lot number and expiration date not provided.), for Covid-19 immunization; Covid-19 vaccine (DOSE 4 (BOOSTER), SINGLE; MANUFACTURER UNKNOWN, lot number and expiration date not provided.), for Covid-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 08Mar2023 at 16:00, outcome "not recovered", described as "Lingering painful headaches"; VACCINATION SITE DISCOLOURATION (non-serious) with onset 08Mar2023 at 16:00, outcome "not recovered", described as "discoloration at the injection site where the bandaid was."; FATIGUE (non-serious) with onset 08Mar2023 at 16:00, outcome "not recovered", described as "exhaustion"; LETHARGY (non-serious) with onset 08Mar2023 at 16:00, outcome "not recovered". Therapeutic measures were not taken as a result of headache, lethargy, fatigue, vaccination site discolouration. Additional Information: It was reported that no allergies and no other vaccination was taken in four weeks. There was no COVID prior vaccination and COVID was not tested post vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: WELLBUTRIN; ATORVASTATIN; FLUOXETINE
Allergien: -
Vorherige Impfungen: -

VAERS 2599439

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

mild

Staat: NY
Alter: 50,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 12.12.2022
Beginn: 12.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity Product administered at inappropriate site

Symptomtext

patient's mother explained patient complained injection seemed higher on her arm than normal and has been having arm pain ever since the injection. her physician said she would need an mri to properly diagnose the root cause.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: unknown- patient's mother reports needing mri per md
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: omeprazole
Allergien: unknown
Vorherige Impfungen: -

VAERS 2599111

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: NM
Alter: 54,0
Geschlecht: F
Eingang: 19.03.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature increased Chills Herpes simplex Injection site pain Oral herpes Rash Rash erythematous Rash papular Rash pruritic

Symptomtext

Strong chills and high body temperature lasting 48 hours; strong body aches lasting for 3 days; soar arm on injection location lasting 4 days; Herpes simplex (cold soar) on the left side corner of lower lip starting within 18 hours of vaccine (patient hadn't had a cold soar for at least 6-8 years before the vaccine); very itchy, slightly raised, pinkish skin rash on both sides of the thighs that went away with antihistamine (Loratadine) and appeared again every 24 hours (this side effect is persisting several weeks after the vaccine).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: One-daily multivitamin supplement, Calcium supplement, Vitamin D supplement.
Allergien: None
Vorherige Impfungen: Chills, fever, body aches, soar arm at location of injection, gallbladder pain.

VAERS 2598264

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: PA
Alter: 47,0
Geschlecht: F
Eingang: 16.03.2023
Impfdatum: 22.02.2023
Beginn: 27.02.2023
Tage bis Beginn: 5,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Cough Fatigue Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test

Symptomtext

I had low grade fever body ache, chills, extreme fatigue, congestion, and cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Covid pharmacy test 02Mar2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Allergies; Asthma; narcolepsy
Andere Medikamente: NUVARING; WEGOVY; TRELEGY; azelastine; SUNOSI; XYZAL; NASACORT; vitamin D & K
Allergien: N/A
Vorherige Impfungen: -

VAERS 2597008

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CA
Alter: 25,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 15.03.2023
Beginn: 15.03.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Hyperhidrosis

Symptomtext

Patient became diaphoretic and experienced dizziness post covid vaccine Pfizer bivalent booster. Attending nurse called team alert and emergency response team quickly arrive. Charge nurse took and attending nurse obtained vitals on 1020 with bp (n/a) p 94 rr 22 with 97% o2. 1025 BP 106/69 P 78 RR 18 AITH 99% O2, 1038 BP 116/69 P 79 O2 98%. Patient was laid Trendelenburg and monitored for 30 minutes. Patients vitals stabilized.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: MODERATE PERSISTENT ASTHMA ASTHMA ACTION PLAN
Andere Medikamente: Fluticasone-Salmeterol (Wixela Inhub) 100-50 mcg/dose Inhl Disk w/devi Fluticasone (FLOVENT HFA) 110 mcg/actuation Inhl HFAA Montelukast (SINGULAIR) 10 mg Oral Tab Albuterol (PROAIR/PROVENTIL/VENTOLIN) 90 mcg/actuation Inhl HFAA
Allergien: Peanuts amoxicillin
Vorherige Impfungen: -

VAERS 2591499

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: CA
Alter: 85,0
Geschlecht: F
Eingang: 05.03.2023
Impfdatum: 01.01.2023
Beginn: 06.01.2023
Tage bis Beginn: 5,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Injection site pain Injection site vesicles Skin weeping

Symptomtext

Patient got Pfizer bivalent dose on 1/5/23. Came back 3/4/23 and reported that she had experienced oozing and tenderness on spot of injection from Pfizer bivalent. She said the oozing occurred not too long after 1/5/23 and it continued for weeks. As of 3/4/23 there was no more oozing, but there is a covered blister-like formation exactly on the spot of injection- subjective from the patient. Patient reported that she did not see a healthcare provider about this ADR until now, because she thought it would get better. On 3/4/23, we told patient to see primary care physician as soon as possible for further treatment options, and that everything would be reported to VAERS as this is a first time this kind type of ADR was reported to us.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2590330

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: NE
Alter: 16,0
Geschlecht: M
Eingang: 02.03.2023
Impfdatum: 01.03.2023
Beginn: 01.03.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Allergy to vaccine Cough Hypersensitivity Pruritus Rash Rash erythematous Rash pruritic Throat irritation Urticaria

Symptomtext

Per notes from medical provider: ?HPI Patient comes in for evaluation of rash. Onset of rash 315. Had just received immunizations including COVID booster, yellow fever, typhoid and flu vaccine 215. Rash is itchy and red. Rash is generalized and spread to his chest back arms neck abdomen and legs. Rash is itchy. States his throat feels irritated and scratchy. States he did have nausea but that is better. Denies chest pain or airway closure. States he did take some ibuprofen. He denies body aches, headache, syncope. Denies history of allergic reactions to vaccines in the past. Mother accompanies patient here in the clinic. Allergic Reaction This is a new problem. The current episode started today. The problem occurs daily. The problem has been rapidly worsening since onset. Associated symptoms include coughing (dry) and a rash. Pertinent negatives include no abdominal pain, chest pain, eye itching, eye redness, stridor, trouble swallowing, vomiting or wheezing. There is no history of food allergies. Encounter Diagnoses -T80.69XA Allergic reaction to vaccine -L50.9 Hives -L29.9 Pruritus Patient was seen today for allergic reaction. Diagnoses and all orders for this visit: Allergic reaction to vaccine - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Educated mother she can give another Benadryl 25 mg if needed. Educational handout given on medications. Educated on EpiPen. If airway closure did educate on administration of EpiPen and to go to the ER immediately or call 911. Mother in agreement with plan and verbalized understanding. Hives - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Pruritus - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min?

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: no known illnesses
Vorgeschichte: Irregular heart beat Premature ventricular contractions Ventricular trigeminy Trigeminy
Andere Medikamente: cetirizine (ZYRTEC) 10 mg EPINEPHrine (EPIPEN) 0.3mg/0.3 mL Atln fluticasone propionate (FLONASE) 50 mcg/actuation nasal spray
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2589521

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: GA
Alter: 44,0
Geschlecht: F
Eingang: 01.03.2023
Impfdatum: 21.02.2023
Beginn: 22.02.2023
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site pain Injection site swelling Pain

Symptomtext

Received COVID Bivalent booster on Tuesday 2/21/23 during annual checkup. The following day (2/22/23) she developed swelling (lemon sized) and burning/ aching pain under her left arm which radiated to her elbow and shoulder. This is the arm in which she received the vaccine. This lasted several days. The swelling gradually improved over several days and resolved on 2/25/23

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2586348

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge GJ6742

mild

Staat: OH
Alter: 85,0
Geschlecht: M
Eingang: 23.02.2023
Impfdatum: 14.02.2023
Beginn: 14.02.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Immunisation reaction Injection site bruising

Symptomtext

Patient's step-daughter came in stating that the patient had experienced an adverse affect from the vaccination he received on 02/14/23. She noted that his arm around the location of the shot "turned black and blue." Did not note any swelling or unusual pain associated with the injection. She said her father wrapped the area with a bandage. The patient did not come to the pharmacy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None.
Vorgeschichte: High cholesterol, prostate dysfunction.
Andere Medikamente: Atorvastatin 40mb, Finasteride ,5mg. No known OTC medications.
Allergien: No known allergies.
Vorherige Impfungen: -

VAERS 2586295

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: AZ
Alter: 53,0
Geschlecht: F
Eingang: 23.02.2023
Impfdatum: 20.01.2023
Beginn: 19.02.2023
Tage bis Beginn: 30,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bone pain COVID-19 Cough Oropharyngeal pain Pain Pyrexia Rhinorrhoea SARS-CoV-2 test Upper-airway cough syndrome

Symptomtext

I started having sore throat, postnasal drip, fever (100-101), runny nose, cough, body pain and bone discomfort. I went to urgent care, and they were closed then I went again on Monday. I was given albuterol inhaler, azelastine, benzonatate, lidocaine, prednisone, and ipratropium. It is helping and I started recovering over the course of three days. I am surprised that I got COVID-19 30 days after getting the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bone pain
Hospital-Tage: -
Labordaten: COVID-19 at home test
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: STRATTERA; LEXAPRO
Allergien: Sulfa; penicillin
Vorherige Impfungen: -

VAERS 2586284

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: AZ
Alter: 53,0
Geschlecht: F
Eingang: 23.02.2023
Impfdatum: 20.02.2023
Beginn: 20.02.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chills Fatigue Feeling abnormal Myalgia Pain Substance use

Symptomtext

After receiving the fifth dose of Pfizer I started having brain fog, fatigue, chills and the next day I had all over body, joint, and muscle pain. I did not take the methocarbamol instead I used cannabis which helped, and I had zero pain and the other medication had a side effect of depression. The pain only lasted for about two days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: STRATTERA
Allergien: Sulfa; penicillin
Vorherige Impfungen: -

VAERS 2584345

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: MI
Alter: 55,0
Geschlecht: F
Eingang: 20.02.2023
Impfdatum: 19.11.2022
Beginn: 14.01.2023
Tage bis Beginn: 56,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache

Symptomtext

Headache in exactly the same spot on the side where the vaccine was given. Does not respond well to NSAIDS rizatriptan refilled to counter headaches. Will be getting an MRI for more info in the future.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: Psoriasis
Andere Medikamente: Sertraline; Wellbutrin; Estoile; Multivitamin; Calcium; Vitamin B Complex with C and Zinc; Vitamin B12; Obvi Detox; Guilt by Obvi; Obvi Burn; OBVI Super Collogen Protein; Magnesium; Advil PM; Benadryl
Allergien: Toradol skm
Vorherige Impfungen: -

VAERS 2582957

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: -
Alter: 72,0
Geschlecht: F
Eingang: 16.02.2023
Impfdatum: 26.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Colonoscopy normal Diarrhoea Laboratory test normal Nausea Stool analysis normal Ultrasound scan normal

Symptomtext

Per pt, the "massive" diarrhea started the next evening after the vaccine, she also had some nausea. After 4-5 days, she took imodium and this improved her symptoms. She has been keeping in contact with her gastroenterologist and states she has already done stool testing, lab tests, colonoscopy, and US and they have been all been normal. Even now about 3 weeks later, when she doesn't take Imodium, the "runs" come back. When she takes Imodium, she only needs to pass stools 1-2 times per day. She doesn't want to take Imodium everyday, which she discussed with her GI doctor. He recommended that she try metamucil. She has also stopped her tumeric supplement. She has not start the metamucil yet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: States she has already done stool testing, lab tests, colonoscopy, and US and they have been all been normal.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2582596

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: MI
Alter: 26,0
Geschlecht: F
Eingang: 15.02.2023
Impfdatum: 06.12.2022
Beginn: 31.12.2022
Tage bis Beginn: 25,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test normal Exfoliative rash Herpes simplex test negative Pityriasis rosea Rash Rash erythematous Scar

Symptomtext

Red scaly rash developed on December 31, 2022 on chest, then spread to arms, stomach, and back in the days and weeks following. On January 17th, 2023 I saw my doctor, and it was then diagnosed as pityriasis rosea. As of February 15, 2023 the rash is still present, but getting better. Some scarring is occurring with the rash spots, but the color is fading to skin tone on the first of the spots. The rash spots that did not develop initially are still red.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Exfoliative rash
Hospital-Tage: -
Labordaten: Visual exam on January 17, 2023 by my doctor and another doctor in the office diagnosed the rash as pityriasis rosea. Because herpes is a possible cause of the rash, I took a blood test for herpes (HSV 1 and 2 IGG) on January 19, 2023. That test came back negative with no previous exposure to herpes.
Aktuelle Erkrankungen: Cough & cold symptoms, sore throat, white throat and tonsils
Vorgeschichte: Obesity
Andere Medikamente: Vyvanse 50mg capsule taken once daily. Occasional imodium (generic).
Allergien: None known
Vorherige Impfungen: -

VAERS 2582018

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: -
Alter: 43,0
Geschlecht: F
Eingang: 15.02.2023
Impfdatum: 27.10.2022
Beginn: 09.02.2023
Tage bis Beginn: 105,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Nasal congestion Oropharyngeal pain

Symptomtext

ST; fatigue; congestion; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). A 43-year-old female patient (unknown if pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 43 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose:1, manufacturer unknown), for Covid-19 Immunization, reaction(s): "ag test 10Feb2023"; Covid-19 vaccine (Dose: 2, manufacturer unknown), for Covid-19 Immunization, reaction(s): "ag test 10Feb2023"; Covid-19 vaccine (Dose: 3, manufacturer unknown), for Covid-19 Immunization, reaction(s): "ag test 10Feb2023". The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 09Feb2023, outcome "recovering", described as "ST"; NASAL CONGESTION (non-serious) with onset 09Feb2023, outcome "recovering", described as "congestion"; FATIGUE (non-serious) with onset 09Feb2023, outcome "recovering". It was unknown if therapeutic measures were taken as a result of oropharyngeal pain, fatigue, nasal congestion. Additional information: Facility type vaccine was workplace clinic. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300063647 same patient, different dose/drug/event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578942

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: IL
Alter: 15,0
Geschlecht: M
Eingang: 09.02.2023
Impfdatum: 07.01.2023
Beginn: 01.01.2023
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Gait disturbance Limb discomfort Pain in extremity

Symptomtext

Presents for R Arm pain after covid vaccine, appointment was made after covid vaccine - arm is better now Right after had vaccine, pain straight down arm and lasted for few days Also after vaccine felt like legs were heavy, difficulty walking, resolved after few days

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Food allergies, Autism
Andere Medikamente: -
Allergien: Cashews, Mold, Walnuts
Vorherige Impfungen: -

VAERS 2577261

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge gj6742

mild

Staat: VA
Alter: 48,0
Geschlecht: F
Eingang: 07.02.2023
Impfdatum: 02.12.2022
Beginn: 04.12.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Abdominal pain upper Biliary dilatation Blood alkaline phosphatase normal Blood urine present Cholecystectomy Cholecystitis Cholelithiasis Full blood count normal Gallbladder enlargement Gallbladder oedema Laparoscopic surgery Lipase normal Liver function test normal Metabolic function test normal Ultrasound biliary tract abnormal Urine analysis abnormal

Symptomtext

Acute RUQ abdominal pain developed 12/4 after eating cheese. Patient has no prior history of gallstones or gallbladder disease. Patient presented to ER 12/4 and ultrasound was initially read as negative. On 12/5 attending radiologist re-read ultrasound as consistent with cholecystitis with biliary sludging and pain persisted, patient returned to ER for surgical consultation. Laparoscopic cholecystectomy was performed 12/5 and the patient was hospitalized and observed overnight. Recovery was uneventful.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain upper
Hospital-Tage: 1,0
Labordaten: 12/4: normal comprehensive metabolic panel including LFTs and alk phos Normal lipase, normal CBC, UA with small blood but otherwise normal Ultrasound preliminarily read as normal but changed on 12/5 to "acute cholecystitis": "gallbladder distended with striated wall thickening due to edema. The wall measures up to 0.5 cm. There is sludge in the gallbladder. No gallstone identified. Small pericholecystic fluid is present."
Aktuelle Erkrankungen: none
Vorgeschichte: endometriosis
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2576610

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: FL
Alter: 87,0
Geschlecht: F
Eingang: 06.02.2023
Impfdatum: 27.12.2022
Beginn: 29.12.2022
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash

Symptomtext

Two days after vax, patient started breaking out on lt arm. Noticed a rash and worsened overtime. Had a feeling it was the vax, because she does not have allergies. Pharmacist advised going to PCP, and doctor said it's an allergy. However, nothing indicated the cause of the rash. Gave her medication cream Triamcinolone Acetonide Creme, and patient used peroxide to clean it and the cream 2x a day. After 3 weeks, cream made rash worse and patient stopped using the cream. Rash still there and patient using Witch Hazel spray and Neosporin for pain relief. Patient tired of treating herself. Some drying up but still prevalent.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: NO
Aktuelle Erkrankungen: NO
Vorgeschichte: Anxiety Hypertension
Andere Medikamente: Lisinopril 20MG Alprazolam 1MG Biotin Ensure Multivitamins
Allergien: NO
Vorherige Impfungen: -

VAERS 2573467

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: SC
Alter: 44,0
Geschlecht: F
Eingang: 01.02.2023
Impfdatum: 30.01.2023
Beginn: 01.02.2023
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Flank pain Haematuria Myalgia

Symptomtext

Gross hematuria and right flank pain, myalgias (generalized

Weitere VAERSDATA-Felder

Praegender Schweregrund: Flank pain
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: NA
Vorgeschichte: Heart murmur
Andere Medikamente: Benadryl, Melatonin, MVI, Omeprazole and Wellbutrin
Allergien: Zantac
Vorherige Impfungen: -

VAERS 2569143

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: MI
Alter: 41,0
Geschlecht: M
Eingang: 26.01.2023
Impfdatum: 08.01.2023
Beginn: 09.01.2023
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Antibody test Arthralgia Blood creatinine C-reactive protein Conjunctivitis Fatigue Full blood count Laboratory test Lymphadenopathy Metabolic function test Oropharyngeal pain Pain Pain in extremity Rash Rash pruritic Red blood cell sedimentation rate Skin warm Spinal pain

Symptomtext

Received booster on left arm 1/8/2023. Left arm sore and warm remainder of the day. 1/9/2023 felt fatigued. 1/10/2023 felt fine. 1/11/2023 fatigue returned. 1/12/2023 enlarged lymph node right side of neck. 1/14/2023 pain cervical spine radiated to right arm lasted a few days. 1/17/2023 rash under arms down trunk also groin area above buttocks which was itchy. 1/18/2023 pink eye in left eye. 1/21/2023 developed arthralgias in both legs, shoulders, knees and ankles. Sore throat since injection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Lab tests 1/25/2023 CBC, CMP, Sed Rate, UA, CRP, Pneumonia Antibody 5 gm, Creatinine
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2568083

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: VA
Alter: 65,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 04.01.2023
Beginn: 04.01.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Chills Decreased appetite Diarrhoea Fatigue Flatulence Nausea Pain in extremity Vision blurred

Symptomtext

03/11/21 - slight headache rest of Day after shot. OK 04/04/21 - Same as above, OK NEXT DAY after shot. 12/16/21 - Same as above. 06/06/22 - Same as above. *See Next page for last shot - issues. 01/04/2023 - 3rd Booster shot. After morning shot, headache in afternoon. Gone by evening. Arm sore. 01/06/2023 - Morning wake up with bad nausea. This lasted all day. Barely ate anything all day, chills. Repeated diarrhea all day, along with severe tiredness. Joint pain. Rested all day. this was all gone by Next day. Arm sore. 01/10/2023 - Woke up with diarrhea and intestonal gas. Gone buy next day. 01/18/2023 - Woke up with left eye blurred vision. This was gone next day. 01/19/2023 - Woke up with nausea and intestonal gas. Texted my Doctor about this repeat issue. Advised virtually that the latest Covid Booster is causing this. Told to treat with over the counter remedies. Symptoms gone next day. 01/20/2023 - Feeling well again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Testosterone 1.62 Daily Rosuvastatin .5 mg daily
Allergien: None
Vorherige Impfungen: -

VAERS 2567655

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: MD
Alter: 69,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 20.01.2023
Beginn: 20.01.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pruritus Rash Urticaria

Symptomtext

Pt states on 1/20/23 he received covid booster shot here at clinic. Started to have itching, rash and urticaria same day, Hot water showers helped, has taken 5 showers per day for past few days Did not eat anything new, no new detergents, soaps. No food allergies, no medication changes 4 days after event, started taking OTC diphenhydramine, taking 50mg q4 hours. Urticaria has resolved, itching improved, rash resolved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Asymptomatic HIV infection Z21 Cataract of both eyes H26.9 Myopia with astigmatism and presbyopia, bilateral H52.13, H52.203, H52.4 Open angle with borderline findings and high glaucoma risk in both eyes H40.023 Long term current use of anticoagulant therapy Z79.01 Mural thrombus of cardiac apex following MI I23.6 Protein S deficiency D68.59 Essential hypertension I10 Pure hypercholesterolemia E78.00 CAD with history of anterior MI I25.10 Tobacco use Z72.0 Ischemic dilated cardiomyopathy I25.5, I42.0 Mild cognitive disorder F09 BPH associated with nocturia N40.1, R35.1 Elevated PSA R97.20 LV (left ventricular) mural thrombus I51.3 CKD (chronic kidney disease) N18.9 Pap smear of anus with ASCUS R85.610
Andere Medikamente: ? acyclovir (Zovirax) 5 % ointment ? aspirin 81 MG EC tablet ? atorvastatin (LIPITOR) 20 MG tablet ? blood pressure test kit-medium Kit ? cholecalciferol (VITAMIN D3) 1,000 unit tablet ? darunavir ethanolate (Prezista) 800 mg tablet ? dolut
Allergien: None
Vorherige Impfungen: -

VAERS 2564105

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CO
Alter: 62,0
Geschlecht: M
Eingang: 20.01.2023
Impfdatum: 13.01.2023
Beginn: 13.01.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature Chills Headache Nausea Pain Pyrexia Respiratory tract congestion Vaccination site pain Vaccination site rash

Symptomtext

FEVER up to 103 F; Chills; Aches; headache; congestion in chest; nauseous; strong ache in left arm; Rash on arm of injection; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 62-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Jan2023 at 13:45 as dose 3 (booster), single (Lot number: GJ6742) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: adhesive on some band aids" (unspecified if ongoing), notes: known allergies: adhesive on some band aids. Concomitant medication(s) included: ATORVASTATIN; MIRTAZAPINE. Vaccination history included: BNT162b2 (Dose Number: 2, Brand: PFIZER, SARS-COV2 (COVID-19) VACCINE, Batch/Lot No: Lot number: #EW0151, Location of injection: Arm Left), administration date: 08Apr2021, when the patient was 60-year-old, for COVID-19 Immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: Lot number: #EN6207, Location of injection: Leg Left), administration date: 18Mar2021, when the patient was 60-year-old, for COVID-19 Immunization, reaction(s): "Location of injection: Leg Left". The following information was reported: PAIN (non-serious) with onset 13Jan2023 at 19:30, outcome "not recovered", described as "Aches"; CHILLS (non-serious) with onset 13Jan2023 at 19:30, outcome "not recovered"; PYREXIA (non-serious) with onset 13Jan2023 at 19:30, outcome "not recovered", described as "FEVER up to 103 F"; VACCINATION SITE RASH (non-serious) with onset 13Jan2023 at 19:30, outcome "not recovered", described as "Rash on arm of injection"; RESPIRATORY TRACT CONGESTION (non-serious) with onset 13Jan2023 at 19:30, outcome "not recovered", described as "congestion in chest"; HEADACHE (non-serious) with onset 13Jan2023 at 19:30, outcome "not recovered"; NAUSEA (non-serious) with onset 13Jan2023 at 19:30, outcome "not recovered", described as "nauseous"; VACCINATION SITE PAIN (non-serious) with onset 13Jan2023 at 19:30, outcome "not recovered", described as "strong ache in left arm". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, chills, pain, headache, respiratory tract congestion, nausea, vaccination site pain, vaccination site rash. Additional information: No other vaccines reported to have administered in four weeks. Medications in two weeks included mirtazapine 15 mg /atorvastatin 10 mg. Patient did not had covid prior vaccination nor tested positive post vaccination but reported known allergies to adhesive on some band aids.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Test Name: Fever; Result Unstructured Data: Test Result:103 Fahrenheit; Comments: FEVER up to 103 F
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Adhesive tape allergy (known allergies: adhesive on some band aids)
Andere Medikamente: ATORVASTATIN; MIRTAZAPINE
Allergien: -
Vorherige Impfungen: -

VAERS 2562340

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: NV
Alter: 5,0
Geschlecht: M
Eingang: 18.01.2023
Impfdatum: 01.01.2023
Beginn: 18.01.2023
Tage bis Beginn: 17,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity

Symptomtext

Sore right arm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2561565

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: FL
Alter: 79,0
Geschlecht: F
Eingang: 17.01.2023
Impfdatum: 29.10.2022
Beginn: 29.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Cough Hypoacusis Influenza Influenza virus test negative Lip blister Neck pain Pyrexia SARS-CoV-2 test negative Skin erosion Sneezing

Symptomtext

She got her vaccine and about an hour later she started coughing, sneezing. She called the pharmacy and they said there was no information on the vaccine yet. She then started using a box of tissues a day due to blowing her nose so much, running a high fever as her top lip blistered up and had a raw nose from all the blowing. She had pains running down both sides of her neck to her shoulders. This went on for about a week. Her best kept trying to call her, she did not answer the phone. She could not hear the phone ringing next to her as a friend was trying to get a hold of her. Her friend called her son and he told her she had to go to the hospital Her BP 85/42 and was given two prescription. She was negative for COVID and the flu even though she had the symptoms of the flu. She wasn't getting better so she called her PCP who called her in Amoxicillin which she has been on for a week. She has to Friday to finish it. She is almost 100% completely. She forced herself to get up after she went home from the ER, and gradually started improving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: No new medications.
Allergien: None.
Vorherige Impfungen: -

VAERS 2561370

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: IL
Alter: 31,0
Geschlecht: M
Eingang: 17.01.2023
Impfdatum: 04.01.2023
Beginn: 07.01.2023
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash

Symptomtext

A rash to upper torso, back, bilateral knees.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: None ordered
Aktuelle Erkrankungen: No acute illnesses at time of vaccination up to one year prior
Vorgeschichte: Severe intellectual disabilities, congenital herpes encephalopathy, seizure disorder
Andere Medikamente: Fluticasone, Lorazepam, Naltrexone, Sertraline, Tab-A-Vite, Azelastine Nasal, Cetirizine, Divalproex Sod DR, Risperidone, Clonidine, Acetaminophen, Immodium A-D, Diphenhydramine, Hydrocortisone, Mupirocin, Triamcinolone, Melatonin, spray
Allergien: Augmentin
Vorherige Impfungen: -

VAERS 2561335

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: IN
Alter: 16,0
Geschlecht: M
Eingang: 17.01.2023
Impfdatum: 09.01.2023
Beginn: 10.01.2023
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Fatigue Feeling hot Headache Pain Poor quality sleep

Symptomtext

He started with dizziness described as the floor being unsteady. Almost like vertigo. He also had headaches, not sure if it was a specific place since he complained about the whole head, and he complained about body aches. He also was fatigued yet could not sleep well. His temperature was normal, not feverish however he complained that he felt like he had a fever. Doctor was not able to see him, so it was either wait 4 weeks for an appointment or go to the ER. We opted to stay at home. He has recovered a bit, just doing home care and giving him electrolytes. Within 12 hours he started to feel better. Everyday he felt better, and is almost fully recovered now 5 days later.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vitamin B
Allergien: None
Vorherige Impfungen: -

VAERS 2561306

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

mild

Staat: IL
Alter: 61,0
Geschlecht: F
Eingang: 17.01.2023
Impfdatum: 17.12.2022
Beginn: 18.12.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Breast pain Neck pain

Symptomtext

Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Severe, Additional Details: intense pain in shoulder, neck, and left lower portion of left breast

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2560884

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: KS
Alter: 49,0
Geschlecht: F
Eingang: 16.01.2023
Impfdatum: 10.12.2022
Beginn: 05.01.2023
Tage bis Beginn: 26,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest discomfort Fatigue Headache Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I woke up with a fever took a home COVID-19 test that came negative. I tested because my husband had tested positive and I thought I may also get it. I retested the next day and the home COVID-19 test then came back positive. I had a low-grade fever, aches, headache that lasted for six days. Then I started having a tightness in my chest, I called the doctor, he prescribed me a MEDROL dose pack. I am still feeling tired, but I am not using the inhaler as much.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home COVID-19 test positive
Aktuelle Erkrankungen: No
Vorgeschichte: Mild Asthma
Andere Medikamente: Verapamil; olmesartan; NEXIUM; vitamin D; ZYRTEC; SINGULAIR; vitamin B-12 injections
Allergien: ULTRAM
Vorherige Impfungen: -

VAERS 2560096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: FL
Alter: 54,0
Geschlecht: M
Eingang: 14.01.2023
Impfdatum: 20.12.2022
Beginn: 21.12.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Loss of personal independence in daily activities Vertigo positional

Symptomtext

Wife reported that day after receiving vaccines, her husband started feeling very dizzy, and like having vertigo with position changes. These symptoms disrupted his ability to conduct normal daily functions for days. He had never complained of dizziness or vertigo before. He had continued experiencing the symptoms but already feeling better by the day it was reported. He never went to the doctor or hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes
Andere Medikamente: Glimepiride, Simvastatin, Furosemide, Victoza, Metformin, Vitamin D
Allergien: Penicillin, bees
Vorherige Impfungen: -

VAERS 2560054

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: MA
Alter: 49,0
Geschlecht: F
Eingang: 14.01.2023
Impfdatum: 08.01.2023
Beginn: 08.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema

Symptomtext

Site: Redness at Injection Site-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2559509

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: WI
Alter: 75,0
Geschlecht: M
Eingang: 13.01.2023
Impfdatum: 06.01.2023
Beginn: 08.01.2023
Tage bis Beginn: 2,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Cough Headache Influenza like illness Lacrimation increased Nasal congestion Pyrexia Vision blurred Vocal cord disorder

Symptomtext

Flue like symptoms, cough, fever, headache, nose congestion, affecting vocal cords, blurred vision/tearing . All symptoms are of a low grade nature (not severe).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2554819

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: WI
Alter: 13,0
Geschlecht: F
Eingang: 09.01.2023
Impfdatum: 09.01.2023
Beginn: 09.01.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Urticaria

Symptomtext

Patient developed 1 hive on inside of left wrist. She had no other symptoms and the hive resolved with in 2 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: pharingitis
Vorgeschichte: mild intermittent asthma
Andere Medikamente: unknown
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2554249

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: -
Alter: 52,0
Geschlecht: M
Eingang: 07.01.2023
Impfdatum: 22.12.2022
Beginn: 22.12.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Injection site pain Myalgia

Symptomtext

Myalgia fatigue, soreness at injection site Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2554245

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge gj6742

mild

Staat: -
Alter: 63,0
Geschlecht: F
Eingang: 07.01.2023
Impfdatum: 05.01.2023
Beginn: 05.01.2023
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Myalgia

Symptomtext

Headache & Myalgia Narrative: NA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2552590

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: PA
Alter: 60,0
Geschlecht: F
Eingang: 06.01.2023
Impfdatum: 03.01.2023
Beginn: 03.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination site rash Vaccination site urticaria

Symptomtext

rash/hives at site of immunization and below waist not itching

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2551523

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: MO
Alter: 38,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 02.01.2023
Beginn: 03.01.2023
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Feeling hot Lymph node pain Lymphadenopathy Night sweats Oral herpes Pain Petechiae

Symptomtext

That night I had severe body aches and muscle spasms and during the night developed tender/swollen LEFT axillary lymph nodes. FYI: I've never had cosmetic fillers before. Tuesday during the day I felt feverish with chills (although had a normal temperature), worsening swelling to LEFT axillary lymph nodes, and night sweats. Wednesday, I continued to be achy, have tender/swollen lymph nodes and night sweats, and also developed petechiae on my face. Today on Thursday, I developed cold sore on my lip.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: Adderall; Yaz; Venlafaxine; Zyrtec.
Allergien: Garlic
Vorherige Impfungen: COVID Pfizer #2 5/2021 had similar reaction

VAERS 2550950

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CA
Alter: 32,0
Geschlecht: M
Eingang: 05.01.2023
Impfdatum: 03.11.2022
Beginn: 29.12.2022
Tage bis Beginn: 56,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature Chills Hyperacusis Off label use Pain COVID-19 SARS-CoV-2 test Vaccination failure Photophobia Product use issue Productive cough Pyrexia Sneezing Vomiting

Symptomtext

Clinitest Rapid COVID-19 Antigen Self-Test positive; Clinitest Rapid COVID-19 Antigen Self-Test positive; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient. A 32-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 03Nov2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 32 years for COVID-19 immunisation; BNT162b2 (BNT162B2), on 19Apr2021 as dose 1, single (Lot number: EN6199), on 11May2021 as dose 2, single (Lot number: EN6199) and on 08Dec2021 as dose 3 (booster), single (Lot number: FF8841) for COVID-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 29Dec2022, outcome "unknown" and all described as "Clinitest Rapid COVID-19 Antigen Self-Test positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29Dec2022) Positive, notes: Nasal Swab.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300002490 Same reporter/patient/drug; different AE;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Test Date: 20221229; Test Name: Clinitest Rapid COVID-19 Antigen Self-Test; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: other medical history No
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2550942

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: MA
Alter: 78,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 18.12.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood sodium Headache Hyponatraemia Investigation Nausea Vomiting

Symptomtext

chronic hyponatremia; Nausea; vomiting; Headache; weak; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient. A 78-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Dec2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 78 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Coronary artery disease" (unspecified if ongoing), notes: Comments: Coronary artery disease; "she is a heart patient" (unspecified if ongoing), notes: Went to hospital Wednesday because, she is a heart patient. They thought she was having a heart attack.; "blood thinners" (unspecified if ongoing), notes: blood thinners. The patient took concomitant medications. Vaccination history included: BNT162b2 (First Dose: 25Feb2021, LOT: EN6955, NDC, EXP: Unknown), administration date: 25Feb2021, when the patient was 77-year-old, for Covid-19 immunization, reaction(s): "MI"; BNT162b2 (Second Dose: 01Jul2021, LOT: EW0198, NDC, EXP: Unknown), administration date: 01Jul2021, when the patient was 77-year-old, for Covid-19 immunization; BNT162b2 (Third Dose: 09Feb2022, LOT: FM0698, NDC, EXP: Unknown), administration date: 09Feb2022, when the patient was 78-year-old, for Covid-19 immunization. The following information was reported: HYPONATRAEMIA (hospitalization), outcome "unknown", described as "chronic hyponatremia"; NAUSEA (hospitalization), outcome "not recovered"; VOMITING (hospitalization), outcome "unknown"; HEADACHE (hospitalization), outcome "unknown"; ASTHENIA (non-serious), outcome "not recovered", described as "weak". The patient was hospitalized for hyponatraemia, nausea, vomiting, headache (start date: 21Dec2022, discharge date: 24Dec2022, hospitalization duration: 4 day(s)). The events "chronic hyponatremia", "nausea", "vomiting", "headache" and "weak" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Blood sodium: low; Test: everything was fine, notes: They did all the tests even again and everything was fine. Additional Context: Call regarding latest Pfizer Omicron Bivalent vaccine. She was hospitalized and had the vaccine Sunday. The next 2 days, stayed home and Wednesday morning went in to the hospital with chronic hyponatremia. Had nausea vomiting, headache, is nearly 79 years old, which she will be in 2 weeks. Wishes she never had it. Has not been sick like this in years. She was told the vaccine was only tried on mice and, Pfizer was rushing through these vaccines with no approval from the FDA, just through emergency orders. Spoke to 2 doctors, one who discharged her, when she was hospitalized over Christmas. Both doctors assured her that the Pfizer booster has 2 subvariants like double doses than the previous booster. They, sadly, are not allowed to talk about it or place a diagnosis on her discharge papers. It is all political. Patient weight was 126, was not weighed upon discharge but has appointment next week with primary. Hope sit is no more than 120. Is still recovering. Has not seen her yet, it was a terrible reaction. She is through. Next appointments Tuesday, after the new year with the FDA. Is not doing the CDC because you can only do that online and is not well enough to do that. Chronic hyponatremia, From there, had no symptoms right away. went to hospital because, she was a heart patient. They thought she was having a heart attack. She went by ambulance to the hospital. Came out Christmas eve, 24Dec2022. was home a couple of days, was really weak. Went right back to urgent care at. They kept her there all day. Sodium was a little better but still low. went back in because she had choked on some small amount of food, what little food she was eating. Came home that same day about 7 hours later, was not admitted that time. Still has nausea and is very weak. Apparently, her lungs are fine. Thinks there is a lot of other people put there with far more worse reactions that she had. She was one of the lucky ones. Relatedness of drug to reaction(s)/event(s): Source of assessment: Primary Source Reporter, Method of assessment: Global Introspection. Result of Assessment: Yes. Reporter details: Retired nurse, RN, is 79 years old. Should have know n better that to receive this vaccine. Causality: Most definitely this was all caused by the Omicron Bivalent booster. Was fine before and had'nt caught the flu or anything from anyone else.; Sender's Comments: Based on the available information and close temporal association, a possible causal relationship cannot be excluded between the suspect vaccine BNT162b2 and the reported events "hyponatremia", "vomiting", "headache", "nausea". The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202300002475 Same patient, different vaccine dose number and different event.;US-PFIZER INC-202300002476 Same patient, different vaccine dose number and different event.;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: 4,0
Labordaten: Test Name: Sodium; Result Unstructured Data: Test Result:low; Test Name: Test; Result Unstructured Data: Test Result:everything was fine; Comments: They did all the tests even again and everything was fine.
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood disorder (blood thinners); Coronary artery disease (Comments: Coronary artery disease); Heart disorder (Went to hospital Wednesday because, she is heart patient. They thought she having heart attack.)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2548252

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

mild

Staat: TX
Alter: 59,0
Geschlecht: M
Eingang: 02.01.2023
Impfdatum: 16.12.2022
Beginn: 26.12.2022
Tage bis Beginn: 10,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash papular

Symptomtext

Patient reports a raised rash on 1/2 of his body. Rash comes and goes and is more severe at times than others. Patient has used a topical benadryl product along with zyrtec 10mg orally and famotidine 20mg orally

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash papular
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2547684

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: -
Alter: 75,0
Geschlecht: F
Eingang: 31.12.2022
Impfdatum: 09.12.2022
Beginn: 10.12.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site erythema Injection site pain Injection site pruritus Injection site swelling

Symptomtext

Swelling at the injection site Large circle of redness at injection site Itching Injection site pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: metroprolol tart tab 25 mg multiple vitamin biotin fish oil COQ10 Calcium Vitamin D 81 mg aspirin colace garlique
Allergien: tramadol
Vorherige Impfungen: -

VAERS 2547599

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: OH
Alter: 17,0
Geschlecht: F
Eingang: 31.12.2022
Impfdatum: 27.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Nausea Pyrexia Vaccination site pain

Symptomtext

Soreness at injection site; nausea; headache; fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 17-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Dec2022 at 14:30 as dose 3 (booster), single (Lot number: GJ6742) at the age of 17 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "IBS" (unspecified if ongoing); "ADHD" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Peanuts" (unspecified if ongoing). Concomitant medication(s) included: SERTRALINE; VITAMIN D [COLECALCIFEROL]; STRATTERA. Vaccination history included: BNT162b2 (DOSE 2, SINGLE, Pfizer BioNTech, Batch/Lot No: FC3180, Location of injection: Arm Left, Vaccine Administration Time: 06:00 PM), administration date: 10Aug2021, when the patient was 15-year-old, for COVID-19 immunization, reaction(s): "COVID-19"; BNT162b2 (DOSE 1, SINGLE, Pfizer BioNTech, Batch/Lot No: FA6780, Location of injection: Arm Left, Vaccine Administration Time: 06:00 PM), administration date: 20Jul2021, when the patient was 15-year-old, for COVID-19 immunization, reaction(s): "COVID-19". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 27Dec2022 at 18:00, outcome "recovering", described as "Soreness at injection site"; PYREXIA (non-serious) with onset 27Dec2022 at 18:00, outcome "recovering", described as "fever"; HEADACHE (non-serious) with onset 27Dec2022 at 18:00, outcome "recovering"; NAUSEA (non-serious) with onset 27Dec2022 at 18:00, outcome "recovering". Therapeutic measures were not taken as a result of vaccination site pain, nausea, headache, pyrexia. Additional information: Location of injection for vaccine received same date: Influenza-Left arm. The most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient been had not tested for COVID-19, since the vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: ADHD; Anxiety; Food allergy; Irritable bowel syndrome
Andere Medikamente: SERTRALINE; VITAMIN D [COLECALCIFEROL]; STRATTERA
Allergien: -
Vorherige Impfungen: -

VAERS 2547594

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: OH
Alter: 56,0
Geschlecht: F
Eingang: 31.12.2022
Impfdatum: 27.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination site pain

Symptomtext

Soreness in left arm at injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 56-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Dec2022 at 14:30 as dose 4 (booster), single (Lot number: GJ6742) at the age of 56 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "IBS" (unspecified if ongoing), notes: IBS; "Cervical Focal Dystonia" (unspecified if ongoing), notes: Cervical Focal Dystonia; "Diverticulosis" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin; "covid" (unspecified if ongoing), notes: if covid prior vaccination reported as yes. Concomitant medication(s) included: AMLODIPINE; ATORVASTATIN; TIZANIDINE; LEVOTHYROXIN. Past drug history included: Codeine, reaction(s): "Known allergies: Codeine", notes: known allergies: Codeine; Erythromycin, reaction(s): "Known allergies: Erythromycin", notes: Known allergies: Erythromycin. Vaccination history included: Covid-19 vaccine (Dose: 1, Unknown Manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose: 2, Unknown Manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose: 3, Unknown Manufacturer), for Covid-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 27Dec2022 at 18:00, outcome "recovering", described as "Soreness in left arm at injection site". Therapeutic measures were not taken as a result of vaccination site pain. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. if covid tested post vaccination reported as no.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Cervical dystonia (Cervical Focal Dystonia); COVID-19 (if covid prior vaccination reported as yes.); Diverticulosis; Irritable bowel syndrome (IBS); Penicillin allergy (Known allergies: Penicillin)
Andere Medikamente: AMLODIPINE; ATORVASTATIN; TIZANIDINE; LEVOTHYROXIN
Allergien: -
Vorherige Impfungen: -

VAERS 2547120

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: IL
Alter: 74,0
Geschlecht: M
Eingang: 30.12.2022
Impfdatum: 27.12.2022
Beginn: 29.12.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Pain SARS-CoV-2 test positive

Symptomtext

12/29/2022 started around 4:00 a.m. with coughing, aches,fatigue, no fever. Covid Tested negative. 12/30/2022 still coughing, aches, fatigue, no fever. Tested positive. Redid test, tested positive again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: PTSD, TBI, Diabetes, umbilical hernia, septoplasty, gunshot wound right shoulder
Vorgeschichte: PTSD, TBI, Diabetes
Andere Medikamente: Metformin, vitamin D3, lamotrigine, aspirin,citalopram, fish oil, fluticasone nasal spray, mesalamine, metoprolol, omeprazole, simvastatin, topiramate
Allergien: Pneumovax, betadine, tramadol
Vorherige Impfungen: -

VAERS 2546375

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: FL
Alter: 64,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 12.12.2022
Beginn: 16.12.2022
Tage bis Beginn: 4,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Hypoaesthesia Muscle tightness Pain in extremity Rash

Symptomtext

Numbness and strong pain in right arm (arm in which patient was vaccinated) starting 4 days after vaccination. Also some pain in upper right back area starting at this time. Also rash on right arm and palm of right hand and tightened muscles in right arm. (Patient had received four (4) prior doses of the original Pfizer COVID-19 vaccine - two primary vaccinations followed by two boosters - and was mildly ill after these doses, but then recovered completely. The booster that seemingly caused the most recent effects was the recent Omicron-targeting Pfizer booster.) Patient received chiropractic treatment on 12/20, 12/21 and 12/22 for this issue; partial success in relieving pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Back pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Had COVID-19 in August 2022; relatively mild symptoms.
Vorgeschichte: Obesity; thyroid problems; gall bladder removed, high blood pressure.
Andere Medikamente: Taking prescribed blood pressure medication.
Allergien: Penicillin
Vorherige Impfungen: Mild illness following previous Pfizer COVID-19 vaccinations. The recent Omicron booster was the only one that seemingly produce

VAERS 2545696

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: AZ
Alter: 79,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 01.12.2022
Beginn: 28.12.2022
Tage bis Beginn: 27,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Nausea

Symptomtext

Severe dizziness and consequent nausea. 12 hours in duration

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Eliquis Mycardis Pravachol Gemtesa
Allergien: none
Vorherige Impfungen: -

VAERS 2544670

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

mild

Staat: CA
Alter: 59,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 26.12.2022
Beginn: 26.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Lymph node pain Lymphadenopathy Pain

Symptomtext

received shot at 10:45 am - symptoms began at 10pm same day chills, body aches, very painful, tender swollen lymph nodes under arm pit of injection site

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: hypothyroid
Andere Medikamente: medroxyprogesterone - 2.5mg levothyroxine sodium - 150mcg meloxicam - 7.5 mg estradiol transdermal patch - 0.025mg/day
Allergien: penicillin
Vorherige Impfungen: chills, headache, body aches, painful swollen lymph nodes under arm pit at injection site

VAERS 2543517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: OR
Alter: 40,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 09.12.2022
Beginn: 11.12.2022
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site pain Neck pain

Symptomtext

Site: Pain at Injection Site-Medium, Additional Details: left shoulder pain (nerve-like) travelling from left shoulder to neck - may not be related to vaccine as patient woke up with shoulder/neck pain a couple days later and could be simply a pinched nerve from sleep

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2542654

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: CT
Alter: 64,0
Geschlecht: F
Eingang: 24.12.2022
Impfdatum: 25.10.2022
Beginn: 17.12.2022
Tage bis Beginn: 53,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Pain Sinus congestion

Symptomtext

Extreme achiness; extreme fatigue; clogged sinuses; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 64-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Covid-19" (unspecified if ongoing), notes: COVID prior vaccination: Yes. The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot No: El3247; Anatomical site: arm Left), administration date: 01Mar2021, when the patient was 62-year-old, for COVID-19 immunization; BNT162b2 (DOSE 2, SINGLE; Lot No: EP6955; Anatomical site: arm Left), administration date: 24Mar2021, when the patient was 62-year-old, for COVID-19 immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot No: FL3197;, Anatomical site: arm Left), administration date: 19Jan2022, when the patient was 63-year-old, for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 17Dec2022, outcome "recovering", described as "Extreme achiness"; SINUS CONGESTION (non-serious) with onset 17Dec2022, outcome "recovering", described as "clogged sinuses"; FATIGUE (non-serious) with onset 17Dec2022, outcome "recovering", described as "extreme fatigue". Therapeutic measures were not taken as a result of pain, fatigue, sinus congestion. Additional Information: The patient did not receive other vaccines within four weeks prior to COVID vaccine. The patient received medications within two weeks of vaccination included Protoxin. The events did not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (COVID prior vaccination: Yes)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2541944

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gJ6742

mild

Staat: SC
Alter: 71,0
Geschlecht: F
Eingang: 23.12.2022
Impfdatum: 19.12.2022
Beginn: 01.12.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ear pain Headache Middle ear effusion Oropharyngeal pain Pain in jaw Pharyngeal erythema

Symptomtext

I woke up two days later with sore throat and earache and jaw hurting on the right side and sharp pain behind the ear felt like it was in my head

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: Went to my primary yesterday and asked him if it could be possible that the vaccine could have caused it he didn't seem to think so said my throat was red and I had some fluid on my ear a little bit and prescribed the z-pack
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Triamterene HCTZ 75/50mg, Omeprazole 40mg, Bariatric multi vitamins, chewable calcium citrate, flaxseed oil. Vitamin e
Allergien: Cipro, plendil, zestril and Nsaids
Vorherige Impfungen: -

VAERS 2540267

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: NY
Alter: 34,0
Geschlecht: F
Eingang: 22.12.2022
Impfdatum: 20.12.2022
Beginn: 22.12.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Urticaria

Symptomtext

Hives all over the body

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hypothyroidism, Hashimotos disease
Andere Medikamente: -
Allergien: Peanut allergy
Vorherige Impfungen: -

VAERS 2540203

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: NJ
Alter: 30,0
Geschlecht: F
Eingang: 22.12.2022
Impfdatum: 15.12.2022
Beginn: 16.12.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Fatigue Headache Hyperhidrosis Nasopharyngeal swab Pain

Symptomtext

Headache; body aches; chills; sweating; extreme fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 30-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Dec2022 at 13:00 as dose 4 (booster), single (Lot number: GJ6742) at the age of 30 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Dose 1; Manufacturer Unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 2; Manufacturer Unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 3; Manufacturer Unknown), for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 16Dec2022, outcome "recovered" (16Dec2022 at 12:00); PAIN (non-serious) with onset 16Dec2022, outcome "recovered" (16Dec2022 at 12:00), described as "body aches"; CHILLS (non-serious) with onset 16Dec2022, outcome "recovered" (16Dec2022 at 12:00); FATIGUE (non-serious) with onset 16Dec2022, outcome "recovered" (16Dec2022 at 12:00), described as "extreme fatigue"; HYPERHIDROSIS (non-serious) with onset 16Dec2022, outcome "recovered" (16Dec2022 at 12:00), described as "sweating". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, pain, chills, hyperhidrosis, fatigue. Additional information: Patient experienced headache, body aches, chills, sweating, extreme fatigue, felt very similar to having COVID infection. Adverse reaction started about 10 hours post vax and lasted for about 12 hours . As a treatment medication, patient took a bunch of ibuprofen. No follow-up attempts are possible. No further information is expected. Sender's Comments: Linked Report(s) : PFIZER INC-202201384552 Same reporter and patient, different product;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Test Date: 20221217; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other medical history: No
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2540127

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: -
Alter: -
Geschlecht: M
Eingang: 22.12.2022
Impfdatum: 15.11.2022
Beginn: 01.11.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Allodynia Hyperaesthesia Investigation Pain Peripheral sensory neuropathy SARS-CoV-2 test Thoracic radiculopathy

Symptomtext

painful thoracic sensory polyneuropathy/right lower thoracic/upper lumbar spine/spread bilaterally to pan-thoracic paraspinal area/along dermatomes to involve the area over the rib cage bilaterally; painful thoracic sensory polyneuropathy/right lower thoracic/upper lumbar spine/spread bilaterally to pan-thoracic paraspinal area/along dermatomes to involve the area over the rib cage bilaterally; severe tactile allodynia/hyperesthesia (up to 7/10)/excruciating allodynia which evoked images of being stabbed with a red-hot knife; hyperesthesia (up to 7/10)/slightest tactile stimulus such as shirt sliding over the skin of the torso produced severe burning pain; severe burning pain; This is a spontaneous report received from a non-contactable reporter(s) (Physician). The reporter is the patient. A 63-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Nov2022 at 09:30 as dose 4 (booster), single (Lot number: GJ6742), in left arm for covid-19 immunisation. The patient's relevant medical history included: "pre-existing peripheral neuropathy" (unspecified if ongoing), notes: pre-existing peripheral neuropathy flared prior to vaccine; "viral respiratory infections" (unspecified if ongoing), notes: does get much milder and shorter-lived cutaneous hyperesthesia during viral respiratory infections. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: HYPERAESTHESIA (non-serious) with onset Nov2022, 1 week after the suspect product(s) administration, outcome "recovered", described as "hyperesthesia (up to 7/10)/slightest tactile stimulus such as shirt sliding over the skin of the torso produced severe burning pain"; PERIPHERAL SENSORY NEUROPATHY (non-serious), THORACIC RADICULOPATHY (non-serious) all with onset Nov2022, latency 1 week after the suspect product(s) administration, outcome "recovered" and all described as "painful thoracic sensory polyneuropathy/right lower thoracic/upper lumbar spine/spread bilaterally to pan-thoracic paraspinal area/along dermatomes to involve the area over the rib cage bilaterally"; PAIN (non-serious) with onset Nov2022, 1 week after the suspect product(s) administration, outcome "recovered", described as "severe burning pain"; ALLODYNIA (non-serious) with onset Nov2022, 1 week after the suspect product(s) administration, outcome "recovered", described as "severe tactile allodynia/hyperesthesia (up to 7/10)/excruciating allodynia which evoked images of being stabbed with a red-hot knife". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of peripheral sensory neuropathy, thoracic radiculopathy, allodynia, hyperaesthesia, pain. Additional information: One week after vaccination patient developed a painful thoracic sensory polyneuropathy characterized by severe tactile allodynia/hyperesthesia (up to 7/10). It commenced right lower thoracic/upper lumbar spine but then spread bilaterally to pan-thoracic paraspinal area and then along dermatomes to involve the area over the rib cage bilaterally. The slightest tactile stimulus such as shirt sliding over the skin of the torso produced severe burning pain. There were areas bilaterally over the lower rib cage which were the sites of excruciating allodynia which evoked images of being stabbed with a red-hot knife. The patient does get much milder and shorter-lived cutaneous hyperesthesia during viral respiratory infections and has a pre-existing peripheral neuropathy. The pre-existing peripheral neuropathy had flared prior to vaccine but the flare involved the left foot and was resolving at the time the adverse event occurred. The patient did not experienced COVID-19 prior to vaccination. A home COVID-19 test was negative post vaccination. No other vaccines in four weeks. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: Test Date: 202211; Test Name: severe tactile allodynia/hyperesthesia; Result Unstructured Data: Test Result:up to 7/10; Comments: One week after vaccination patient developed a painful thoracic sensory polyneuropathy characterized by severe tactile allodynia/hyperesthesia (up to 7/10). It commenced right lower thoracic/upper lumbar spine but then spread bilaterally to pan-thoracic paraspinal area and then along dermatomes to involve the area over the rib cage bilaterally; Test Date: 2022; Test Name: Nasal Swab; Test Result: Negative ; Comments: Post vaccination
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Peripheral neuropathy (pre-existing peripheral neuropathy flared prior to vaccine); Respiratory tract infection viral (does get much milder and shorter-lived cutaneous hyperesthesia during viral respiratory infections)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2539448

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: WY
Alter: 64,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 01.12.2022
Beginn: 14.12.2022
Tage bis Beginn: 13,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Lymph node pain Lymphadenitis Lymphadenopathy

Symptomtext

Starting the day after the vaccination (12/14), patient reports having soreness in region of right lymph node. Starting 2 days later (12/15), patient noticed area in neck above right collarbone also inflamed, swollen, and sore. The soreness lasted for approximately 5 days, through 12/18. The swelling was still present at time of this report on 12/21 - patient reports that the swelling has improved but is still present at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lymph node pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None reported
Andere Medikamente: None reported
Allergien: Penicillin, sulfa
Vorherige Impfungen: Fever, chills

VAERS 2538723

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CT
Alter: 31,0
Geschlecht: M
Eingang: 21.12.2022
Impfdatum: 14.12.2022
Beginn: 14.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain

Symptomtext

General Achiness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 31-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Dec2022 at 01:45 as dose 4 (booster), single (Lot number: GJ6742) at the age of 31 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "If COVID prior vaccination: Yes" (unspecified if ongoing), notes: If COVID prior vaccination: Yes. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 14Dec2022 at 23:00, outcome "recovering", described as "General Achiness". Therapeutic measures were not taken as a result of pain. Additional information: General Achiness starting at night through the next day. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive other vaccines within 4 weeks prior to the vaccination. The patient did not have any known allergies or any other medical history. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (If COVID prior vaccination: Yes)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2538706

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: NC
Alter: 48,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 13.12.2022
Beginn: 14.12.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Decreased appetite Headache Pain Pain in extremity Swelling

Symptomtext

left armpit swollen; soreness in left arm; chills; headache; body aches; loss of appetite; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 48-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Dec2022 at 08:00 as dose 5 (booster), single (Lot number: GJ6742) at the age of 48 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: VALACYCLOVIR [VALACICLOVIR]; FISH OIL [EICOSAPENTAENOIC ACID]; VITAMIN D3; CINNAMON [CINNAMOMUM CASSIA]. Vaccination history included: Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 4 (BOOSTER); MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: PAIN (non-serious) with onset 14Dec2022 at 12:15, outcome "recovering", described as "body aches"; CHILLS (non-serious) with onset 14Dec2022 at 12:15, outcome "recovering"; HEADACHE (non-serious) with onset 14Dec2022 at 12:15, outcome "recovering"; SWELLING (non-serious) with onset 14Dec2022 at 12:15, outcome "recovering", described as "left armpit swollen"; DECREASED APPETITE (non-serious) with onset 14Dec2022 at 12:15, outcome "recovering", described as "loss of appetite"; PAIN IN EXTREMITY (non-serious) with onset 14Dec2022 at 12:15, outcome "recovering", described as "soreness in left arm". Therapeutic measures were not taken as a result of swelling, pain in extremity, chills, headache, pain, decreased appetite. Additional information: The patient did not receive any other vaccine in four weeks prior to suspect vaccination. The patient did not had COVID prior vaccination and was not tested for COVID post vaccination. The patient had no known allergies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Asthma
Andere Medikamente: VALACYCLOVIR [VALACICLOVIR]; FISH OIL [EICOSAPENTAENOIC ACID]; VITAMIN D3; CINNAMON [CINNAMOMUM CASSIA]
Allergien: -
Vorherige Impfungen: -

VAERS 2537243

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: NY
Alter: 43,0
Geschlecht: F
Eingang: 20.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Hyperhidrosis Injection site pain Myalgia

Symptomtext

soreness at injection site; sore body; chills/sweats; chills/sweats; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 43-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Dec2022 at 12:00 as dose 4 (booster), single (Lot number: GJ6742) at the age of 43 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "covid" (unspecified if ongoing), notes: If covid prior vaccination: Yes. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: CHILLS (non-serious), HYPERHIDROSIS (non-serious) all with onset 13Dec2022 at 21:00, outcome "unknown" and all described as "chills/sweats"; MYALGIA (non-serious) with onset 13Dec2022 at 21:00, outcome "unknown", described as "sore body"; INJECTION SITE PAIN (non-serious) with onset 13Dec2022 at 21:00, outcome "unknown", described as "soreness at injection site". Therapeutic measures were not taken as a result of injection site pain, myalgia, chills, hyperhidrosis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (If covid prior vaccination: Yes)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2536202

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: WI
Alter: 61,0
Geschlecht: F
Eingang: 18.12.2022
Impfdatum: 13.12.2022
Beginn: 17.12.2022
Tage bis Beginn: 4,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Axillary pain Ear discomfort Oedema peripheral Tinnitus

Symptomtext

I noticed swelling and mild pain in my left axilla on Thursday, 12/15/2022, two days after the vaccine in my left arm. I was told by the nurse that gave me the shot that common side effects are:pain at the injection site, frontal Headache, and lymph node involvement. I took the axilla pain and swelling to be lymph node response to the Covid vaccine. This is still slightly noticeable on 12/18/2022. On 12/17/2022, at around 2:00 PM, I walked into my house from an errand, and not long after, experienced sudden onset tinnitus (a high pitched buzzing), in my left ear only. This lasted approximately 6 hours constant. It seemed to disappear gradually. While I experienced the tinnitus, I also had crackling or popping noises in my ear for a very short while, maybe 15 minutes. I realized after the tinnitus started, that I had had a feeling that I could feel my heartbeat in my left ear intermittently in the day or so prior to the onset of the tinnitus. It was somewhat bothersome in that it was a strong heartbeat feel. It has not recurred since the tinnitus ended.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Axillary pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN Paroxysmal A Fib Hypothyroid
Andere Medikamente: apixaban metoprolol succinate levothyroxine losartan omeprazole Vitamin D
Allergien: NKDA NKA
Vorherige Impfungen: -

VAERS 2536079

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: CA
Alter: 29,0
Geschlecht: M
Eingang: 17.12.2022
Impfdatum: 17.12.2022
Beginn: 17.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Interchange of vaccine products

Symptomtext

Patient requested for Moderna covid booster, Intern accidentally gave patient the Pfizer vaccine instead. Patient reported dizziness after vaccination, but expressed that he usually gets dizzy with the Moderna doses in the past as well. Patient was monitored on site for 15 minutes and left after feeling well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Patient reported dizziness after Moderna vaccination in the past

VAERS 2536071

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: MI
Alter: 35,0
Geschlecht: F
Eingang: 17.12.2022
Impfdatum: 26.11.2022
Beginn: 04.12.2022
Tage bis Beginn: 8,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Fatigue Lymphadenopathy Nasal congestion Oropharyngeal pain SARS-CoV-2 test negative Upper-airway cough syndrome

Symptomtext

Sore throat, swollen glands, nasal congestion, post nasal drainage, cough, fatigue. Treated symptoms with ibuprofen and rest. Tested for Covid, test was negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: At home Covid 19 test done 12/17/22. Results were negative.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin
Allergien: Sulfa medications
Vorherige Impfungen: -

VAERS 2531694

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: NY
Alter: 39,0
Geschlecht: F
Eingang: 15.12.2022
Impfdatum: 06.12.2022
Beginn: 07.12.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Headache Peripheral coldness

Symptomtext

Cold feet; Pounding headache; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient. A 39-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Dec2022 at 10:00 as dose 3 (booster), single (Lot number: GJ6742) at the age of 39 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Anaemia" (unspecified if ongoing), notes: Other medical history: Anemia; "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin, Sulfur drugs. There were no concomitant medications. Past drug history included: Sulfur drugs, reaction(s): "known allergies: Sulfur drugs", notes: Known allergies: Penicillin, Sulfur drugs. Vaccination history included: BNT162b2 (Dose 1, Single, Batch/Lot No: EL3247, Location of injection: Arm Left, Route of Administration: Intramuscular, Facility type vaccine: Workplace clinic), administration date: 22Feb2021, when the patient was 37-year-old, for covid-19 immunization; BNT162b2 (Dose 2, Single, Batch/Lot No: EL3247, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 15Mar2021, when the patient was 37-year-old, for covid-19 immunization. The following information was reported: PERIPHERAL COLDNESS (non-serious) with onset 07Dec2022, outcome "recovered" (07Dec2022 at 08:00), described as "Cold feet"; HEADACHE (non-serious) with onset 07Dec2022, outcome "recovered" (07Dec2022 at 08:00), described as "Pounding headache". Therapeutic measures were taken as a result of peripheral coldness, headache. Additional information: Patient is a Pfizer employee and registered nurse (DNP). Patient received her COVID-19 booster shot yesterday morning and around 12am this morning she experienced extremely cold feet and a pounding headache. The events resolved as of 8am this morning. AE treatment was took Motrin for the headache. Patient did not received other vaccine in four weeks and other medication in two weeks. Patient did not had covid Prior vaccination and was not tested for covid post vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Anemia (Other medical history: Anemia); Penicillin allergy (Known allergies: Penicillin, Sulfur drugs)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2531792

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: CA
Alter: 44,0
Geschlecht: F
Eingang: 14.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Cough Dry throat Headache Pain Pyrexia SARS-CoV-2 test Throat irritation

Symptomtext

at night body ache, headache and low grade fever 100.2 the next morning still body ache and very dry iitchy throat and dry cough having chills.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: covid test 10/14 around 3:30pm at local facility
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2529431

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: IL
Alter: 48,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 05.12.2022
Beginn: 06.12.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Fatigue Pain Pyrexia

Symptomtext

This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 48-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Dec2022 at 16:45 as dose 4 (booster), single (Lot number: GJ6742) at the age of 48 years intramuscular, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: QUADRIVALENT INFLUENZA VACCINE taken for immunisation, on 16Nov2022 as dose 1, single; PREMPRO LOW DOSE oral. Vaccination history included: Bnt162b2 (Dose 3, single, lot number: 33130BA, vaccine location: Left arm), for COVID-19 Immunization, reaction(s): "Chills", "Fatigue", "Body Aches", "Fever"; Bnt162b2 (Dose 2, single, lot number: EN6207, vaccine location: Left arm), for COVID-19 Immunization, reaction(s): "Chills", "Fatigue", "Body Aches", "Fever"; Bnt162b2 (Dose 1, single, lot number: EN6205, vaccine location: Left arm), for COVID-19 Immunization, reaction(s): "Chills", "Fatigue", "Body Aches", "Fever". The following information was reported: PAIN (non-serious) with onset 06Dec2022 at 04:30, outcome "recovered" (Dec2022), described as "Body Aches"; CHILLS (non-serious) with onset 06Dec2022 at 04:30, outcome "recovered" (Dec2022); FATIGUE (non-serious) with onset 06Dec2022 at 04:30, outcome "recovered" (Dec2022); PYREXIA (non-serious) with onset 06Dec2022 at 04:30, outcome "recovered" (Dec2022), described as "Fever". Therapeutic measures were not taken as a result of pyrexia, chills, pain, fatigue. Additional information: The seriousness of the events was reported as non-serious. The patient had no COVID prior vaccination and not tested COVID post vaccination. The patient had no known allergies. Fever, Chills, Body Aches, Fatigue began approximately 12 hrs post dose and continued for 12-16 hrs.; Sender's Comments: Linked Report(s): PFIZER INC-202201359444 same patient/AE, different vaccine dose; PFIZER INC-202201359445 same patient/AE, different vaccine dose; PFIZER INC-202201359446 same patient/AE, different vaccine dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None.
Andere Medikamente: PREMPRO LOW DOSE
Allergien: -
Vorherige Impfungen: -

VAERS 2529506

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: WA
Alter: 75,0
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Rash Skin discolouration

Symptomtext

Patient came in on 12/12/22 to report a large rash on arm spanning about 6-8 inches from vaccination sites. It was very red and patient said it lighten to lighter pink. Patient also states there were some rash underneath her breast as well. Upon discussion with patient, the rash is still very visible and large.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: unknown allergies-patient reports that doctor is figuring it out still. may have to be on cetirizine for her lifetime according to patient
Vorherige Impfungen: -

VAERS 2529488

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: WI
Alter: 34,0
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 10.12.2022
Beginn: 11.12.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site reaction Injection site warmth Rash erythematous

Symptomtext

Patient developed a slightly warm, red rash around injection site. It is not painful or itchy. It has not disappeared, but has gotten slightly smaller since it first appeared.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2528905

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: IL
Alter: 47,0
Geschlecht: M
Eingang: 12.12.2022
Impfdatum: 11.12.2022
Beginn: 11.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered Fatigue Pain Pyrexia

Symptomtext

Patient received Monovalent Pfizer on 4/4/2021, 4/25/2021, 11/30/2021 and Pfizer Bivalent on 9/21/2022. He was able to schedule an additional Pfizer Bivalent on 12/11/2022 Medical director was notified, His primary PCP was notified. Patient having normal side affects from vaccine ( Fatique, low grade-fever, body aches)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Unknown-None listed
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2528501

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

mild

Staat: NY
Alter: 60,0
Geschlecht: F
Eingang: 11.12.2022
Impfdatum: 11.12.2022
Beginn: 11.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness

Symptomtext

10 minutes or so after receiving vaccine pt attested to feeling lightheaded and had to sit down. She did not fall, and it resolved after 5 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: SVT
Andere Medikamente: rosuvastatin, levothyroxine, metoprolol tartrate, levothyroxine, topiramate
Allergien: ampicillin, altace, avelox, nickel, penicillin, bactrim, macrobid
Vorherige Impfungen: -

VAERS 2526818

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: -
Alter: 50,0
Geschlecht: F
Eingang: 08.12.2022
Impfdatum: 05.12.2022
Beginn: 05.12.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Impaired work ability Incorrect product formulation administered Malaise

Symptomtext

Patient presented to clinic to receive Shingles vaccine and was administered COVID Bivalent Booster instead. Patient had already received this booster on 10/4/22 so received two bivalent boosters. Patient did experience ill feelings the day after the vaccination and did have to leave work. Resolved by the following day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2525630

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: NJ
Alter: 56,0
Geschlecht: M
Eingang: 07.12.2022
Impfdatum: 07.12.2022
Beginn: 07.12.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal discomfort Abdominal pain upper

Symptomtext

Patient's stomach began to hurt and felt like it was in "knots", wanted to lay down ;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain upper
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Patient on Dialysis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2522538

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge gj6742

mild

Staat: CA
Alter: 39,0
Geschlecht: F
Eingang: 03.12.2022
Impfdatum: 28.11.2022
Beginn: 28.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain

Symptomtext

the patient was complaining about the pain the following day after receiving the vaccines

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2513641

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CT
Alter: 60,0
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal discomfort Pain Pain in extremity

Symptomtext

Sore arm; Body ache; Stomach discomfort; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 60-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Nov2022 at 11:00 as dose 4 (booster), single (Lot number: GJ6742) at the age of 60 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VITAMIN D3; ATORVASTATIN. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot no: EL3247; Location of injection: Arm right; Vaccine administration time: 10:30), administration date: 02Feb2021, when the patient was 58-year-old, for COVID-19 immunization; BNT162b2 (DOSE 2, SINGLE; Lot no: EL3247; Location of injection: Arm right; Vaccine administration time: 10:30), administration date: 23Feb2021, when the patient was 58-year-old, for COVID-19 immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot no: FH8027; Anatomical location of injection: Arm right; Vaccine administration time: 10:00), administration date: 03Dec2021, when the patient was 59-year-old, for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 16Nov2022 at 22:00, outcome "recovered" (Nov2022), described as "Body ache"; PAIN IN EXTREMITY (non-serious) with onset 16Nov2022 at 22:00, outcome "recovered" (Nov2022), described as "Sore arm"; ABDOMINAL DISCOMFORT (non-serious) with onset 16Nov2022 at 22:00, outcome "recovered" (Nov2022), described as "Stomach discomfort". Therapeutic measures were not taken as a result of pain in extremity, pain, abdominal discomfort. Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive other vaccines within 4 weeks prior to the vaccination. AEs did not result in physician office visit or emergency room visit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: VITAMIN D3; ATORVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 2511312

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: MA
Alter: 44,0
Geschlecht: M
Eingang: 18.11.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Off label use Product use issue Pyrexia Wrong product administered

Symptomtext

"mild symptoms including fever"; Pfizer Bivalent - Dose Number: 1; Flucelvax Quad Flu vaccine Seqirus: 04Oct2022 ...Pfizer Bivalent: 04Oct2022; Flucelvax Quad Flu vaccine Seqirus: 04Oct2022 ...Pfizer Bivalent: 04Oct2022; This is a spontaneous report received from a contactable reporter(s) (Nurse). A 44-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 as dose 1, single (Lot number: GJ6742) at the age of 44 years intramuscular, in right arm for covid-19 immunisation; influenza vaccine inact sag 4v (FLUCELVAX QUAD), on 04Oct2022 as dose number unknown, single (Lot number: 942381), in left deltoid for immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious) with onset 04Oct2022, outcome "recovered", described as ""mild symptoms including fever""; OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 04Oct2022, outcome "unknown" and all described as "Flucelvax Quad Flu vaccine Seqirus: 04Oct2022 ...Pfizer Bivalent: 04Oct2022"; WRONG PRODUCT ADMINISTERED (non-serious) with onset 04Oct2022, outcome "unknown", described as "Pfizer Bivalent - Dose Number: 1". It was unknown if therapeutic measures were taken as a result of pyrexia. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events and BNT162B2.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2510327

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: MA
Alter: 27,0
Geschlecht: F
Eingang: 17.11.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Myalgia Pain in extremity

Symptomtext

Soreness in right arm; chills; muscle soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 27-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Nov2022 at 10:30 as dose 4 (booster), single (Lot number: GJ6742) at the age of 27 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history included: "known allergy: Penicillin" (unspecified if ongoing); "COVID-19" (unspecified if ongoing). Concomitant medication(s) included: FLU VACCINE VII, on 26Oct2022 as dose number unknown, single; KURVELO; FLUOXETINE. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot no: EL3247; Route of administration: intramuscular; Location of injection: arm right), administration date: 25Jan2021, when the patient was 25-year-old, for COVID-19 Immunization, reaction(s): "slight soreness in my right arm"; BNT162b2 (DOSE 2, SINGLE; Lot No: EL3247; Route of administration: Intramuscular; Location of injection: Arm right), administration date: 15Feb2021, when the patient was 25-year-old, for COVID-19 Immunization, reaction(s): "fatigue", "My right arm was also a bit sore", "I had slight muscle soreness", "Very slight chills"; BNT162b2 (DOSE 3, SINGLE; Lot no: EW0217; Route of administration: Intramuscular; Location of injection: arm right), administration date: 14Oct2021, when the patient was 25-year-old, for COVID-19 Immunization, reaction(s): "Stomach ache", "Injection site slight pain", "Fatigue", "Chills". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 10Nov2022 at 21:00, outcome "recovering", described as "Soreness in right arm"; CHILLS (non-serious) with onset 10Nov2022 at 21:00, outcome "recovering"; MYALGIA (non-serious) with onset 10Nov2022 at 21:00, outcome "recovering", described as "muscle soreness". Therapeutic measures were not taken as a result of pain in extremity, chills, myalgia. Additional information: It was reported that, the patient received other vaccine in four weeks. The patient had not been tested for COVID post vaccination. Other medical history was reported as no. Adverse events did not result in Emergency room visit or Physician office visit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19; Penicillin allergy
Andere Medikamente: KURVELO; FLUOXETINE
Allergien: -
Vorherige Impfungen: -

VAERS 2501335

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: -
Alter: 51,0
Geschlecht: F
Eingang: 08.11.2022
Impfdatum: 02.11.2022
Beginn: 02.11.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Headache Myalgia Pain in extremity

Symptomtext

Sore arm; headache; muscle aches; weakness; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 51-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 02Nov2022 at 14:45 as dose 5 (booster), single (Lot number: GJ6742) at the age of 51 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary series immunization complete but manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose: 3, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (Dose: 4, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 02Nov2022, outcome "not recovered", described as "Sore arm"; HEADACHE (non-serious) with onset 02Nov2022, outcome "not recovered"; MYALGIA (non-serious) with onset 02Nov2022, outcome "not recovered", described as "muscle aches"; ASTHENIA (non-serious) with onset 02Nov2022, outcome "not recovered", described as "weakness". Therapeutic measures were not taken as a result of pain in extremity, headache, myalgia, asthenia. Additional information: The patient did not receive other vaccine in four weeks. The patient did not have covid prior vaccination and was not tested for covid post vaccination. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2494642

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: MI
Alter: 53,0
Geschlecht: M
Eingang: 01.11.2022
Impfdatum: 26.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Feeling of body temperature change Headache Muscle twitching Nausea Nodule Pain

Symptomtext

Body aches; hot and cold; knot in arm; arm twitching; headache; nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Oct2022 at 14:00 as dose 5 (booster), single (Lot number: GJ6742) at the age of 53 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing), notes: Other medical history: high blood pressure, cholesterol, AFIB; "cholesterol" (unspecified if ongoing), notes: Other medical history: high blood pressure, cholesterol, AFIB; "AFIB" (unspecified if ongoing), notes: Other medical history: high blood pressure, cholesterol, AFIB; "Known allergies: bees" (unspecified if ongoing), notes: known allergies Cipro, sulfa, bees. Concomitant medication(s) included: FLU [INFLUENZA VACCINE] taken for immunisation as dose number unknown, single. Past drug history included: Cipro, reaction(s): "Known allergies: Cipro", notes: Known allergies: Cipro, sulfa, bees; Sulfa, reaction(s): "Known allergies: sulfa", notes: known allergies Cipro, sulfa, bees. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE; Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (DOSE 4 (BOOSTER), SINGLE; Unknown manufacturer), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 27Oct2022 at 03:00, outcome "recovering", described as "Body aches"; MUSCLE TWITCHING (non-serious) with onset 27Oct2022 at 03:00, outcome "recovering", described as "arm twitching"; HEADACHE (non-serious) with onset 27Oct2022 at 03:00, outcome "recovering"; FEELING OF BODY TEMPERATURE CHANGE (non-serious) with onset 27Oct2022 at 03:00, outcome "recovering", described as "hot and cold"; NODULE (non-serious) with onset 27Oct2022 at 03:00, outcome "recovering", described as "knot in arm"; NAUSEA (non-serious) with onset 27Oct2022 at 03:00, outcome "recovering". Therapeutic measures were not taken as a result of pain, feeling of body temperature change, nodule, muscle twitching, headache, nausea. Additional information: Reportedly, dose received were more than 3. For most recent dose details Facility type vaccine was Workplace clinic. No covid prior vaccination and no covid tested post vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: AFib (Other medical history: high blood pressure, cholesterol, AFIB); Bee sting hypersensitivity (known allergies Cipro, sulfa, bees); Blood cholesterol abnormal (Other medical history: high blood pressure, cholesterol, AFIB); Blood pressure high (Other medical history: high blood pressure, cholesterol, AFIB)
Andere Medikamente: FLU [INFLUENZA VACCINE]
Allergien: -
Vorherige Impfungen: -

VAERS 2493205

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: MA
Alter: -
Geschlecht: U
Eingang: 29.10.2022
Impfdatum: 25.10.2022
Beginn: 26.10.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Body temperature Chills Headache Pain Pyrexia Vaccination site pain

Symptomtext

chills; Joint aches (specifically my hands/fingers); body aches; headache the first half of the morning; minor pain at the injection site; fever of 100.5F. This was its highest later in the day at 101.5F.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Oct2022 at 12:30 as dose number unknown (booster), single (Lot number: GJ6742, Expiration Date: 31Jul2023) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Series of primary immunization completed. Unknown manufacturer), for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 26Oct2022, outcome "recovering", described as "fever of 100.5F. This was its highest later in the day at 101.5F."; CHILLS (non-serious), outcome "unknown"; ARTHRALGIA (non-serious), outcome "unknown", described as "Joint aches (specifically my hands/fingers)"; PAIN (non-serious), outcome "unknown", described as "body aches"; HEADACHE (non-serious), outcome "unknown", described as "headache the first half of the morning"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "minor pain at the injection site". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia. Additional information: The fever was accompanied by chills, joint aches (specifically my hands/fingers), and body aches. Patient had a headache the first half of the morning. Patient also had minor pain at the injection site. For the fever patient took Tylenol every 5-6 hours. The fever seemed to subside by late evening around 10-11pm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Test Name: fever; Result Unstructured Data: Test Result:101.5 Fahrenheit; Test Date: 20221026; Test Name: fever; Result Unstructured Data: Test Result:100.5 Fahrenheit
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2493194

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CT
Alter: 52,0
Geschlecht: F
Eingang: 29.10.2022
Impfdatum: 25.10.2022
Beginn: 26.10.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature Pyrexia Vaccination site erythema Vaccination site mass Vaccination site pain Vaccination site pruritus Vaccination site warmth

Symptomtext

Woke up with a fever (100.3) at 2:20am (26Oct). By late morning fever was up to 101.7. Started taking Tylenol around 1pm which brough fever down to 101; Injections site is hot; Injections site raised; Injections site itchy; Injections site red; Injections site pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 52-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Oct2022 at 11:30 as dose 4 (booster), single (Lot number: GJ6742) at the age of 52 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: penicillin" (unspecified if ongoing). Concomitant medication(s) included: MULTI VITAMIN, ROSUVASTATIN; GABAPENTIN; VICTOZA; AMITRIPTYLINE; CALCIUM; LISINOPRIL; VITAMIN D3; MELATONIN; ASPIRIN [ACETYLSALICYLIC ACID]; FISH OIL; OCUVITE [ASCORBIC ACID;BETACAROTENE;COPPER;TOCOFERSOLAN;ZINC]. Vaccination history included: Bnt162b2 (Other vaccine same date product Pfizer,, Other vaccine same date lot number EL3247,, Other vaccine same date dose number 1, Other vaccine same date vaccine location Left Arm,), for Covid-19 immunization; Bnt162b2 (Other vaccine same date productPfizer, Other vaccine same date lot number EP6955, Other vaccine same date dose number 2,, Other vaccine same date vaccine location Left Arm,), for Covid-19 immunization; Bnt162b2 (Other vaccine same date product Pfizer,, Other vaccine same date lot number FH8027,, Other vaccine same date dose number 3,, Other vaccine same date vaccine location Left Arm,), for Covid-19 immunization. The following information was reported: VACCINATION SITE WARMTH (non-serious) with onset 26Oct2022 at 02:00, outcome "not recovered", described as "Injections site is hot"; VACCINATION SITE PRURITUS (non-serious) with onset 26Oct2022 at 02:00, outcome "not recovered", described as "Injections site itchy"; VACCINATION SITE PAIN (non-serious) with onset 26Oct2022 at 02:00, outcome "not recovered", described as "Injections site pain"; VACCINATION SITE MASS (non-serious) with onset 26Oct2022 at 02:00, outcome "not recovered", described as "Injections site raised"; VACCINATION SITE ERYTHEMA (non-serious) with onset 26Oct2022 at 02:00, outcome "not recovered", described as "Injections site red"; PYREXIA (non-serious) with onset 26Oct2022 at 02:00, outcome "not recovered", described as "Woke up with a fever (100.3) at 2:20am (26Oct). By late morning fever was up to 101.7. Started taking Tylenol around 1pm which brough fever down to 101". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia. Therapeutic measures were not taken as a result of vaccination site warmth, vaccination site mass, vaccination site pruritus, vaccination site erythema, vaccination site pain. Additional information: Woke up with a fever (100.3) at 2:20am (26Oct). By late morning fever was up to 101.7. Started taking Tylenol around 1pm which brough fever down to 101. took Tylenol again at 7pm which brought fever down to 100. Temp was 99.5 in am. Temp normal by noon (27Oct). Injections site is hot, raised, red, painful and itchy. This started the evening of the shot with no improvement. Patient didn't receive other vaccine in four weeks. No covid prior vaccination. Patient didn't test covid post vaccination. No follow-up attempts are possible. No further information is expected

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: Test Date: 20221026; Test Name: fever; Result Unstructured Data: Test Result:101.7; Test Date: 20221026; Test Name: fever; Result Unstructured Data: Test Result:101; Test Date: 20221026; Test Name: fever; Result Unstructured Data: Test Result:100.3; Test Date: 20221026; Test Name: fever; Result Unstructured Data: Test Result:99.5; Test Date: 20221026; Test Name: fever; Result Unstructured Data: Test Result:100
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Penicillin allergy
Andere Medikamente: ROSUVASTATIN; GABAPENTIN; VICTOZA; AMITRIPTYLINE; CALCIUM; LISINOPRIL; VITAMIN D3; MELATONIN; ASPIRIN [ACETYLSALICYLIC ACID]; FISH OIL; OCUVITE [ASCORBIC ACID;BETACAROTENE;COPPER;TOCOFERSOLAN;ZINC]
Allergien: -
Vorherige Impfungen: -

VAERS 2492109

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CT
Alter: 35,0
Geschlecht: F
Eingang: 28.10.2022
Impfdatum: 21.10.2022
Beginn: 21.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Vaccination site pain

Symptomtext

Moderate soreness at injection site; tiredness; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 35-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Oct2022 at 12:00 as dose 4 (booster), single (Lot number: GJ6742) at the age of 35 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies Sulfa drugs" (unspecified if ongoing). Concomitant medication(s) included: NEXPLANON. Past drug history included: Morphine, reaction(s): "Known allergies morphine", notes: Known allergies morphine. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 21Oct2022 at 16:00, outcome "recovering", described as "Moderate soreness at injection site"; HEADACHE (non-serious) with onset 21Oct2022 at 16:00, outcome "recovering"; FATIGUE (non-serious) with onset 21Oct2022 at 16:00, outcome "recovering", described as "tiredness". Therapeutic measures were not taken as a result of vaccination site pain, fatigue, headache. Additional information: Facility type vaccine was workplace clinic. Patient did not receive any other vaccine in four weeks. Patient did not have covid prior vaccination and not tested covid post vaccination. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Sulfonamide allergy
Andere Medikamente: NEXPLANON
Allergien: -
Vorherige Impfungen: -

VAERS 2489470

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CT
Alter: 55,0
Geschlecht: M
Eingang: 26.10.2022
Impfdatum: 18.10.2022
Beginn: 19.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Oropharyngeal pain

Symptomtext

Sore throat, lasted less than 6 hr; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 55-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Oct2022 at 14:15 as dose 5 (booster), single (Lot number: GJ6742) at the age of 55 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Nuts allergy" (unspecified if ongoing); "Shellfish allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1, Manufacturer: Unknown), for COVID-19 immunization; Covid-19 vaccine (Dose: 2, Manufacturer: Unknown), for COVID-19 immunization; Covid-19 vaccine (Dose: 3, Manufacturer: Unknown), for COVID-19 immunization; Covid-19 vaccine (Dose: 4, Manufacturer: Unknown), for COVID-19 immunization. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 19Oct2022 at 12:00, outcome "recovered" (19Oct2022), described as "Sore throat, lasted less than 6 hr". Therapeutic measures were not taken as a result of oropharyngeal pain. Additional Information: It was reported that patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination and Since the vaccination. Device date was reported as 20Oct2022. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy to nuts; Shellfish allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2484937

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CT
Alter: 26,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Vaccination site erythema Vaccination site pain

Symptomtext

Injection site had redness; was sore to the touch for 3 days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 26-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 at 11:00 as dose 4 (booster), single (Lot number: GJ6742) at the age of 26 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Wheat" (unspecified if ongoing), notes: Known allergies: Wheat. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 Immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset 04Oct2022 at 11:00, outcome "recovered" (07Oct2022), described as "Injection site had redness"; VACCINATION SITE PAIN (non-serious) with onset 04Oct2022 at 11:00, outcome "recovered" (07Oct2022), described as "was sore to the touch for 3 days". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site pain. Additional Information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no other vaccine in four weeks. The events did not result in emergency room, physician office visit or intensive care unit. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Food allergy (Known allergies: Wheat)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2482511

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: PA
Alter: 54,0
Geschlecht: F
Eingang: 19.10.2022
Impfdatum: 12.10.2022
Beginn: 12.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Headache Pain Pyrexia

Symptomtext

Minor body aches; fever; headache; This is a spontaneous report received from a contactable reporter (consumer or other non-HCP). The reporter is the patient. A 54-year-old female patient (not pregnant) received BNT162b2, BNT162b2 OMI BA.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Oct2022 at 11:45 as DOSE NUMBER UNKNOWN (BOOSTER), SINGLE (lot number: GJ6742) at the age of 54 years, administered in the left arm for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, (unknown manufacturer)), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 12Oct2022 at 22:30, outcome "recovered" (Oct2022), described as "Minor body aches"; PYREXIA (non-serious) with onset 12Oct2022 at 22:30, outcome "recovered" (Oct2022), described as "fever"; HEADACHE (non-serious) with onset 12Oct2022 at 22:30, outcome "recovered" (Oct2022). Therapeutic measures were not taken as a result of pain, pyrexia, and headache. Additional information: Facility type vaccine is a Workplace clinic. Patient did not receive other vaccine in four weeks. Other medication in two weeks: N/A. If covid Prior vaccination: No. If covid tested post vaccination: No. Known allergies: N/A; Other medical history: N/A.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2482494

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CT
Alter: -
Geschlecht: M
Eingang: 19.10.2022
Impfdatum: -
Beginn: 13.10.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Pain in extremity

Symptomtext

Sore arm/arm is still a little sore; chills; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient. A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Lot number: GJ6742), in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer Unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose 2, Manufacturer Unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose 3, Manufacturer Unknown), for Covid-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 13Oct2022 at 20:00, outcome "recovering", described as "Sore arm/arm is still a little sore"; CHILLS (non-serious) with onset 13Oct2022 at 20:00, outcome "recovered" (14Oct2022). Therapeutic measures were not taken as a result of pain in extremity, chills. Additional information: No prior vaccination for COVID-19. No post vaccination if the patient tested for COVID-19. No known allergies and other medical history. Sore arm and chills starting approximately 9 hours after vaccination at 20:00. The arm is still a little sore but the chills went away overnight on 14Oct2022. The outcome of the events was reported as recovering. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021325922 same reporter/patient, different AE/dose;US-PFIZER INC-202101578176 same reporter/patient, different AE/dose;US-PFIZER INC-202200792194 same reporter/patient, different AE/dose;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2481315

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: NH
Alter: 27,0
Geschlecht: F
Eingang: 18.10.2022
Impfdatum: 11.10.2022
Beginn: 12.10.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site bruising Injection site erythema Injection site pruritus Injection site swelling

Symptomtext

The day after injection, a large red, raised bump appeared at the injection site. It was approximately 2 inches in diameter and the height of a quarter. It was very itchy, but not warm to touch. 4 days after injection the swelling went down and it faded into a bruise. No other noticeable symptoms were present.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Nexplanon
Allergien: N/A
Vorherige Impfungen: -

VAERS 2481239

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: NC
Alter: 34,0
Geschlecht: F
Eingang: 18.10.2022
Impfdatum: 12.10.2022
Beginn: 12.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Fatigue Influenza like illness Pain

Symptomtext

Chills; Aches; Fatigue; Flu-like symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 34-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Oct2022 at 09:45 as dose 4 (booster), single (Lot number: GJ6742) at the age of 34 years intramuscular, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 2, SINGLE; Route of administration: Intramuscular; Anatomical location: Arm left), administration date: 09Feb2021, when the patient was 33-year-old, for COVID-19 immunization, reaction(s): "flu-like symptoms", "Chills", "fatigue", "headache"; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot number: FG3527; Route of administration: Intramuscular; Anatomical location: Arm left), administration date: 07Dec2021, when the patient was 33-year-old, for COVID-19 immunization, reaction(s): "flu-like symptoms", "Chills", "fatigue", "headache"; Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 12Oct2022 at 23:45, outcome "recovering", described as "Aches"; CHILLS (non-serious) with onset 12Oct2022 at 23:45, outcome "recovering"; FATIGUE (non-serious) with onset 12Oct2022 at 23:45, outcome "recovering"; INFLUENZA LIKE ILLNESS (non-serious) with onset 12Oct2022 at 23:45, outcome "recovering", described as "Flu-like symptoms". Therapeutic measures were not taken as a result of chills, pain, fatigue, influenza like illness. Additional information: the patient had no other vaccine in four weeks, nor other medications in two weeks. The patient had no COVID prior to vaccination and was not tested for COVID post vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101752510 Same patient/vaccine, different event/dose;US-PFIZER INC-2021147534 Same patient/vaccine, different event/dose;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Other medical history: no Known allergies: no
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2479425

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: CT
Alter: 46,0
Geschlecht: M
Eingang: 15.10.2022
Impfdatum: 11.10.2022
Beginn: 11.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature Chills Pain Pain in extremity Pyrexia

Symptomtext

Arm soreness; fever 99-102 over 24hrs; body ache; chills; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 at 09:00 as dose 4 (booster), single (Lot number: GJ6742) at the age of 46 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN; AMLODIPINE; LOSARTAN; XANAX. Past drug history included: Doxycycline, reaction(s): "Known allergies: Doxycycline"; Celebrex, reaction(s): "Known allergies: Celebrex". Vaccination history included: Covid-19 vaccine (Dose 3 (Booster), unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Primary Immunization series completed, Unknown manufacturer), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 11Oct2022 at 19:00, outcome "recovering", described as "Arm soreness"; PAIN (non-serious) with onset 11Oct2022 at 19:00, outcome "recovering", described as "body ache"; CHILLS (non-serious) with onset 11Oct2022 at 19:00, outcome "recovering"; PYREXIA (non-serious) with onset 11Oct2022 at 19:00, outcome "recovering", described as "fever 99-102 over 24hrs". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity, pyrexia, pain, chills. Additional information: The patient had no other vaccine in four weeks. The patient had no covid prior vaccination and was not covid tested post vaccination. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Test Date: 20221011; Test Name: Fever; Result Unstructured Data: Test Result:99-102; Comments: over 24hrs
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Penicillin allergy
Andere Medikamente: ATORVASTATIN; AMLODIPINE; LOSARTAN; XANAX
Allergien: -
Vorherige Impfungen: -

VAERS 2478058

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: -
Alter: 52,0
Geschlecht: F
Eingang: 14.10.2022
Impfdatum: 10.10.2022
Beginn: 10.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Fatigue Pain Vaccination site pain

Symptomtext

Chills (recovered), pain at site of injection, body aches, tiredness; Chills (recovered), pain at site of injection, body aches, tiredness; Chills (recovered), pain at site of injection, body aches, tiredness; Chills (recovered), pain at site of injection, body aches, tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. A 52-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 52 years for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU [INFLUENZA VACCINE] taken for immunisation, on 14Sep2022 as dose number unknown, single. Vaccination history included: Covid-19 vaccine (Dose: 3 (1st booster), Unknown Manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose: 2, Unknown Manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose: 1, Unknown Manufacturer), for COVID-19 Immunization. The following information was reported: CHILLS (non-serious) with onset 10Oct2022, outcome "recovered" (2022), VACCINATION SITE PAIN (non-serious), PAIN (non-serious), FATIGUE (non-serious) all with onset 10Oct2022, outcome "recovering" and all described as "Chills (recovered), pain at site of injection, body aches, tiredness". Therapeutic measures were taken as a result of chills, vaccination site pain, pain, fatigue. Additional information: Patient received more than 3 dose. Flu vaccine received in four weeks on 14Sep2022. Patient received treatment with Tylenol. Patient had no covid prior vaccination and not tested post vaccination. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2474445

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CT
Alter: 49,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 05.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Myalgia

Symptomtext

headache; Muscle ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 49-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Oct2022 as dose 3 (booster), single (Lot number: GJ6742) at the age of 49 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Second dose, lot number=EP6955,), for COVID-19 Immunization; Bnt162b2 (First dose, lot number=EL3247), for COVID-19 Immunization. The following information was reported: MYALGIA (non-serious) with onset 06Oct2022, outcome "unknown", described as "Muscle ache"; HEADACHE (non-serious) with onset 06Oct2022, outcome "unknown". Therapeutic measures were not taken as a result of headache, myalgia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2474439

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: MI
Alter: 56,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Vaccination site pain

Symptomtext

fatigue; pain at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 56-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Oct2022 at 13:45 as dose 5 (booster), single (Lot number: GJ6742) at the age of 56 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Allergy multiple" (unspecified if ongoing), notes: Known allergies: yes. Many; "MDS" (unspecified if ongoing); "Greves disease" (unspecified if ongoing); "bone marrow transplant" (unspecified if ongoing); "aplastic anemia" (unspecified if ongoing); "GVHD" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. Concomitant medication(s) included: FLU [INFLUENZA VACCINE] taken for immunisation, on 20Sep2022 as dose 1, single; SYNTHROID; PREMARIN; TACROLIMUS; ASPIRIN [ACETYLSALICYLIC ACID]. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTUERER UNKNOWN), for Covid-19 Immunization; Covid-19 vaccine (DOSE 2; MANUFACTUERER UNKNOWN), for Covid-19 Immunization; Covid-19 vaccine (DOSE 3; MANUFACTUERER UNKNOWN), for Covid-19 Immunization; Covid-19 vaccine (DOSE 4; MANUFACTUERER UNKNOWN), for Covid-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 05Oct2022 at 18:00, outcome "recovering", described as "pain at the injection site"; FATIGUE (non-serious) with onset 05Oct2022 at 21:00, outcome "recovering". Therapeutic measures were not taken as a result of vaccination site pain, fatigue. Additional information: The reporter both the patient and a Pfizer colleague. Other medications in two weeks: vit. No covid tested post vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy multiple (Known allergies: yes. Many); Aplastic anemia; Bone marrow transplant; COVID-19 (If covid prior vaccination: Yes); Graves' disease; GVHD; MDS
Andere Medikamente: SYNTHROID; PREMARIN; TACROLIMUS; ASPIRIN [ACETYLSALICYLIC ACID]
Allergien: -
Vorherige Impfungen: -

VAERS 2472439

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: CT
Alter: 56,0
Geschlecht: F
Eingang: 08.10.2022
Impfdatum: 04.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Headache Pain Pain in extremity

Symptomtext

headache; Woke up with aches in my right side, right hand where I have arthritis, right hip, right foot where I've had a stress fracture, right shoulder where I've had some stuff going on; Woke up with aches in my right side, right hand where I have arthritis, right hip, right foot where I've had a stress fracture, right shoulder where I've had some stuff going on; Woke up with aches in my right side, right hand where I have arthritis, right hip, right foot where I've had a stress fracture, right shoulder where I've had some stuff going on; Woke up with aches in my right side, right hand where I have arthritis, right hip, right foot where I've had a stress fracture, right shoulder where I've had some stuff going on; Woke up with aches in my right side, right hand where I have arthritis, right hip, right foot where I've had a stress fracture, right shoulder where I've had some stuff going on; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 56-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 at 12:00 as dose 5 (booster), single (Lot number: GJ6742) at the age of 56 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Breast Cancer", start date: Sep2018 (unspecified if ongoing); "Known allergies: Sulfa drugs" (unspecified if ongoing); "stress fracture" (unspecified if ongoing), notes: right foot where I've had a stress fracture; "arthritis" (unspecified if ongoing), notes: right hand where I have arthritis. Concomitant medication(s) included: LIPITOR; CELEBREX; TAMOXIFEN. Past drug history included: Leviquin, reaction(s): "Known allergies: Leviquin". Vaccination history included: BNT162b2 (previous dose details, prev dose product= COVID-19,, prev dose brand= Pfizer,, prev dose brand unknown= False,, is bivalent= False,, prev dose lot number= FL3197, prev dose lot unknown= False,, prev dose administration date= 22Jun2022,, prev dose dose number= 4,, prev dose vaccine location= Right arm,), administration date: 22Jun2022, when the patient was 55-year-old, for Covid-19 Immunization; BNT162b2 (prev dose product= COVID-19,, prev dose brand= Pfizer,, prev dose brand unknown= False,, is bivalent= False,, prev dose lot number= FH8027,, prev dose lot unknown= False,, prev dose administration date= 13Dec2021,, prev dose dose number= 3,, prev dose vaccine location= Right arm,), administration date: 13Dec2021, when the patient was 55-year-old, for COVID-19 immunization; BNT162b2 (prev dose product= COVID-19,, prev dose brand= Pfizer,, prev dose brand unknown= False,, is bivalent= False,, prev dose lot number= el3247,, prev dose lot unknown= False,, prev dose administration date= 01Mar2021,, prev dose dose number= 1,, prev dose vaccine location= Right arm), administration date: 01Mar2021, when the patient was 54-year-old, for COVID-19 Immunization; Bnt162b2 (prev dose product= COVID-19,, prev dose brand= Pfizer,, prev dose brand unknown= False,, is bivalent= False,, prev dose lot number= EP6955,, prev dose lot unknown= False,, prev dose administration date= 23Mar2022,, prev dose dose number= 2,, prev dose vaccine location= Right arm,), for COVID-19 Immunization. The following information was reported: PAIN (non-serious), PAIN IN EXTREMITY (non-serious), ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious), ARTHRALGIA (non-serious) all with onset 05Oct2022 at 05:30, outcome "unknown" and all described as "Woke up with aches in my right side, right hand where I have arthritis, right hip, right foot where I've had a stress fracture, right shoulder where I've had some stuff going on"; HEADACHE (non-serious) with onset 05Oct2022 at 05:30, outcome "unknown". Therapeutic measures were not taken as a result of headache, pain, pain in extremity, arthralgia, pain in extremity, arthralgia. Additional information: The patient woke up with ache in her right side, right hand (where she have arthritis), right hip, right foot (where she had a stress fracture), and right shoulder (where she have had some stuff going on). No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Arthritis (right hand where I have arthritis); Breast cancer; Stress fracture (right foot where I've had a stress fracture); Sulfonamide allergy
Andere Medikamente: LIPITOR; CELEBREX; TAMOXIFEN
Allergien: -
Vorherige Impfungen: -

VAERS 2472423

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 08.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Axillary pain Body temperature Body temperature increased Fatigue Headache Myalgia Pain Vaccination site pain

Symptomtext

Very sore arm in area of injection; sore underarm area; body aches; muscle aches; headache; lingering fatigue; slightly elevated temperature; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 46 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Covid" (unspecified if ongoing), notes: If covid prior vaccination: Yes. Concomitant medication(s) included: FLU VACCINE VII taken for immunisation. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose 2, Unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose 3, Unknown manufacturer), for Covid-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 04Oct2022, outcome "unknown", described as "Very sore arm in area of injection"; PAIN (non-serious) with onset 04Oct2022, outcome "unknown", described as "body aches"; HEADACHE (non-serious) with onset 04Oct2022, outcome "unknown"; FATIGUE (non-serious) with onset 04Oct2022, outcome "unknown", described as "lingering fatigue"; MYALGIA (non-serious) with onset 04Oct2022, outcome "unknown", described as "muscle aches"; BODY TEMPERATURE INCREASED (non-serious) with onset 04Oct2022, outcome "unknown", described as "slightly elevated temperature"; AXILLARY PAIN (non-serious) with onset 04Oct2022, outcome "unknown", described as "sore underarm area". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vaccination site pain, axillary pain, pain, myalgia, headache, fatigue, body temperature increased. Additional information included: Very sore arm in area of injection including sore underarm area, body/muscle aches and headache within 12 hours of vaccination, with lingering fatigue, body aches, slightly elevated temperature and headache 24 hours after injection. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Axillary pain
Hospital-Tage: -
Labordaten: Test Date: 20221004; Test Name: temperature; Result Unstructured Data: Test Result:slightly elevated
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (If covid prior vaccination: Yes)
Andere Medikamente: FLU VACCINE VII
Allergien: -
Vorherige Impfungen: -

VAERS 2470492

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: MA
Alter: 46,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Nausea Pain Product use issue Pyrexia Urticaria Wheezing

Symptomtext

Hives; wheezing; fever; aches; fatigue; headache; nausea; Product use for unapproved combination; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 at 13:45 as dose 4 (booster), single (Lot number: GJ6742) at the age of 46 years intramuscular, in right arm for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 29Sep2022 as dose 1, single (Batch/Lot number: unknown), in left arm for immunisation. The patient's relevant medical history included: "Chronic Asthma" (unspecified if ongoing); "Allergies" (unspecified if ongoing); "Alopecia" (unspecified if ongoing); "High Blood Pressure" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing); "Known allergies: Sulfonamide Antibiotics" (unspecified if ongoing); "Known allergies: Tree nuts" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; ATENOLOL; CALAN [VERAPAMIL HYDROCHLORIDE]. Vaccination history included: Covid-19 vaccine (DOSE 1,SINGLE, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2,SINGLE, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3,SINGLE, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: PRODUCT USE ISSUE (non-serious) with onset 29Sep2022, outcome "unknown", described as "Product use for unapproved combination"; URTICARIA (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering", described as "Hives"; PAIN (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering", described as "aches"; FATIGUE (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering"; PYREXIA (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering", described as "fever"; HEADACHE (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering"; NAUSEA (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering"; WHEEZING (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering". Therapeutic measures were taken as a result of urticaria, wheezing, pyrexia, pain, fatigue, headache, nausea. Additional information: The patient did not receive any other vaccine in four weeks. The patient did not have covid prior vaccination and patient had not tested for covid post vaccination. The patient received Benadryl, Albuterol Inhaler, Ice pack, Rest, Advil as treatment for the events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy; Allergy to nuts; Alopecia; Asthma chronic; Blood pressure high; Penicillin allergy; Sulfonamide allergy
Andere Medikamente: SYNTHROID; ATENOLOL; CALAN [VERAPAMIL HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -

VAERS 2470472

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: NJ
Alter: 33,0
Geschlecht: M
Eingang: 06.10.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature Chills Fatigue Headache Hyperhidrosis Pain Pyrexia Vaccination site pain Wrong product administered

Symptomtext

Fever lasting 48hrs; tiredness; full body aches (most intense at injection site); full body aches (most intense at injection site); headaches; chills; sweating; Wrong vaccine administered; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 32-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 at 11:15 as dose 1, single (Lot number: GJ6742) at the age of 33 years intramuscular, in left arm for covid-19 immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history included: "Known allergies: Sulpha Antibiotics" (unspecified if ongoing). Concomitant medication(s) included: TRUMENBA taken for immunisation, on 09Sep2022 as dose number unknown, single; INFLUENZA taken for immunisation, on 09Sep2022 as dose number unknown, single. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 29Sep2021, outcome "unknown", described as "Wrong vaccine administered"; PYREXIA (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering", described as "Fever lasting 48hrs"; CHILLS (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering"; PAIN (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 29Sep2022 at 14:45, outcome "recovering" and all described as "full body aches (most intense at injection site)"; HEADACHE (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering", described as "headaches"; HYPERHIDROSIS (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering", described as "sweating"; FATIGUE (non-serious) with onset 29Sep2022 at 14:45, outcome "recovering", described as "tiredness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, fatigue, pain, vaccination site pain, headache, chills, hyperhidrosis. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Test Date: 20220929; Test Name: Fever; Result Unstructured Data: Test Result:Unknown Results; Comments: Fever lasting 48hrs
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Sulfonamide allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2468143

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

mild

Staat: PA
Alter: -
Geschlecht: U
Eingang: 04.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Headache Somnolence Vomiting

Symptomtext

Vomiting; Diarrhea; Headache; Sleepiness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Lot number: GJ6742) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer), for COVID-19 Immunization. The following information was reported: VOMITING (non-serious), outcome "unknown"; DIARRHOEA (non-serious), outcome "unknown", described as "Diarrhea"; HEADACHE (non-serious), outcome "unknown"; SOMNOLENCE (non-serious), outcome "unknown", described as "Sleepiness". No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2468133

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: NY
Alter: 50,0
Geschlecht: F
Eingang: 04.10.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Off label use Vaccination site pain

Symptomtext

I experienced some pain at the injection site in the left arm. It began in the evening of the day of injection and resolved by the early afternoon of the following day.; BNT162B2, BNT162B2 OMI BA.4-5; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 50-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 at 12:45 as dose 4 (booster), single (Lot number: GJ6742) at the age of 50 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing), notes: Other medical history: Asthma; "Known allergies: seasonal" (unspecified if ongoing), notes: Known allergies: seasonal; "Known allergies: Pet" (unspecified if ongoing), notes: Known allergies: pet; "food allergies" (unspecified if ongoing), notes: Known allergies: food allergies. Concomitant medication(s) included: FLU [INFLUENZA VACCINE] taken for immunisation, on 13Sep2022 as dose 1, single; ALLEGRA [FEXOFENADINE HYDROCHLORIDE]; NASACORT; VITAMIN D [COLECALCIFEROL]; FISH OIL. Past drug history included: Robitussin, reaction(s): "Known allergies: Robitussin", notes: Known allergies: Robitussin. Vaccination history included: BNT162b2 (Dose Number: 3, Batch/Lot No: FF8841, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 01Dec2021, when the patient was 49-year-old, for COVID-19 Immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: EK3248, Location of injection: Arm Left, Route of Administration: Intramuscular, administration time:02:00 PM), administration date: 10Mar2021, when the patient was 48-year-old, for COVID-19 Immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Left, Route of Administration: Intramuscular, administration time:02:00 PM), administration date: 19Feb2021, when the patient was 48-year-old, for COVID-19 Immunization. The following information was reported: OFF LABEL USE (non-serious) with onset 29Sep2022 at 19:30, outcome "unknown", described as "BNT162B2, BNT162B2 OMI BA.4-5"; VACCINATION SITE PAIN (non-serious) with onset 29Sep2022 at 19:30, outcome "recovered" (30Sep2022), described as "I experienced some pain at the injection site in the left arm. It began in the evening of the day of injection and resolved by the early afternoon of the following day.". Therapeutic measures were not taken as a result of vaccination site pain. Additional Information: Other vaccine in four weeks: Seasonal influenza vaccine, vaccine date:13Sep2022, dose number:1, vaccine location:Left arm. Other medications in two week were allegra, nasacort, vitamin D, fish oil, multivitamin. Covid prior vaccination was no. Covid tested post vaccination was no. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy to animals (Known allergies: pet); Asthma (Other medical history: Asthma); Food allergy (Known allergies: food allergies); Seasonal allergy (Known allergies: seasonal)
Andere Medikamente: ALLEGRA [FEXOFENADINE HYDROCHLORIDE]; NASACORT; VITAMIN D [COLECALCIFEROL]; FISH OIL
Allergien: -
Vorherige Impfungen: -

VAERS 2468110

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

mild

Staat: PA
Alter: 53,0
Geschlecht: M
Eingang: 04.10.2022
Impfdatum: 28.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Pain

Symptomtext

Experienced chills and bodyaches throughout the following day with; Experienced chills and bodyaches throughout the following day with; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53-year-old male patient received BNT162b2 (BNT162B2), on 28Sep2022 at 13:00 as dose 1, single (Lot number: GJ6742) at the age of 53 years intramuscular, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 28Sep2022 as dose number unknown, single (Batch/Lot number: unknown), in right arm for immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: CHILLS (non-serious), PAIN (non-serious) all with onset 29Sep2022 at 12:00, outcome "recovering" and all described as "Experienced chills and bodyaches throughout the following day with". Therapeutic measures were not taken as a result of chills, pain. Additional information: The patient had COVID prior vaccination and not tested for COVID post vaccination. No known allergies and no other medical history was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2721981

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CT
Alter: 50,0
Geschlecht: F
Eingang: 07.12.2023
Impfdatum: 25.10.2022
Beginn: 01.11.2023
Tage bis Beginn: 372,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

covid; covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 51-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Oct2022 as dose 3 (booster), single (Lot number: GJ6742) at the age of 50 years, in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 11Mar2021 as dose 1, single (Lot number: EL3247), in left arm and on 01Apr2021 as dose 2, single (Lot number: EP6955), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2023, outcome "unknown" and all described as "covid". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient took Paxlovid from 22Nov2023 to 27Nov2023. Conclusion: The complaint for lack of effect of the PFIZER-BIONTECH COVID-19 VACCINE lot EL3247, lot EP6955, was investigated. The investigation included a review of manufacturing and packaging batch records, deviation investigations, and an analysis of complaint history for the reported lot. The final scope included the reported finished goods lot EL3247, fill lot EL3230, and lot EP6955, fill lot EP6954 and the formulated drug product lot EL3223, lot EP6953. A complaint sample was not returned, and photographs were not received. No related quality issues were identified during the investigation. There is no impact to product quality. No root cause or corrective/preventative actions were identified as the complaint was not confirmed. All release testing performed prior to the release of the reported batch was within specifications. The complaint for lack of effect of the PFIZER-BIONTECH COVID-19 VACCINE lot GJ6742 was investigated. The investigation included a review of manufacturing and packaging records, deviations, and the complaint history for in scope lots. The final scope was determined to be the finished goods lot GJ6742, bulk and fill lots GJ6729, and GJ6736. A complaint sample was not returned. No related quality issues were identified during the investigation. There is no impact on product quality. No root cause or CAPA were identified as the complaint was not confirmed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2710567

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CT
Alter: 14,0
Geschlecht: M
Eingang: 07.11.2023
Impfdatum: 13.12.2022
Beginn: 28.10.2023
Tage bis Beginn: 319,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

Tested positive for COVID on 01Nov2023. Sore throat, runny nose, cough; Tested positive for COVID on 01Nov2023. Sore throat, runny nose, cough; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the parent. A 15-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Dec2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 14 years, in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. Patient received bivalent Pfizer COVID-19 vaccine in Pharmacy or Drug Store. The patient's relevant medical history included: "Lactose intolerance" (unspecified if ongoing). No covid prior vaccination. Patient had no allergies. There were no concomitant medications. No other vaccine in four weeks, no other medications in two weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 28Oct2023, outcome "recovering" and all described as "Tested positive for COVID on 01Nov2023. Sore throat, runny nose, cough". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Nov2023) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of drug ineffective, covid-19. Adverse event start date was 28Oct2023. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20231101; Test Name: COVID-19 test; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Lactose intolerance
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2709075

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CT
Alter: 51,0
Geschlecht: F
Eingang: 03.11.2023
Impfdatum: 18.10.2022
Beginn: 01.10.2023
Tage bis Beginn: 348,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 52-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Oct2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 51 years for covid-19 immunisation; bnt162b2 (BNT162B2), on 01Mar2021 as dose 1, single (Lot number: EL3247), on 24Mar2021 as dose 2, single (Lot number: EP6955), on 18Oct2021 as dose 3 (booster), single (Lot number: 320308D) and on 14Apr2022 as dose 4 (booster), single (Lot number: FL3197) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient had no known allergies. Patient received Paxlovid for treatment of COVID-19 from 20Oct2023 to 24Oct2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300350598 Same reporter/patient, different drug/events;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2707036

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: NJ
Alter: 77,0
Geschlecht: F
Eingang: 31.10.2023
Impfdatum: 28.04.2023
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Muscle disorder

Symptomtext

with every dose of the vaccine caller has had muscle problems; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 77-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Apr2023 as dose 5 (booster), single (Lot number: GJ6742) at the age of 77 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (ongoing), notes: in her late 30s. Doctor tried to figure out if it was rheumatoid arthritis or Lupus.; "Hashimoto's" (ongoing), notes: Hashimoto's; "Fibromyalgia" (ongoing), notes: Fibromyalgia; "Sjogren's" (ongoing), notes: Sjogren's. The patient's family history included: "Rheumatoid arthritis" (ongoing), notes: in her late 30s. Doctor tried to figure out if it was rheumatoid arthritis or Lupus. There were no concomitant medications. Vaccination history included: bnt162b2 (DOSE 1, SINGLE, Batch/lot number: EN6205, Anatomical location: Upper left arm), administration date: 02Mar2021, for Covid-19 immunization, reaction(s): "polymyalgia rheumatica", "had muscle problems", "arm irritation", "arm tenderness"; bnt162b2 (DOSE 2, SINGLE, Batch/Lot number: ER8727, Anatomical location: Upper left arm), administration date: 23Mar2021, for Covid-19 immunization, reaction(s): "arm sensitive/ had tenderness", "every muscle in body was bothering patient/ muscle problems", "leg cramps", "very tired", "Headache", "sore throat", "polymyalgia rheumatica"; bnt162b2 (DOSE 3 (BOOSTER), SINGLE, Batch/Lot number: 30135BA, Anatomical location: Upper left arm), administration date: 21Oct2021, for Covid-19 immunization, reaction(s): "with every dose of the vaccine caller has had muscle problems", "Pericarditis", "couldn't breathe"; bnt162b2;bnt162b2 omi ba.4-5 (DOSE 4 (BOOSTER), SINGLE, Batch/Lot number: GH9694, Anatomical location: Upper left arm), administration date: 21Sep2022, for Covid-19 immunization, reaction(s): "with every dose of the vaccine caller has had muscle problems". The following information was reported: MUSCLE DISORDER (non-serious) with onset 2023, outcome "unknown", described as "with every dose of the vaccine caller has had muscle problems". Additional information: It was clarified and confirmed that caller had all of the Pfizer COVID-19 vaccines.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300337361 same patient/vaccine, different doses/event.;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Muscle disorder
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Fibromyalgia (Fibromyalgia); Hashimoto's disease (Hashimoto's); Lupus erythematosus (in her late 30s. Doctor tried to figure out if it was rheumatoid arthritis or Lupus.); Rheumatoid arthritis (in her late 30s. Doctor tried to figure out if it was rheumatoid arthritis or Lupus.); Sjogren's (Sjogren's)
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2699471

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CT
Alter: 56,0
Geschlecht: M
Eingang: 20.10.2023
Impfdatum: 05.10.2022
Beginn: 01.10.2023
Tage bis Beginn: 361,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 57-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 56 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High LDL" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid on 17Oct2023. Clinical Course: Patient had no known allergies.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300333486 same patient, different drug /event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Increased LDL
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2692255

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 06.10.2023
Impfdatum: 01.12.2022
Beginn: 01.09.2023
Tage bis Beginn: 274,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 60-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Dec2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 60 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing); "mild allergy-related asthma" (unspecified if ongoing), notes: mild allergy-related asthma treated with Zyrtec-D. The patient's concomitant medications were not reported. Past drug history included: Zyrtec-d for mild allergy-related asthma. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "recovered" (2023) and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (19Sep2023) Negative, notes: Tested negative on 19Sep and 20Sep on home test; (20Sep2023) Negative, notes: Tested negative on 19Sep and 20Sep on home test; (21Sep2023) Positive, notes: Tested positive on 21Sep; (28Sep2023) Negative, notes: 28Sep tested negative on home test and again on 30Sep; (30Sep2023) Negative, notes: 28Sep tested negative on home test and again on 30Sep. Therapeutic measures were taken as a result of drug ineffective, covid-19 with paxlovid from 21Sep2023 till 26Sep2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300317391 same reporter/patient, different drug/AE;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230919; Test Name: home test; Test Result: Negative ; Comments: Tested negative on 19Sep and 20Sep on home test; Test Date: 20230920; Test Name: home test; Test Result: Negative ; Comments: Tested negative on 19Sep and 20Sep on home test; Test Date: 20230921; Test Name: home test; Test Result: Positive ; Comments: Tested positive on 21Sep; Test Date: 20230928; Test Name: home test; Test Result: Negative ; Comments: 28Sep tested negative on home test and again on 30Sep.; Test Date: 20230930; Test Name: home test; Test Result: Negative ; Comments: 28Sep tested negative on home test and again on 30Sep.
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergic asthma (mild allergy-related asthma treated with Zyrtec-D); Penicillin allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2690224

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: OH
Alter: 72,0
Geschlecht: F
Eingang: 03.10.2023
Impfdatum: 16.05.2023
Beginn: 25.09.2023
Tage bis Beginn: 132,0
Dosis: 6
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 72-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Sep2022 as dose 5 (booster), single (Lot number: GH9694), in right arm and on 16May2023 as dose 6 (booster), single (Lot number: GJ6742) at the age of 72 years, in right arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 13Feb2021 as dose 1, single (Lot number: EL2964), in right arm, on 06Mar2021 as dose 2, single (Lot number: EN6199), in right arm, on 25Sep2021 as dose 3 (booster), single (Lot number: 301308A), in right arm and on 06Apr2022 as dose 4 (booster), single (Lot number: FK9893), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 25Sep2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from Sep2023 to Sep2023. Clinical course: Bronchospasm unable stop coughing. Never experienced before could only talk short time before spasmodic coughing Bronchitis and fluid in airways crackling noise in chest that can be heard across the room.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hypothyroidism; Sulfonamide allergy (known allergies: Sulfa)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2679831

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CT
Alter: 53,0
Geschlecht: F
Eingang: 07.09.2023
Impfdatum: 09.11.2022
Beginn: 01.08.2023
Tage bis Beginn: 265,0
Dosis: UNK
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 54-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Nov2022 as dose number unknown (booster), single (Lot number: GJ6742) at the age of 53 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 04May2022 as dose number unknown, single (Lot number: FL3197), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Ulcerative colitis" (unspecified if ongoing); "allergies: IV contrast dye" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Colazol, reaction(s): "known allergies: Colazol". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2023, outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included PAXLOVID from 29Aug2023 to 02Sep2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Allergy to intravenous contrast media; Ulcerative colitis
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2676587

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CO
Alter: 60,0
Geschlecht: M
Eingang: 25.08.2023
Impfdatum: 07.03.2023
Beginn: 07.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Vaccine error- vaccine was administered past its beyond use date. The vaccine had been stored in the refrigerator beyond the time frame recommended by the manufacture.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666237

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 04.08.2023
Impfdatum: 22.02.2023
Beginn: 07.04.2023
Tage bis Beginn: 44,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Chronic respiratory failure Respiratory failure

Symptomtext

J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/7/2023 CHRONIC HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chronic respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2656628

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 14.07.2023
Impfdatum: 06.05.2023
Beginn: -
Tage bis Beginn: -
Dosis: 6
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 71-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06May2023 at 10:00 as dose 6 (booster), single (Lot number: GJ6742) at the age of 71 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown) and as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Sulfa drugs" (unspecified if ongoing), notes: known allergies: Sulfa drugs. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included treatment with Paxlovid from 26Jun2023 to 01Jul2023. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300249432 same reporter/patient, different drug/event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Sulfonamide allergy (known allergies: Sulfa drugs)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2650889

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 31,0
Geschlecht: F
Eingang: 29.06.2023
Impfdatum: 04.01.2023
Beginn: 28.02.2023
Tage bis Beginn: 55,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypoxia Symptom recurrence

Symptomtext

HYPOXEMIA 2/12/2023 & 3/12/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypoxia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2650820

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 75,0
Geschlecht: F
Eingang: 29.06.2023
Impfdatum: 18.01.2023
Beginn: 17.02.2023
Tage bis Beginn: 30,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypoxia

Symptomtext

HYPOXEMIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypoxia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2650791

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 29.06.2023
Impfdatum: 30.01.2023
Beginn: 10.02.2023
Tage bis Beginn: 11,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Angina pectoris

Symptomtext

STABLE ANGINA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Angina pectoris
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2650457

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 55,0
Geschlecht: M
Eingang: 28.06.2023
Impfdatum: 03.02.2023
Beginn: 27.02.2023
Tage bis Beginn: 24,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypersensitivity Symptom recurrence

Symptomtext

ALLERGIC REACTION, INIT 2/22/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypersensitivity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2649048

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: TX
Alter: 52,0
Geschlecht: M
Eingang: 24.06.2023
Impfdatum: 30.12.2022
Beginn: 01.06.2023
Tage bis Beginn: 153,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Dec2022 as dose 3 (booster), single (Lot number: GJ6742) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Gout" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2023, outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient took Paxlovid (lot number: 00069-0345-30) from 13Jun2023 to 18Jun2023 for the treatment of COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Gout; Hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2649038

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CA
Alter: 63,0
Geschlecht: M
Eingang: 24.06.2023
Impfdatum: 15.12.2022
Beginn: 16.06.2023
Tage bis Beginn: 183,0
Dosis: 5
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

Caught COVID (tested positive in home test); Caught COVID (tested positive in home test); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A 64-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Dec2022 at 14:15 as dose 5 (booster), single (Lot number: GJ6742) at the age of 63 years intramuscular, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 02Mar2021 at 10:30 as dose 1, single (Lot number: EN5318), in left arm, on 23Mar2021 at 15:15 as dose 2, single (Lot number: EN6199), in left arm, on 30Sep2021 at 10:45 as dose 3 (booster), single (Lot number: EP6955), in left arm and on 26May2022 at 11:00 as dose 4 (booster), single (Lot number: FH8028), in left arm, all intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Psoriatic arthritis" (unspecified if ongoing). Concomitant medication(s) included: CELEBREX; FOLIC ACID; METHOTREXATE. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 16Jun2023 at 18:00, outcome "recovering" and all described as "Caught COVID (tested positive in home test)". The event "caught covid (tested positive in home test)" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (20Jun2023) Positive, notes: Nasal Swab; (16Jun2023) Positive, notes: tested positive in home test. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Adverse event resulted in: [Doctor or other healthcare professional office/clinic visit] and treated with Paxlovid, Flonase. The patient did not have Covid prior vaccination. The patient had no known allergies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230620; Test Name: Floflex antigen home test; Test Result: Positive ; Comments: Nasal Swab; Test Date: 20230616; Test Name: Home Test; Test Result: Positive ; Comments: tested positive in home test
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Psoriatic arthritis
Andere Medikamente: CELEBREX; FOLIC ACID; METHOTREXATE
Allergien: -
Vorherige Impfungen: -

VAERS 2648356

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 56,0
Geschlecht: F
Eingang: 22.06.2023
Impfdatum: 15.12.2022
Beginn: 28.12.2022
Tage bis Beginn: 13,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypersensitivity

Symptomtext

ALLERGIC REACTION, INIT

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypersensitivity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2646615

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: OH
Alter: 47,0
Geschlecht: M
Eingang: 17.06.2023
Impfdatum: 09.06.2023
Beginn: 09.06.2023
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypoaesthesia

Symptomtext

A few hours after vaccination patient reported feeling numbness in his arm and hand. He says this feeling improved the next day without treatment but has worsened again and not improved since. He has not sought any treatment or used any medication at this time but still has a numb feeling in the arm and hand.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypoaesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2645892

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 75,0
Geschlecht: F
Eingang: 15.06.2023
Impfdatum: 16.11.2022
Beginn: 02.12.2022
Tage bis Beginn: 16,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Respiratory failure

Symptomtext

ACUTE MI RESPIRATORY FAILURE, UNSPECIFIED ACUITY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2645448

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: IL
Alter: 54,0
Geschlecht: F
Eingang: 15.06.2023
Impfdatum: 09.12.2022
Beginn: 01.05.2023
Tage bis Beginn: 143,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 54-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Dec2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 54 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing). The patient is not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2023, outcome "recovering", and all described as "Treatment of COVID-19". Symptoms of COVID-19 includes fever, sore throat, congestion, and cough. Therapeutic measures were taken (Paxlovid from 28May2023 to 01Jun2023) as a result of drug ineffective, covid-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Sulfonamide allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2644644

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 60,0
Geschlecht: F
Eingang: 13.06.2023
Impfdatum: 15.12.2022
Beginn: 21.04.2023
Tage bis Beginn: 127,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angina pectoris Troponin I increased

Symptomtext

I20.9 ANGINA, UNSPECIFIED 4/13/2023 ELEVATED TROPONIN I

Weitere VAERSDATA-Felder

Praegender Schweregrund: Angina pectoris
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2637957

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CO
Alter: 50,0
Geschlecht: M
Eingang: 30.05.2023
Impfdatum: 19.12.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 50-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Dec2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 50 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 23Mar2021 as dose 1, single (Lot number: ER8727), in left arm, on 13Apr2021 as dose 2, single (Lot number: EW0151), in left arm, on 13Oct2021 as dose 3 (booster), single (Lot number: FF2584), in left arm and on 16Jun2022 as dose 4 (booster), single (Lot number: FP7135), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Depression" (not ongoing); "Anxiety" (not ongoing); "sleep apnea" (not ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Negative. Therapeutic measures were taken as a result of vaccination failure, covid-19 with Paxlovid (start date: 10May2023 and stop date: 15May2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: after testing negative/ COVID-19 virus test; Test Result: Negative ; Test Name: after testing negative/ COVID-19 virus test; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Anxiety; Depression; Sleep apnea
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2636412

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: PA
Alter: 42,0
Geschlecht: M
Eingang: 25.05.2023
Impfdatum: 17.11.2022
Beginn: 21.05.2023
Tage bis Beginn: 185,0
Dosis: 4
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

Breakthrough COVID-19 infection detected by at home test kit on 21May2023; Breakthrough COVID-19 infection detected by at home test kit on 21May2023; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 42-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Nov2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 42 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypercholesterolemia" (unspecified if ongoing); "Congenital glaucoma" (unspecified if ongoing); "Covid prior vaccination" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 21May2023, outcome "recovering" and all described as "Breakthrough COVID-19 infection detected by at home test kit on 21May2023". The event "breakthrough covid-19 infection detected by at home test kit on 21may2023" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (21May2023) Positive, notes: Nasal Swab. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: patient was treated with Paxlovid. Patient had No Known allergies.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300186551 Same patient, different drug, different event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230521; Test Name: Flowflex; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Congenital glaucoma; COVID-19; Hypercholesterolemia
Andere Medikamente: ATORVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 2631208

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 57,0
Geschlecht: F
Eingang: 12.05.2023
Impfdatum: 10.02.2023
Beginn: 01.03.2023
Tage bis Beginn: 19,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tinnitus

Symptomtext

Tinnitus - ongoing.0

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tinnitus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Tinnitus since last booster.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2628450

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MN
Alter: 77,0
Geschlecht: F
Eingang: 08.05.2023
Impfdatum: 13.12.2022
Beginn: 27.03.2023
Tage bis Beginn: 104,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Computerised tomogram thorax Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

Symptomtext

had COVID after the vaccine and now has a new diagnosis of DIPNECH

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: chest CT 1/11/23
Aktuelle Erkrankungen: MI 12/22
Vorgeschichte: asthma, bronchiectasis. VCD, OSA, s/p TAVR, non rheumatic aortic valve stenosis, RLS, HfpEF
Andere Medikamente: Atenolol, bimantoprost, wllbutrin, cac03, zyrtec, D3, zetia, pepcid, proscar, lasix, atrovent neb, lisinopril, mg, singulair, revia, omega 3, omeprazole, potassium, pravachol. nacl3%, aldactone, symbicort, retin a
Allergien: PCN, keflex, escitalopram, nabumetone, sulfa
Vorherige Impfungen: -

VAERS 2627871

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 84,0
Geschlecht: M
Eingang: 06.05.2023
Impfdatum: 16.02.2023
Beginn: 16.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627863

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 76,0
Geschlecht: F
Eingang: 06.05.2023
Impfdatum: 02.03.2023
Beginn: 02.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627862

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 61,0
Geschlecht: F
Eingang: 06.05.2023
Impfdatum: 02.03.2023
Beginn: 02.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627861

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 62,0
Geschlecht: F
Eingang: 06.05.2023
Impfdatum: 16.02.2023
Beginn: 16.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627860

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 85,0
Geschlecht: F
Eingang: 06.05.2023
Impfdatum: 02.03.2023
Beginn: 02.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627859

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 85,0
Geschlecht: F
Eingang: 06.05.2023
Impfdatum: 02.03.2023
Beginn: 02.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627858

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 83,0
Geschlecht: F
Eingang: 06.05.2023
Impfdatum: 02.03.2023
Beginn: 02.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627857

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 90,0
Geschlecht: F
Eingang: 06.05.2023
Impfdatum: 01.03.2023
Beginn: 01.03.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627856

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 87,0
Geschlecht: M
Eingang: 06.05.2023
Impfdatum: 16.02.2023
Beginn: 16.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627845

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 74,0
Geschlecht: M
Eingang: 06.05.2023
Impfdatum: 16.02.2023
Beginn: 16.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627844

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 88,0
Geschlecht: F
Eingang: 06.05.2023
Impfdatum: 16.02.2023
Beginn: 16.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627843

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 70,0
Geschlecht: M
Eingang: 06.05.2023
Impfdatum: 16.02.2023
Beginn: 16.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627842

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 81,0
Geschlecht: M
Eingang: 06.05.2023
Impfdatum: 16.02.2023
Beginn: 16.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627814

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: NY
Alter: 43,0
Geschlecht: F
Eingang: 06.05.2023
Impfdatum: 01.11.2022
Beginn: 02.11.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination site erythema Vaccination site induration

Symptomtext

Injection site redness and induration; Injection site redness and induration; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 43-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Nov2022 at 10:15 as dose 4 (booster), single (Lot number: GJ6742) at the age of 43 years intramuscular, in left arm for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 01Nov2022 as dose 1, single (Batch/Lot number: unknown), in right arm for immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing), notes: prior to vaccination; "chronic autoimmune hives" (unspecified if ongoing); "ocular migraines" (unspecified if ongoing). Concomitant medication(s) included: ALLI; MVI [VITAMINS NOS]; CULTURELLE; CETIRIZINE; TYLENOL. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE INDURATION (non-serious) all with onset 02Nov2022 at 12:00, outcome "recovering" and all described as "Injection site redness and induration". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site induration. Additional information: The patient had no known allergies. The patient first noticed the redness and induration at the injection site on left arm around noon on 02Nov2022. She can see it and feel the induration when touched. It is tender to the touch but did not feel the redness or induration prior to that. It is currently ongoing. There is mild sensitivity at the injection site only. The patient was not tested for COVID-19 post-vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (prior to vaccination); Hives; Ocular migraine
Andere Medikamente: ALLI; MVI [VITAMINS NOS]; CULTURELLE; CETIRIZINE; TYLENOL
Allergien: -
Vorherige Impfungen: -

VAERS 2627318

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 69,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627317

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 78,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627315

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 71,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627314

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 61,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627313

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 83,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627312

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 72,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627311

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 66,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627310

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 87,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627108

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 62,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Vaccination error

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627106

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 90,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627104

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 83,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627101

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 63,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627100

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 90,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627099

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 43,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 87,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627095

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 92,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627094

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 63,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627093

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 72,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627092

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 77,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627091

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 71,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627090

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 79,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627089

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 63,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627088

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 80,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627087

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 66,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627086

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 76,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627085

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 67,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627084

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 90,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627083

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 79,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627082

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 89,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627081

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 82,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627080

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 87,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627079

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 93,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627078

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 75,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 17.02.2023
Beginn: 17.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627068

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 72,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627067

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 75,0
Geschlecht: M
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627066

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 75,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627065

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 77,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2627064

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 65,0
Geschlecht: F
Eingang: 05.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626470

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 77,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626468

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 75,0
Geschlecht: M
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626466

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 75,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626464

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 72,0
Geschlecht: M
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626460

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 65,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626459

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 69,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired Covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626457

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 78,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626453

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 71,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626451

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 61,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626449

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 83,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626448

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 72,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Pharmacy inadvertently sent expired covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626446

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 66,0
Geschlecht: M
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO NURSING HOME/SENIOR LIVING FACILITY.WHICH WAS ADMINISTERED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626442

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 87,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO NURSING HOME/SENIOR LIVING FACILITY.WHICH WAS ADMINISTERED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626441

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 62,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO HEALTHCARE WHICH WAS ADMINISTERED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626439

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 90,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO NURSING HOME/SENIOR LIVING FACILITY.WHICH WAS ADMINISTERED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626437

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 83,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO NURSING HOME WHICH WAS ADMINISTERED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626191

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 67,0
Geschlecht: M
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

PRIVACY PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO PRIVACY HEALTHCARE @ PRIVACY. WHICH WAS ADMINISTERED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626189

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 63,0
Geschlecht: F
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

PRIVACY PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO PRIVACY HEALTHCARE @ PRIVACY. WHICH WAS ADMINISTERED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626187

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 90,0
Geschlecht: M
Eingang: 04.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

PHARMACY INADVERTENTLY DISPENSED EXPIRED COVID VACCINE TO LOCAL HEALTHCARE UNIT WHICH WAS ADMINISTERED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2626055

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge gj6742

gering

Staat: CT
Alter: 59,0
Geschlecht: M
Eingang: 03.05.2023
Impfdatum: 26.10.2022
Beginn: 01.05.2023
Tage bis Beginn: 187,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

I tested positive on 01May2023 with a home test.; I tested positive on 01May2023 with a home test.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 60-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Oct2022 as dose 5 (booster), single (Lot number: gj6742) at the age of 59 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 03Mar2021 as dose 1, single (Lot number: el3247), on 25Mar2021 as dose 2, single (Lot number: ep6955), in right arm, on 29Oct2021 as dose 3 (booster), single (Lot number: fe3509), in right arm and on 07Apr2022 as dose 4 (booster), single (Lot number: fl3197), in right arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: AMBIEN. The following information was reported: VACCINATION FAILURE (medically significant) with onset 01May2023, outcome "not recovered", COVID-19 (medically significant) with onset 01May2023, outcome "not recovered" and all described as "I tested positive on 1May2023 with a home test.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01May2023) Positive, notes: I tested positive on 01May2023 with a home test. Therapeutic measures were not taken as a result of vaccination failure, covid-19. Clinical Information: Facility type vaccine was clinic. No other other vaccine in four weeks. Other medications in two weeks: ambien. Patient tested positive on 1May2023 with a home test. No covid prior vaccination. If covid tested post vaccination was Unknown

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230501; Test Name: Home test; Test Result: Positive ; Comments: I tested positive on 01May2023 with a home test.
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none, Comment: Known allergies: no Other medical history: None
Andere Medikamente: AMBIEN
Allergien: -
Vorherige Impfungen: -

VAERS 2625711

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MI
Alter: 89,0
Geschlecht: M
Eingang: 03.05.2023
Impfdatum: 01.12.2022
Beginn: 03.02.2023
Tage bis Beginn: 64,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 5 vaccines Pfizer 1/19/21 Lot# EL3249; Pfizer 2/9/21 Lot# El9267; Pfizer 10/7/21 Lot# FF2589; Pfizer 5/31/22 Lot# FM7553; Pfizer 12/1/22 Lot# GJ6742

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2625606

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 43,0
Geschlecht: M
Eingang: 03.05.2023
Impfdatum: 15.02.2023
Beginn: 15.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

EXPIRED VACCINES WERE INADVERTENTLY SENT TO OUR FACILITY.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624231

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: DC
Alter: 68,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 25.04.2023
Beginn: 25.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

patient received vaccine that was improperly stored. it should have been disposed of on the use by date of 1/27/23

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624230

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: DC
Alter: 29,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 25.04.2023
Beginn: 25.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

pt received vaccine that was stored improperly,, store in fridge past use by date of 1/29/23

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624199

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 22,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624192

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 69,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624153

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 21,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624147

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 32,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624143

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 32,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624138

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 30,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624131

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 33,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624129

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 21,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624126

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 43,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624123

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 28,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624116

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 20,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624113

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 50,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624108

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 34,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624106

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 51,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624100

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 58,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624098

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 29,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 22,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624093

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 33,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624089

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 48,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624088

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 19,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624086

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 59,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624084

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 22,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624081

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 19,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 03.02.2023
Beginn: 03.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624078

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 20,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624073

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 28,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

No adverse event. Pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624067

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 41,0
Geschlecht: U
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

no adverse event. pt administered an expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624062

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 24,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

no adverse event. pt administered expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624058

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 18,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

no adverse event. pt administered expired vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624053

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 29,0
Geschlecht: F
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

administered expired vaccine. no adverse event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2624001

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 37,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

vaccine expires. not an adverse event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2623999

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 37,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

vaccine expired, no adverse event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2623995

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 46,0
Geschlecht: M
Eingang: 01.05.2023
Impfdatum: 27.01.2023
Beginn: 27.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Expired vaccine given, not an adverse event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2623272

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: DC
Alter: 75,0
Geschlecht: F
Eingang: 28.04.2023
Impfdatum: 22.04.2023
Beginn: 22.04.2023
Tage bis Beginn: 0,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

Patient received Pfizer Bivalent booster shot on 4/22/23. The booster dose received was improperly stored. Vaccine had expired due to storage conditions on 1/27/23.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2619011

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CO
Alter: 63,0
Geschlecht: M
Eingang: 21.04.2023
Impfdatum: 29.12.2022
Beginn: 09.04.2023
Tage bis Beginn: 101,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough

Symptomtext

I flew out of town to see my new grandchild, I generally have a problem with the recirculated air on the plane. I chose not to wear a mask thinking I would be okay for the short flight. When I got home, I had a dry nonproductive cough. I did not go to the doctor as I know this is just what happens every time I am on a flight, it will go away with time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cough
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: Rheumatoid Arthritis
Andere Medikamente: Simvastatin
Allergien: Aspirin
Vorherige Impfungen: -

VAERS 2618014

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: IL
Alter: 64,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 06.01.2023
Beginn: 23.03.2023
Tage bis Beginn: 76,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

testing Positive on 23Mar2023; testing Positive on 23Mar2023; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 64-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Jan2023 as dose 5 (booster), single (Lot number: GJ6742) at the age of 64 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 08Apr2021 as dose 1, single (Lot number: ER8733), in right arm, on 29Apr2021 as dose 2, single (Lot number: EW0151), in left arm, on 13Oct2021 as dose 3 (booster), single (Lot number: FH8020), in left arm and on 15Jul2022 as dose 4 (booster), single (Lot number: FP7135), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "depression" (unspecified if ongoing); "Known allergies:shrimp" (unspecified if ongoing); "Known allergies: Iodine" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 23Mar2023, outcome "unknown" and all described as "testing Positive on 23Mar2023". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (23Mar2023) positive. Conclusion of Previously Completed Investigation: The complaint for lack of effect of the PFIZER-BIONTECH COVID-19 VACCINE lot GJ6742, FE3593, FH8020, EW0151, ER8733 was investigated. The investigation included a review of manufacturing and packaging records, deviations, and the complaint history for in scope lots. The final scope was determined to be the finished goods lot GJ6742, bulk and fill lots GJ6729, and GJ6736. The final scope was determined to be the reported finished goods lot FP7135, fill lot FP7126, and the bulk formulated drug product lot FP6245. The final scope was determined to be the reported finished goods lot FH8020, fill lot FG3521, and the bulk formulated drug product lot FH0137. The final scope was determined to be the reported finished goods lot EW0151, fill lot EP8691, and the formulated drug product lot EP8588. The final scope was determined to be the reported finished goods lot ER8733, fill lot EP8685, and the bulk formulated drug product EP8572. A complaint sample was not returned. No related quality issues were identified during the investigation. There is no impact on product quality. No root cause were identified as the complaint was not confirmed. All release testing performed prior to the release of the reported batch was within specifications.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230323; Test Name: home COVID test; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Asthma; Blood pressure high; Depression; Iodine allergy; Seafood allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2617987

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 11.10.2022
Beginn: 11.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective Interchange of vaccine products SARS-CoV-2 test

Symptomtext

Tested positive for COVID 15Apr; Tested positive for COVID 15Apr; Pfizer / Moderna Vaccine Bivalent; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 46 years intramuscular for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. No covid prior vaccination. covid tested post vaccination. No known allergies. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 11Oct2022, outcome "recovering", described as "Pfizer / Moderna Vaccine Bivalent"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 15Apr2023, outcome "recovering" and all described as "Tested positive for COVID 15Apr". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Apr2023) positive. Therapeutic measures were not taken as a result of drug ineffective, covid-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230415; Test Name: COVID; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2617987

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 11.10.2022
Beginn: 11.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective Interchange of vaccine products SARS-CoV-2 test

Symptomtext

Tested positive for COVID 15Apr; Tested positive for COVID 15Apr; Pfizer / Moderna Vaccine Bivalent; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 46 years intramuscular for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. No covid prior vaccination. covid tested post vaccination. No known allergies. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 11Oct2022, outcome "recovering", described as "Pfizer / Moderna Vaccine Bivalent"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 15Apr2023, outcome "recovering" and all described as "Tested positive for COVID 15Apr". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Apr2023) positive. Therapeutic measures were not taken as a result of drug ineffective, covid-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230415; Test Name: COVID; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2616865

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: TN
Alter: 69,0
Geschlecht: F
Eingang: 18.04.2023
Impfdatum: 09.12.2022
Beginn: 26.02.2023
Tage bis Beginn: 79,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

I called my doctor's office to let them know that I was positive, the office said I needed to come in to be seen. It was two days after I tested positive that I was able to be seen to get the antiviral. I was prescribed the LAGEVRIO, I did get over the virus in five days, I got rebound COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 27FEB2023 home COIVD-19 test positive; 03MAR2023 home COVID-19 test negative
Aktuelle Erkrankungen: No
Vorgeschichte: Chronic Kidney Disease Stage 3; Heart Failure
Andere Medikamente: ENTRESTO; furosemide; JARDIANCE; carvedilol; vitamin D; TYLENOL arthritis
Allergien: NEOSPORIN
Vorherige Impfungen: -

VAERS 2610656

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 100,0
Geschlecht: F
Eingang: 06.04.2023
Impfdatum: 09.01.2023
Beginn: 09.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

No ADR Bivalent dose administered prior to primary series given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2610651

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 06.04.2023
Impfdatum: 09.01.2023
Beginn: 09.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

No ADR Bivalent dose administered prior to primary series being administered

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2610149

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: WI
Alter: 68,0
Geschlecht: M
Eingang: 05.04.2023
Impfdatum: 27.12.2022
Beginn: 15.02.2023
Tage bis Beginn: 50,0
Dosis: 4
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chest X-ray normal Computerised tomogram head normal Computerised tomogram spine Fall Full blood count abnormal Head injury Hypoxia SARS-CoV-2 RNA SARS-CoV-2 test positive Skin abrasion White blood cell count increased

Symptomtext

2/15/2023: CLINICAL IMPRESSION: Fall, initial encounter Injury of head, initial encounter Hypoxia COVID-19 68-year-old male presents after unwitnessed fall, with abrasion over the right periorbital region. He is also hypoxic down to 86% on room air recently diagnosed with COVID. Given this he was given Decadron, supplemental nasal cannula oxygen with improvement in his oxygen saturations. He does not appear to be in any respiratory distress. His CBC does note a white count of 12.29 COVID-10 -will start remdesivir due to risk of progression Submitter does not have access to further medical records or information on hospital course. If further information is needed, please contact admitting hospital:

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 2/15/2023: SARS-CoV-2 RNA Resp Ql NAA+probe Detected CT of the head without acute intercranial process. CT Cspine and facial bones pending. Chest x-ray without acute cardiopulmonary process
Aktuelle Erkrankungen: unknown
Vorgeschichte: Problem List: Diagnosis Date Noted ? HTN (hypertension) 04/03/2021 ? Seizure disorder 04/03/2021 ? Early onset Alzheimer's dementia with behavioral disturbance 03/31/2021 Class: Psychiatric Past Medical History Past Medical History: Diagnosis Date ? Anxiety ? Arthritis ? Dementia ? GERD (gastroesophageal reflux disease) ? Hyperlipidemia ? Hypertension ? Seizures
Andere Medikamente: unknown
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2608302

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: KY
Alter: 68,0
Geschlecht: M
Eingang: 03.04.2023
Impfdatum: 23.02.2023
Beginn: 23.02.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Vaccine was given after the BUD date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Essential hypertension Hypercholesterolemia Bilateral carpal tunnel syndrome Psoriatic arthritis Macrocytosis without anemia
Vorgeschichte: Essential hypertension Hypercholesterolemia Bilateral carpal tunnel syndrome Psoriatic arthritis Macrocytosis without anemia
Andere Medikamente: Ferrous sulfate 325 Loratadine 10mg Melatonin 3mg SulfaSALAzine 500mg
Allergien: NONE
Vorherige Impfungen: -

VAERS 2606311

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: MA
Alter: 38,0
Geschlecht: F
Eingang: 30.03.2023
Impfdatum: 28.09.2022
Beginn: 23.03.2023
Tage bis Beginn: 176,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

Symptoms 3/23 = coughing, back ache, leg discomfort, sore throat, congestion, fatigue. Mild to moderate + 3/24; Symptoms 3/23 = coughing, back ache, leg discomfort, sore throat, congestion, fatigue. Mild to moderate. Home AG + 3/24; This is a spontaneous report received from a contactable reporter(s) (Nurse). A 38-year-old female patient (unknown if pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 4 (booster), sngle (Lot number: GJ6742) at the age of 38 years intramuscular, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), sngle (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 23Mar2023, outcome "recovering" and all described as "Symptoms 3/23 = coughing, back ache, leg discomfort, sore throat, congestion, fatigue. Mild to moderate.+ 3/24". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Mar2023) Positive. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on temporal relationship.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230324; Test Name: Nasal Swab; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2605654

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge gj6742

gering

Staat: NJ
Alter: 61,0
Geschlecht: F
Eingang: 29.03.2023
Impfdatum: 01.12.2021
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 62-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Dec2021 as dose 4 (booster), single (Lot number: gj6742) at the age of 61 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 23Feb2021 as dose 1, single (Lot number: el3247), in left arm, on 16Mar2021 as dose 2, single (Lot number: el3247), in left arm and on 03Dec2021 as dose 3 (booster), single (Lot number: fj8762), in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: Covid-19 Test; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: other medical history: No
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2603543

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: OH
Alter: 51,0
Geschlecht: F
Eingang: 24.03.2023
Impfdatum: 17.01.2023
Beginn: 17.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

No ADR. Bivalent booster administered as 1st dose in primary series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2603538

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: OH
Alter: 71,0
Geschlecht: F
Eingang: 24.03.2023
Impfdatum: 17.01.2023
Beginn: 17.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

No ADR Bivalent booster administered as 1st dose in primary series

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2602432

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MN
Alter: 50,0
Geschlecht: F
Eingang: 23.03.2023
Impfdatum: 03.01.2023
Beginn: 09.02.2023
Tage bis Beginn: 37,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anxiety Blood electrolytes normal Blood test normal Caffeine consumption Cardiac monitoring Cardiac stress test normal Cardiac telemetry abnormal Echocardiogram normal Electrocardiogram abnormal Exercise electrocardiogram abnormal Extrasystoles Stress Thyroid function test normal Ventricular extrasystoles

Symptomtext

Beginning on 02/09/2023, I started having skipped heart beats. They became more frequent that I decided to go to the ER on the morning of 02/14/2023. These skipped heart beats were becoming so frequent that I was becoming worried about arrhythmias or something else that could be wrong. I was seen in the ER and had some assessments done including an ECG. I was seen by the cardiologist on call for a consult in the ER. I was having PVCs. In addition to the ECG, they had me on a heart monitor in the ER and they also drew some blood for blood work to rule out any organic issues like an electrolyte imbalance that could cause this problem. They were able to rule out an electrolyte or thyroid imbalance. My PVCs were very frequent. They discharged me from the ER and had me on cardiac mobile telemetry for one week. When I was discharged, I also had a follow up echocardiogram and stress test as well. The cardiac stress test (exercise ECG) was fine and the echocardiogram - it was a transthoracic echocardiogram - and that was fine. It did not show any problems. I had another follow up visit with an internist as well. It was believed in the end that my PVCs were due to a combination of caffeine and stress. Eventually with my trying to be less stressed and stopped caffeine completely, the PVCs have disappeared. More or less I get them every now and then but they've gone down.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anxiety
Hospital-Tage: -
Labordaten: 14FEB2023 ECG indicated frequent PVCs; 14FEB2023 Heart Monitor (Cardiac Mobile Telemetry), frequent PVCs; 16FEB2023 Echocardiogram, normal; 20FEB2023 Stress test, normal; 14FEB2023 Blood work for Electrolytes and Thyroid, normal
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Iron; escitalopram; estradiol; progesterone; multivitamin
Allergien: CLORAZINE
Vorherige Impfungen: -

VAERS 2600179

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MI
Alter: 62,0
Geschlecht: M
Eingang: 21.03.2023
Impfdatum: 21.12.2022
Beginn: 21.03.2023
Tage bis Beginn: 90,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

covid vaccine breakthrough case; All Pfizer dose 1 3/24/21 ER8733; dose 2 4/22/21 EW0169; dose 3 4/8/22 FK9893.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 3/20/23 COVID+
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2600064

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 66,0
Geschlecht: F
Eingang: 21.03.2023
Impfdatum: 16.03.2023
Beginn: 16.03.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Bivalent COVID booster was given to patient that was beyond the use date of reconstitution (BUD was 3/15/23 @21:51 and patient received the booster on 3/16/23 @11:19). Informed patient we would not re-vaccinate and would call with further information. Patient did not have any adverse reaction and after further discussion with our drug information team, another dose will not be given to the patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599026

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 30,0
Geschlecht: F
Eingang: 18.03.2023
Impfdatum: 04.10.2022
Beginn: 13.03.2023
Tage bis Beginn: 160,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

Drug ineffective; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). A 30-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 30 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: INFLUENZA VACCINE taken for influenza immunisation as dose number unknown, single (seqirus). The following information was reported: COVID-19 (medically significant) with onset 13Mar2023, outcome "unknown"; DRUG INEFFECTIVE (medically significant) with onset 13Mar2023, outcome "unknown". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Mar2023) Positive, notes: Nasal Swab. Clinical course: Patient received vaccine at Workplace clinic. Viral sx cough rhinorrhea HA body aches mild 13Mar2023. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on available information, a possible contributory role of the subject vaccine cannot be excluded for suspected LOE. There is limited information provided in this report. This case will be reassessed upon receipt of follow-up information.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230315; Test Name: COVID-19 Home Ag Test; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: INFLUENZA VACCINE
Allergien: -
Vorherige Impfungen: -

VAERS 2598163

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: PA
Alter: 48,0
Geschlecht: F
Eingang: 17.03.2023
Impfdatum: 10.11.2022
Beginn: 10.03.2023
Tage bis Beginn: 120,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

Breakthrough COVID-19 infection; positive COVID-19 test on 10Mar2023; Breakthrough COVID-19 infection; positive COVID-19 test on 10Mar2023; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from product quality group. The reporter is the patient. A 49-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Nov2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 48 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hashimoto's" (unspecified if ongoing). Concomitant medication(s) included: SYNTHYROID; MELATONIN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 10Mar2023, outcome "unknown" and all described as "Breakthrough COVID-19 infection; positive COVID-19 test on 10Mar2023". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10Mar2023) Positive. Therapeutic measures were not taken as a result of drug ineffective, covid-19. Clinical course: It was reported that the patient has no Known allergies. Facility type vaccine: Workplace clinic. Patient had not received any other vaccine in four weeks. Patient had no covid prior vaccination. If Patient was tested covid positive post vaccination.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events Drug ineffective and Covid-19 and the use of suspect product BNT162B2, BNT162B2 OMI BA.4-5 cannot be fully excluded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230310; Test Name: Nasal Swab; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hashimoto's disease
Andere Medikamente: SYNTHYROID; MELATONIN
Allergien: -
Vorherige Impfungen: -

VAERS 2598146

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 36,0
Geschlecht: F
Eingang: 17.03.2023
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective Interchange of vaccine products SARS-CoV-2 test

Symptomtext

Sx of cough on 07Mar then COVID positive test on 09Mar2023; Sx of cough on 07Mar then COVID positive test on 09Mar2023; Moderna, Dose Number: 1, 2, 3 / Pfizer, Dose Number: 4; This is a spontaneous report received from a non-contactable reporter (nurse). A 36-year-old female patient (not pregnant) received BNT162b2, BNT162b2 OMI BA.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Sep2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 36 years intramuscular for COVID-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 09Jan2021 as dose 1, single (Lot number: 011J20A), on 01Feb2021 as dose 2, single (Lot number: 028L20A) and on 05Nov2021 as dose 3 (booster), single (Lot number: 032F21A) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 30Sep2022, outcome "unknown", described as "Moderna, Dose Number: 1, 2, 3 / Pfizer, Dose Number: 4"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 07Mar2023, outcome "recovering" and all described as "Sx of cough on 07Mar then COVID positive test on 09Mar2023". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Mar2023) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of drug ineffective, COVID-19. Clinical course: The patient has no COVID prior to vaccination. No follow-up attempts are possible. No further information is expected.; Sender's Comments: A causal relationship to the suspect drugs cannot be excluded for events drug ineffective, COVID-19, and interchange of vaccine product. This case will be reassessed upon receipt of additional information.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230309; Test Name: COVID test (Home Ag); Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2597967

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: MO
Alter: 50,0
Geschlecht: F
Eingang: 16.03.2023
Impfdatum: 09.12.2022
Beginn: 01.01.2023
Tage bis Beginn: 23,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

SARS-CoV-2 test negative Sinusitis

Symptomtext

12/09/2023 I started feeling symptoms of a Sinus Infection. I went to Urgent Care and was prescribed antibiotics, nasal spray and Sudafed for 10 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: SARS-CoV-2 test negative
Hospital-Tage: -
Labordaten: 12/09/2023 COVID-19 - negative
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroidism
Andere Medikamente: None
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2596888

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: ND
Alter: 32,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 09.10.2022
Beginn: 10.02.2023
Tage bis Beginn: 124,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Eye irritation Eye swelling Hordeolum Ocular hyperaemia Tenderness

Symptomtext

I developed a Stye in my left eye and it kept getting worse. It was very red, tender, swelling, and my eye itself was very red and irritated. I went to the walk-in clinic and was prescribed Polymyxin B Sulfate Trimethoprim Ophthalmic Solution. I used the medication and the Stye is gone now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Eye irritation
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Prenatal Vitamin; Flonase; Metformin
Allergien: Cefaclor
Vorherige Impfungen: -

VAERS 2596135

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CO
Alter: 33,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 03.03.2023
Beginn: 03.03.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered No adverse event

Symptomtext

No adverse event occured. Administered expired vaccine on 03/03/2023. Vaccine expired on 03/02/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/a
Vorgeschichte: N/A
Andere Medikamente: N/a
Allergien: N/a
Vorherige Impfungen: -

VAERS 2595050

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 85,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 05.01.2023
Beginn: 05.01.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Localised infection

Symptomtext

The patient called on 03/05/2023 saying she got a vaccine at rite aid on 01/05/2023 and caused an infection at her left arm. She thought it would get better but it did not, She sought medical treatment on 03/09/2023. According to the patient, the doctor diagnosed her arm as being infected and prescribed antibiotic.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Localised infection
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2592730

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CA
Alter: 61,0
Geschlecht: F
Eingang: 08.03.2023
Impfdatum: 14.01.2023
Beginn: 28.02.2023
Tage bis Beginn: 45,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test Weight

Symptomtext

covid; covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group, Program ID. The reporter is the patient. A 61-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Jan2023 as dose 5 (booster), single (Lot number: GJ6742) at the age of 61 years, in arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 03Feb2021 as dose 1, single (Lot number: EN6203), in arm, on 24Mar2021 as dose 2, single (Lot number: ER8733), in arm, on 06Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown), in arm and on 17Jun2022 as dose 4 (booster), single (Lot number: FJ4991), in arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes", start date: 2008 (ongoing), notes: Diagnosed in 2008 after hysterectomy; "hysterectomy" (unspecified if ongoing), notes: Diagnosed in 2008 after hysterectomy. Concomitant medication(s) included: INSULIN taken for type 2 diabetes mellitus (ongoing). She rarely takes medication, but does take Insulin 70/30 everyday. They put her on a keto diet recently. she has been on insulin a long time. The patient called because she wanted to report after getting the five Covid vaccines from Pfizer she got Covid this week. The first vaccine was in Feb2021 and then the last was on 14Jan2023. She never had Covid before. Her first Covid vaccine was in Feb2021, the second in Mar2021, the third was in Nov2021, the fourth was in Jun2022, and the last one was Jan of this year (2023). She took two different home test that said, she was positive. She went to a local walk in and thought about checking in to get the medication to shorten it. Her husband got sick first, but he only had four Covid shots. She thinks her husband brought Covid to her after a trip to. Her husband got "pissy," and wouldn't wait at the clinic, so they didn't get Paxlovid. She doesn't feel that sick. Feels like a bad cold. She coughs a lot. If she lays down, she coughs more. She is taking Alka-Seltzer Plus Cold during the day and Nyquil at night. She has also taken Sudafed once a day for the past two days. She is not falling down dead, but doesn't feel particular great. She clarified that her symptoms started Tuesday, 28Feb2023, but she tested positive for Covid on 02Mar2023. She weighs 170-175 pounds right now (2023). The patient had not recovered from COVID at the time of report. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300094238 similar report from same reporter;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 2023; Test Name: Covid home test; Test Result: Positive ; Comments: She took two different home test that said she was positive; Test Date: 2023; Test Name: Covid home test; Test Result: Positive ; Comments: She took two different home test that said she was positive; Test Date: 20230302; Test Name: Covid home test; Test Result: Positive ; Comments: Result: Positive; Unit: Not Provided; Test Date: 2023; Test Name: weight; Result Unstructured Data: Test Result:170-175 lbs; Comments: 170-175 pounds right now
Aktuelle Erkrankungen: Type 2 diabetes mellitus (Diagnosed in 2008 after hysterectomy)
Vorgeschichte: Medical History/Concurrent Conditions: Hysterectomy (Diagnosed in 2008 after hysterectomy)
Andere Medikamente: INSULIN
Allergien: -
Vorherige Impfungen: -

VAERS 2592512

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 46,0
Geschlecht: M
Eingang: 07.03.2023
Impfdatum: 08.12.2022
Beginn: 07.02.2023
Tage bis Beginn: 61,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Retinopexy Vitreous detachment

Symptomtext

S/p pneumatic retinopexy right eye C3F8 (2/14/23) OD CSR

Weitere VAERSDATA-Felder

Praegender Schweregrund: Retinopexy
Hospital-Tage: -
Labordaten: Fundus exam/ Posterior segment: OD: Discs: 0.3 C/D. Macula: central RPE mottling Periphery: horseshoe tear at 11:30 well treated with cryo. RPE atrophic patch inferiorly. Infratemporally patch. previous tr subretinal fluid from 2:30 to 4:30 resolved. No obvious new break seen. 360 scleral depression exam done Vessels: ok Vitreous: posterior vitreous detachment with debris, 25% gas bubble
Aktuelle Erkrankungen: ANXIETY, HYPERLIPIDEMIA (HIGH BLOOD FATS), SLEEP APNEA DISORDER, ASTHMA, HISTORY OF SMOKING, GERD (GASTRO-ESOPHAGEAL REFLUX DISEASE) (HEARTBURN), BILIARY COLIC, RIGHT CATARACT, RIGHT CENTRAL SEROUS CHOROIDOPATHY
Vorgeschichte: ANXIETY, HYPERLIPIDEMIA (HIGH BLOOD FATS), SLEEP APNEA DISORDER, ASTHMA, HISTORY OF SMOKING, GERD (GASTRO-ESOPHAGEAL REFLUX DISEASE) (HEARTBURN), BILIARY COLIC, RIGHT CATARACT, RIGHT CENTRAL SEROUS CHOROIDOPATHY
Andere Medikamente: NRT (Nicotine Patch), multi-vitamin.
Allergien: Bupropion, Montelukast Sodium, Ciclesonide
Vorherige Impfungen: -

VAERS 2592398

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: MI
Alter: 37,0
Geschlecht: M
Eingang: 07.03.2023
Impfdatum: 24.02.2023
Beginn: 24.02.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

PATIENT RECEIVED HIS 1ST PRIMARY DOSE OF PFIZER AS THE BI-VALENT, INSTEAD OF THE MONO-VALENT

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2591842

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 78,0
Geschlecht: M
Eingang: 06.03.2023
Impfdatum: 03.02.2022
Beginn: 25.02.2023
Tage bis Beginn: 387,0
Dosis: 6
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Exposure to SARS-CoV-2 Nasal congestion SARS-CoV-2 test positive

Symptomtext

I tested positive for COVID-19. The people in my home had already tested positive. I just thought to test myself at home. Afterwards I had no symptoms at the time. Later on, I did have a stuffy nose. I had a mild case. I feel I was asymptomatic. My doctor prescribed a treatment, but I was not sick enough, I felt to get the treatment. I still have the stuffy nose and other that I am fine. I am still doing normal exercise and activities. It almost it didn't happen any how. I'm pretty sure I still have that.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Bronchitis
Vorgeschichte: AFib
Andere Medikamente: XARELTO; tamsulosin; irbesartan; hydrochlorothiazide
Allergien: N/A
Vorherige Impfungen: -

VAERS 2589580

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: UT
Alter: 25,0
Geschlecht: F
Eingang: 01.03.2023
Impfdatum: 14.02.2023
Beginn: 14.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2589578

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: UT
Alter: 30,0
Geschlecht: M
Eingang: 01.03.2023
Impfdatum: 09.02.2023
Beginn: 09.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2589299

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: UT
Alter: 22,0
Geschlecht: F
Eingang: 01.03.2023
Impfdatum: 09.02.2023
Beginn: 09.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Error: Expired Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2588114

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 24,0
Geschlecht: M
Eingang: 28.02.2023
Impfdatum: 25.10.2022
Beginn: 17.02.2023
Tage bis Beginn: 115,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

Sore Throat started 17Feb2023 then _ AG on 18Feb + rhinorrhea/Covid-19 Ag Test: positive; Sore Throat started 17Feb2023 then _ AG on 18Feb + rhinorrhea/Covid-19 Ag Test: positive; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). A 25-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 24 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine inact split 4v (QUADRIVALENT INFLUENZA VACCINE), on 25Oct2022 as dose number unknown, single (Lot number: 942381) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 17Feb2023, outcome "recovering" and all described as "Sore Throat started 17Feb2023 then _ AG on 18Feb + rhinorrhea/Covid-19 Ag Test: positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (17Feb2023) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19. It was unknown whether the patient was diagnosed as COVID-19 prior to vaccination. Since the vaccination, the patient had been tested for COVID-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: The efficacy of a vaccine varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine product BNT162B2 to the reported events drug ineffective and COVID-19 cannot be ruled out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230217; Test Name: Covid-19 Ag Test; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2588135

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: PA
Alter: 74,0
Geschlecht: F
Eingang: 27.02.2023
Impfdatum: 01.02.2023
Beginn: 08.01.2023
Tage bis Beginn: -
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bacterial test negative Conjunctival oedema Ocular hyperaemia Swelling of eyelid

Symptomtext

Swollen eye lids, red eyes. Worse on right side. Diagnosis was chemosis . Treated with antibiotics, steroids, antihistamine, compresses and it still continues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bacterial test negative
Hospital-Tage: -
Labordaten: Swabs for bacteria have all been negative from the most recent Dr.s visit. But this was after the initial round of antibiotic/ steroid eye drops
Aktuelle Erkrankungen: None
Vorgeschichte: Hashimoto?s,
Andere Medikamente: Lipitor, arimidex, losartan,,amlodopine, synthroid
Allergien: -
Vorherige Impfungen: -

VAERS 2587383

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: GA
Alter: 30,0
Geschlecht: F
Eingang: 26.02.2023
Impfdatum: 30.01.2023
Beginn: 30.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Wrong dose was given. Patient has not received initial Pfizer vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2587304

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 47,0
Geschlecht: F
Eingang: 25.02.2023
Impfdatum: 16.02.2023
Beginn: 16.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Pfizer bivalent booster dose was given past the BUD of 2/14/23. The vaccine was given on 2/16/23- no adverse reaction reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2587248

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge Gj6742

gering

Staat: -
Alter: 33,0
Geschlecht: F
Eingang: 25.02.2023
Impfdatum: 28.09.2022
Beginn: 16.02.2023
Tage bis Beginn: 141,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asymptomatic COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

she had no symptoms but tested positive; she had no symptoms but tested positive; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). A 33-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 4 (booster), single (Lot number: Gj6742) at the age of 33 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 26Jan2021 as dose 1, single (Lot number: EL3247), on 16Feb2021 as dose 2, single (Lot number: EL3247) and as dose 3 (booster), single (Lot number: FF2589) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), ASYMPTOMATIC COVID-19 (medically significant) all with onset 16Feb2023, outcome "recovering" and all described as "she had no symptoms but tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16Feb2023) Positive, notes: post vaccination. There was no other vaccine in four weeks. Child with COVID first then she had no symptoms but tested positive 16Feb2023 PM. It was unknown if therapeutic measures were taken as a result of drug ineffective, asymptomatic covid-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Asymptomatic COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230216; Test Name: Ag Covid test/Nasal Swab; Test Result: Positive ; Comments: post vaccination
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2586888

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: TX
Alter: 89,0
Geschlecht: M
Eingang: 24.02.2023
Impfdatum: 01.02.2023
Beginn: 01.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Underdose

Symptomtext

injected 0.2 ml of Pfizer Bivalent instead of 0.3 ml. Patient has not had any adverse reactions or events due to this immunization.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: urinary incontinence.
Vorgeschichte: Prostate Cancer Diabetes Mellitus Type 2 CAD - Coronary Artery Disease HTN - Hypertension Urinary Incontinence GERD - Gastro-Esophageal Reflux Sensorineural Hearing Loss, Bilater
Andere Medikamente: 1) AMLODIPINE BESYLATE TAB 2.5MG 2.5MG MOUTH ACTIVE EVERY DAY 2) CHOLECALCIF 10MCG (D3-400UNIT) TAB 10MCG MOUTH ACTIVE EVERY DAY 3) HYDROCHLOROTHIAZIDE 25MG TAB 12.5MG MOUTH ACTIVE EVERY
Allergien: asa- hives
Vorherige Impfungen: -

VAERS 2586398

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 37,0
Geschlecht: F
Eingang: 23.02.2023
Impfdatum: 13.01.2023
Beginn: 13.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered

Symptomtext

Patient had never received covid-19 vaccines before, and received Pfizer bivalent booster vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2586369

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IN
Alter: 12,0
Geschlecht: F
Eingang: 23.02.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event

Symptomtext

No known adverse effects, treatment, or outcomes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No known illnesses.
Vorgeschichte: Celiac Disease and Lactose intolerance
Andere Medikamente: Patient takes Azstarys 39.2-7.8 mg everyday. Patient also takes Prilosec, Aldara cream, FloNase, and Zyrtec PRN.
Allergien: Allergies include Gluten and Lactose.
Vorherige Impfungen: -

VAERS 2586364

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IN
Alter: 12,0
Geschlecht: M
Eingang: 23.02.2023
Impfdatum: 16.02.2023
Beginn: 16.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event

Symptomtext

No known adverse effects, treatment, or outcomes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No known illnesses.
Vorgeschichte: Mild intermittent Asthma
Andere Medikamente: Patient is taking Tretinoin cream, FloNase, albuterol inhaler, and Zyrtec all PRN.
Allergien: No known allergies listed in chart.
Vorherige Impfungen: -

VAERS 2586361

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IN
Alter: 12,0
Geschlecht: M
Eingang: 23.02.2023
Impfdatum: 14.02.2023
Beginn: 14.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event

Symptomtext

No known adverse effects, treatment, or outcomes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No known illnesses at the time of vaccination.
Vorgeschichte: Asthma, mild intermittent
Andere Medikamente: Patient takes Concerta 27 mg every day. PRN Medications include: Albuterol inhaler, Proventil, Flo Nase, and Melatonin.
Allergien: No known allergies are listed on patients chart.
Vorherige Impfungen: -

VAERS 2585079

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: WA
Alter: 66,0
Geschlecht: F
Eingang: 21.02.2023
Impfdatum: 21.02.2023
Beginn: 21.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product use issue

Symptomtext

Vaccine out of BUD date (2/16/23) was administered on 2/20/23 to patient. Vaccine was in the refrigerator which was not taken out of the fridge on 2/16/23. According to Pfizer, we should reach out to patient for readministration of the vaccine for full protection, and have patients report any side effects

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N?A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2585078

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: WA
Alter: 70,0
Geschlecht: M
Eingang: 21.02.2023
Impfdatum: 20.02.2023
Beginn: 20.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product use issue

Symptomtext

Vaccine out of BUD date (2/16/23) was administered on 2/20/23 to patient. Vaccine was in the refrigerator which was not taken out of the fridge on 2/16/23. According to Pfizer, we should reach out to patient for readministration of the vaccine for full protection, and have patients report any side effects

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2585075

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: WA
Alter: 71,0
Geschlecht: F
Eingang: 21.02.2023
Impfdatum: 20.02.2023
Beginn: 20.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product use issue

Symptomtext

Vaccine out of BUD date (2/16/23) was administered on 2/20/23 to patient. Vaccine was in the refrigerator which was not taken out of the fridge on 2/16/23. According to Pfizer, we should reach out to patient for readministration of the vaccine for full protection, and have patients report any side effects

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2585073

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge GJ6742

gering

Staat: WA
Alter: 25,0
Geschlecht: F
Eingang: 21.02.2023
Impfdatum: 20.02.2023
Beginn: 20.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

Pfizer bivalent vaccine was expired on 2/16/23 (that were remaining in the refrigerator), and was accidently administered to patient on 2/21/23. According to Pfizer, patient would need to be readministered for an additional dose for full protection, and for patient to report any side effects if any.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2585072

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: WA
Alter: 31,0
Geschlecht: F
Eingang: 21.02.2023
Impfdatum: 21.02.2023
Beginn: 21.02.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Pfizer bivalent vaccine was expired on 2/16/23 (that were remaining in the refrigerator), and was accidently administered to patient on 2/21/23. According to Pfizer, patient would need to be readministered for an additional dose for full protection, and for patient to report any side effects if any.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2584346

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IL
Alter: 17,0
Geschlecht: F
Eingang: 20.02.2023
Impfdatum: 16.01.2023
Beginn: 16.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered No adverse event

Symptomtext

No adverse effects. The patient was given the pfizer bivalent covid 19 vaccine erroneously as the first dose of the covid19 vaccine series instead of a monovalent vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: N.K.D.A
Vorherige Impfungen: -

VAERS 2584050

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: TX
Alter: 81,0
Geschlecht: M
Eingang: 19.02.2023
Impfdatum: 16.02.2023
Beginn: 01.02.2023
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Patient received bivalent covid-19 vaccine after the beyond use date of the lot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2583560

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 34,0
Geschlecht: M
Eingang: 17.02.2023
Impfdatum: 14.02.2023
Beginn: 14.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

VACCINE ADMINISTERED ONE DAY AFTER THE BEYOND EXPIRATION DATE OF 12/13/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2582633

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 43,0
Geschlecht: F
Eingang: 16.02.2023
Impfdatum: 27.10.2022
Beginn: 10.02.2023
Tage bis Beginn: 106,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

ag test 10Feb2023; ag test 10Feb2023; This is a spontaneous report received from a non-contactable reporter(s) (Nurse) from product quality group. A 43-year-old female patient (unknown if pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 43 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 10Feb2023, outcome "recovering" and all described as "ag test 10Feb2023". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10Feb2023) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Considering a plausible drug-event temporal association, a reasonable possibility that the events drug ineffective and Covid-19 are related to BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5) cannot be excluded. This case will be reassessed should additional information become available.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230210; Test Name: Home Ag; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2582341

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: PA
Alter: 64,0
Geschlecht: M
Eingang: 15.02.2023
Impfdatum: 28.12.2022
Beginn: 03.01.2023
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Electrocardiogram Extrasystoles Stress echocardiogram Supraventricular extrasystoles

Symptomtext

Skipped heart beats determined to be premature atrial contractions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electrocardiogram
Hospital-Tage: -
Labordaten: EKG, Stress Echo
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic Kidney Disease
Andere Medikamente: Valsartan
Allergien: Penicillin; CECLOR; BACTRIM
Vorherige Impfungen: -

VAERS 2582276

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: WA
Alter: 74,0
Geschlecht: M
Eingang: 15.02.2023
Impfdatum: 10.02.2023
Beginn: 10.02.2023
Tage bis Beginn: 0,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered No adverse event Product administration error

Symptomtext

Patient's EHR showed that he was due for a bivalent covid vaccine, and even after the state vaccine database, no records showed until after the vaccine had been given. In other words, patient received an errant bivalent booster, as he had already had a bivalent booster in October. Patient also did not remember receiving one in October. Patient was notified of the error and it was documented in EHR appropriately. No adverse event reported for patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2581128

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 31,0
Geschlecht: M
Eingang: 14.02.2023
Impfdatum: 18.10.2022
Beginn: 01.06.2022
Tage bis Beginn: -
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective Interchange of vaccine products SARS-CoV-2 test

Symptomtext

she tested positive; she tested positive; Moderna Dose Number: 4 ... Pfizer Dose Number 3; This is a spontaneous report received from a non-contactable reporter(s) (Nurse) from product quality group. A 31-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Oct2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 31 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 26Jan2021 as dose 1, single (Lot number: EL3247), on 16Feb2021 as dose 2, single (Lot number: EL3247) and on 08Oct2021 as dose 3 (booster), single (Lot number: FF2589) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), in Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Exposed to COVID-19", start date: 2023 (unspecified if ongoing), notes: exposed the week before she tested positive. The patient took concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset Jun2022, outcome "unknown", described as "Moderna Dose Number: 4 ... Pfizer Dose Number 3"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 07Feb2023, outcome "unknown" and all described as "she tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Feb2023) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of interchange of vaccine products, drug ineffective, covid-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events interchange of vaccine products, drug ineffective, covid-19 and BNT162B2.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230207; Test Name: Ag; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Exposure to SARS-CoV-2 (exposed the week before she tested positive)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2581126

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 14.02.2023
Impfdatum: 04.10.2022
Beginn: 06.02.2023
Tage bis Beginn: 125,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

Home Ag (Nasal Swab): Positive; Home Ag (Nasal Swab): Positive; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). A 46-year-old female patient (unknown if pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 46 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 06Feb2023, outcome "unknown" and all described as "Home Ag (Nasal Swab): Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (06Feb2023) Positive. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information : Covid test type post vaccination: Nasal Swab (Home Ag) and was positive. No follow-up attempts are possible. No further information is expected.; Sender's Comments: The reported COVID-19 positive after BNT162b2, BNT162b2 omi ba.4-5 immunization is considered ineffective of suspect, and the Company cannot completely exclude the possible causality between the reported events and BNT162b2, BNT162b2 omi ba.4-5 administration.,Linked Report(s) : US-PFIZER INC-202300060734 same patient different dose/drug/event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230206; Test Name: Home Ag (Nasal Swab); Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2581084

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 42,0
Geschlecht: M
Eingang: 14.02.2023
Impfdatum: 28.09.2022
Beginn: 04.02.2023
Tage bis Beginn: 129,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

got COVID; got COVID; This is a spontaneous report received from a non-contactable reporter(s) (Nurse) from product quality group. A 43-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 42 years intramuscular, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 04Feb2023, outcome "not recovered" and all described as "got COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Feb2023) Negative, notes: Nasal Swab; (04Feb2023) Positive, notes: Nasal Swab; (05Feb2023) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported event drug ineffective and COVID-19 cannot be ruled out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230202; Test Name: Home Ag; Test Result: Negative ; Comments: Nasal Swab; Test Date: 20230204; Test Name: Home Ag; Test Result: Positive ; Comments: Nasal Swab; Test Date: 20230205; Test Name: Home Ag; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2580474

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: SC
Alter: 20,0
Geschlecht: F
Eingang: 13.02.2023
Impfdatum: 14.01.2023
Beginn: 14.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

This was the patients first dose in the primary series. Patient was suppose to receive the monovalent pfizer vaccine but received the bivalent instead.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578847

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IN
Alter: 45,0
Geschlecht: F
Eingang: 09.02.2023
Impfdatum: 09.02.2023
Beginn: 09.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

The medication/ vaccine was expired at the time of administration, We discovered this after the patient had left.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: hypertension, PCOS, high cholesterol, obesity and scoliosis
Andere Medikamente: COVID -19 vaccine
Allergien: cephalexin
Vorherige Impfungen: -

VAERS 2578594

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CT
Alter: 77,0
Geschlecht: M
Eingang: 09.02.2023
Impfdatum: 10.01.2023
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tinnitus

Symptomtext

Tinnitus; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 77-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Jan2023 as dose 4 (booster), single (Lot number: GJ6742) at the age of 77 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (dose 1, single, Lot: EL3249), administration date: 23Jan2021, when the patient was 75-year-old, for COVID-19 Immunization; BNT162b2 (dose 2, single, Lot: EN6201), administration date: 13Feb2021, when the patient was 75-year-old, for COVID-19 Immunization; BNT162b2 (dose 3 (booster), single, Lot: FE3592), administration date: 23Oct2021, when the patient was 76-year-old, for COVID-19 Immunization, reaction(s): "Tinnitus". The following information was reported: TINNITUS (non-serious), outcome "not recovered". Additional information: The patient received his 3rd dose of the Pfizer Covid vaccine, which was his first booster dose on 23Oct2021, and 3-5 days later he got tinnitus in both ears. He has spoken to his primary care doctor, and even had another booster dose on 10Jan2023 (Lot: GJ6742). He spoke to a hearing doctor but nobody seemed to care or saying anything about it. He stated the side effects were on the news all the time and a doctor mentioned that tinnitus could be a side effect of the vaccine. He saw the hearing doctor shortly after the tinnitus began and was told that other veterans have complained about it as well. The hearing doctor sent him home with a music machine to use for the tinnitus. The patient clarified that the doctor told him that other people said that they got tinnitus after getting the vaccine but did not know what manufacturer's product those other patients received. The patient did not have other vaccinations within four weeks prior to the first administration date of the suspect vaccine and did not have family medical history relevant to the adverse events; Sender's Comments: Linked Report(s): PFIZER INC-202300056289 Same patient/drug/event, different doses.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tinnitus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578116

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: CA
Alter: 26,0
Geschlecht: M
Eingang: 08.02.2023
Impfdatum: 16.12.2022
Beginn: 07.02.2023
Tage bis Beginn: 53,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Vaccination error

Symptomtext

Patient received Pfizer Covid Bivalent in error based on the information provided by the patient at the time of the vaccine. Patient stated that he had received J&J as his primary series and was due for the bivalent. Website was down or pharmacy was having browser problems that evening. Patient was very adament that he was due for a bivalent vaccine. Error was caught when patient came back to the pharmacy insisting on another vaccine shot. Based on this information, I reported this error to VAERS and am not giving the patient another vaccine until clarification from my supervisor. Patient has no adverse reactions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578004

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MN
Alter: 71,0
Geschlecht: M
Eingang: 08.02.2023
Impfdatum: 29.12.2022
Beginn: 30.01.2023
Tage bis Beginn: 32,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Unevaluable event

Symptomtext

Transfer from facility to facility. Treatment includes therapy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes, HTN, CKD stg 2, Afib
Andere Medikamente: -
Allergien: PCN, Conray
Vorherige Impfungen: -

VAERS 2575892

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 30,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 04.02.2023
Beginn: 04.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered No adverse event

Symptomtext

No adverse event patient was given a second dose of Pfizer Bivalent.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2570490

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 66,0
Geschlecht: M
Eingang: 30.01.2023
Impfdatum: 14.01.2023
Beginn: 14.01.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

Error: Dose in Series Given Too Early-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2569413

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: GA
Alter: 70,0
Geschlecht: F
Eingang: 27.01.2023
Impfdatum: 06.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 2,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation Electrocardiogram ambulatory abnormal Heart rate increased Heart rate irregular

Symptomtext

Irregular heartbeat, fast pulse, several instances of A-fib

Weitere VAERSDATA-Felder

Praegender Schweregrund: Atrial fibrillation
Hospital-Tage: -
Labordaten: Heart monitor worn for one week - during that time one incident of A-fib recorded. Several observed by self following removal of heart monitor. Incidents seemed to have stopped around 1/2/23
Aktuelle Erkrankungen: Cold
Vorgeschichte: None
Andere Medikamente: Claritin, Metroprolol Tartrate
Allergien: None
Vorherige Impfungen: -

VAERS 2568832

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: VA
Alter: 23,0
Geschlecht: M
Eingang: 26.01.2023
Impfdatum: 23.01.2023
Beginn: 23.01.2023
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered No adverse event

Symptomtext

PATIENT CAME IN FOR A COVID PRIMARY SECOND DOSE MONOVALENT AND RECEIVED BIVALENT VACCINE BY MISTAKE. PATIENT DIDN'T STATE ANY ADVERSE SYMPTOMS AND CAME BACK IN THE NEXT DAY TO FOLLOW UP ON THE INCIDENT AND ALSO DIDN'T STATE ANY ADVERSE SYMPTOMS. WE HAD CALLED PFIZER AND CDC TO VERIFY OUR NEXT STEPS AND THEY RECOMMENDED NOT NEEDING TO BE REVACCINATED AND BIVALENT CAN COUNT AS A FULL 30 MCG DOSE AND TO CONTINUE REGULAR VACCINE SCHEDULE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568818

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 75,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 08.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 19,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568811

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 69,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 15.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 12,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Adulterated product No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Adulterated product
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568809

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 32,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 14.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 13,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperate excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568807

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 90,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 13.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 14,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568806

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 33,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 12.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 15,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568805

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 38,0
Geschlecht: M
Eingang: 26.01.2023
Impfdatum: 12.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 15,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Adulterated product No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Adulterated product
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568801

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 34,0
Geschlecht: M
Eingang: 26.01.2023
Impfdatum: 12.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 15,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568798

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge gj6742

gering

Staat: IN
Alter: 59,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 12.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 15,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568797

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 69,0
Geschlecht: M
Eingang: 26.01.2023
Impfdatum: 09.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 18,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Adulterated product No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Adulterated product
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568795

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 23,0
Geschlecht: M
Eingang: 26.01.2023
Impfdatum: 09.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 18,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568794

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 51,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 08.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 19,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

Vaccine adulterated due to temperature excursion. No adverse events experienced/reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567814

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 66,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 15.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 12,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Poor quality product administered Product storage error

Symptomtext

Vaccine adulterated due to excursion in temperature

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567810

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: IN
Alter: 66,0
Geschlecht: F
Eingang: 25.01.2023
Impfdatum: 15.12.2022
Beginn: 27.12.2022
Tage bis Beginn: 12,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Poor quality product administered Product storage error

Symptomtext

Vaccine adulterated due to excursion in temperature.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567620

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: OH
Alter: 70,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 13.12.2022
Beginn: 18.01.2023
Tage bis Beginn: 36,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood potassium increased Blood test

Symptomtext

I had my annual blood panel completed and the results of the blood test showed the deficiency. My potassium was high. It's never been high. I contracted COVID-19 on September 5th which required me to delay my 5th dose of the booster. In January my potassium was like 5.5 so my doctor wanted me to go back and have my blood retested. The next day it went from 5.5 to 6. The doctor prescribed 20 mg of LASIX once a day. I started the medication on Friday. Monday I had my blood tested again and the potassium level was at 4.7. I do still have follow up appointments to address this. I feel that a large portion of the problem was my diet but I won't know if that's true until I get another blood test.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood potassium increased
Hospital-Tage: -
Labordaten: Blood panel 01/18/2023 potassium 5.5, Blood panel 01/19/2023 potassium 6.0, Blood panel 01/23/2023 potassium 4.7
Aktuelle Erkrankungen: N/A
Vorgeschichte: Pseudo Colon Esterase Deficiency; High Blood Pressure; Coronary Artery Disease
Andere Medikamente: Meloxicam; FLOMAX; LIPITOR; spironolactone; aspirin; BYSTOLIC; multivitamin; coQ10; turmeric
Allergien: Caine drugs
Vorherige Impfungen: -

VAERS 2566273

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge gj6742

gering

Staat: MA
Alter: 49,0
Geschlecht: M
Eingang: 24.01.2023
Impfdatum: 27.10.2022
Beginn: 18.01.2023
Tage bis Beginn: 83,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective Nasopharyngeal swab

Symptomtext

Covid - AG + test 18Jan; Covid - AG + test 18Jan; This is a spontaneous report received from a contactable reporter(s) (Nurse). A 50-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Oct2022 as dose 4 (booster), single (Lot number: gj6742) at the age of 49 years intramuscular, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 18Jan2023, outcome "recovering" and all described as "Covid - AG + test 18Jan". The patient underwent the following laboratory tests and procedures: Nasopharyngeal swab: (18Jan2023) Positive. Therapeutic measures were not taken as a result of drug ineffective, covid-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information given in narrative, the causal relationship between the reported events drug ineffective/COVID 19 and the suspect drug BNT162B2 cannot be excluded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230118; Test Name: Nasal Swab; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565766

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: KS
Alter: 72,0
Geschlecht: M
Eingang: 23.01.2023
Impfdatum: 23.01.2023
Beginn: 23.01.2023
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered

Symptomtext

non-approved administration of a booster dose of the covid bi-valent vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565189

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IL
Alter: 28,0
Geschlecht: F
Eingang: 22.01.2023
Impfdatum: 19.01.2023
Beginn: 19.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

The patient was given a COVID Pfizer Bivalent vaccine as a first dose of the primary series instead of a monovalent COVID vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565477

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IN
Alter: 15,0
Geschlecht: M
Eingang: 20.01.2023
Impfdatum: 18.01.2023
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

No adverse events to report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2563939

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: NY
Alter: 23,0
Geschlecht: M
Eingang: 19.01.2023
Impfdatum: 19.01.2023
Beginn: 19.01.2023
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

ptient was given pfizer bivalet booster after he got the 1st dose only before he got the 2nd dose (2nd pfizer vaccine is not available)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2563503

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AL
Alter: 72,0
Geschlecht: M
Eingang: 19.01.2023
Impfdatum: 19.01.2023
Beginn: 19.01.2023
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration Incorrect product formulation administered

Symptomtext

PATIENT HAD ONLY RECIEVED FIRST DOSE OF INTIAL SERIES AND RECEIEVED THE BOOSTER BEFORE HIS SECOND SHOT OF INITAL SERIERS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2563500

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge Gj6742

gering

Staat: WI
Alter: 60,0
Geschlecht: F
Eingang: 19.01.2023
Impfdatum: 19.01.2023
Beginn: 19.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

Patient was given Bivalent COVID immunization but not received primary series with monovalent COVID vaccine. No known injury to this point.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2562234

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IL
Alter: 60,0
Geschlecht: M
Eingang: 18.01.2023
Impfdatum: 17.01.2023
Beginn: 17.01.2023
Tage bis Beginn: 0,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered No adverse event

Symptomtext

RN was informed by his primary care doctor that he needed to have his COVID bivalent booster. It was charted that he previously received 4 COVID vaccine doses (with the most recent one charted in 5/27/22). RN confirmed with patient that this was correct. RN gave COVID vaccine and charted this. When RN asked for COVID vaccine card, it was noted that he previously did receive a COVID bivalent vaccine at another pharmacy on 9/22/22. Since this was at another location, it was not in patient's chart yet and patient wasn't sure of what vaccines he previously received. I reached out to patient on 1/18/23 to discuss if he was feeling any side effects of vaccine administration the day after and he denies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes, hypertension, obesity, migraines, hyperlipidemia, covid pneumonia 12/2020
Andere Medikamente: Lipitor 20 mg triamterene /hctz 37.5/25 phentermine 37.5 viagra 20 mg nexium i tab daily allegra 24 hr
Allergien: NKA
Vorherige Impfungen: -

VAERS 2561584

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IL
Alter: 17,0
Geschlecht: F
Eingang: 17.01.2023
Impfdatum: 17.01.2023
Beginn: 17.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

No reported symptoms. This vaccine was given erroneously as the first dose of the COVID-19 vaccination series instead of as third dose after completing two monovalent doses.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None reported.
Vorgeschichte: None reported.
Andere Medikamente: None reported.
Allergien: None reported.
Vorherige Impfungen: -

VAERS 2561221

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: IN
Alter: 69,0
Geschlecht: F
Eingang: 16.01.2023
Impfdatum: 03.01.2023
Beginn: 06.01.2023
Tage bis Beginn: 3,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Herpes zoster oticus

Symptomtext

Ramsey-Hunt Syndrome

Weitere VAERSDATA-Felder

Praegender Schweregrund: Herpes zoster oticus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN
Andere Medikamente: Amlodipine 5mg
Allergien: None
Vorherige Impfungen: -

VAERS 2560881

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 49,0
Geschlecht: M
Eingang: 16.01.2023
Impfdatum: 15.01.2023
Beginn: 16.01.2023
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

The patient came in to receive the 2nd original Pfizer vaccine but was given the Bivalent Pfizer booster dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2560880

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: FL
Alter: 32,0
Geschlecht: M
Eingang: 16.01.2023
Impfdatum: 16.01.2023
Beginn: 16.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

The patient was given the Bivalent Booster dose instead of the first dose in the original series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2560787

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: TX
Alter: 52,0
Geschlecht: F
Eingang: 16.01.2023
Impfdatum: 02.01.2023
Beginn: 16.01.2023
Tage bis Beginn: 14,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Patient received a second dose of the Pfizer bivalent 3 months apart which is not recommended that this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2560713

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: VA
Alter: 82,0
Geschlecht: F
Eingang: 16.01.2023
Impfdatum: 16.01.2023
Beginn: 01.01.2023
Tage bis Beginn: -
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered No adverse event

Symptomtext

NO ADVERSE REACTION YET RCVD SECOND BIVALENT DOSE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: LEVOTHYROXIN 25MCG , ZOCOR 40, CHLORTHALIDONE 25MG, POTASSIUM 20MEQ,
Allergien: PENICILLIN
Vorherige Impfungen: -

VAERS 2560256

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MD
Alter: 10,0
Geschlecht: F
Eingang: 15.01.2023
Impfdatum: 15.01.2023
Beginn: 15.01.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Product administered to patient of inappropriate age

Symptomtext

Incorrect Dosage given to patient based on her age.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2559940

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 30,0
Geschlecht: F
Eingang: 14.01.2023
Impfdatum: 15.12.2022
Beginn: 10.01.2023
Tage bis Beginn: 26,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

Tested positive; Tested positive; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). A 31-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Dec2022 as dose 3 (booster), single (Lot number: GJ6742) at the age of 30 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 19Feb2021 as dose 1, single (Lot number: EN6200) and on 18Mar2021 as dose 2, single (Lot number: EP7534) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 10Jan2023, outcome "unknown" and all described as "Tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10Jan2023) Positive. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information provided in the narrative, a causal association between the events and the suspect drug cannot be completely excluded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230110; Test Name: Covid-19 test; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2560000

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: WI
Alter: 65,0
Geschlecht: F
Eingang: 13.01.2023
Impfdatum: 01.01.2022
Beginn: 18.12.2022
Tage bis Beginn: 351,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Contusion Incision site haemorrhage Platelet count decreased

Symptomtext

Drop in platelet count to 3,000, multiple bruises and bleeding from prior incision

Weitere VAERSDATA-Felder

Praegender Schweregrund: Contusion
Hospital-Tage: 3,0
Labordaten: Hospitalization for 3 days and required oral medication plus several follow up appointments
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic itp
Andere Medikamente: Dicyclomine imodium
Allergien: None
Vorherige Impfungen: -

VAERS 2559132

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: MA
Alter: 66,0
Geschlecht: M
Eingang: 13.01.2023
Impfdatum: 28.09.2022
Beginn: 08.01.2023
Tage bis Beginn: 102,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

COVID infection; Covid infection; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient. A 66-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 66 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 22Feb2021 as dose 1, single (Lot number: EL3247), in left arm, on 15Mar2021 as dose 2, single (Lot number: EL3247), in left arm, on 01Sep2021 as dose 3 (booster), single (Lot number: FF2589), in left arm and on 05Apr2022 as dose 4 (booster), single (Lot number: EL3247), in left arm for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing), notes: Other medical history: Hypertension, asthma; "asthma" (unspecified if ongoing). Concomitant medication(s) included: LIPTOR [ATORVASTATIN]; CHLORTHALIDONE; KCL; VIT C; VITAMIN B12 [VITAMIN B12 NOS]; and multivitamins. Past drug history included: Mucinex, reaction(s): "Known allergy: Mucinex", notes: Known allergy: Mucinex. The following information was reported: VACCINATION FAILURE (medically significant) with onset 08Jan2023, outcome "recovering", described as "COVID infection"; COVID-19 (medically significant) with onset 08Jan2023, outcome "recovering", described as "Covid infection". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (08Jan2023) Positive, notes: Nasal Swab. Therapeutic measures were taken as a result of vaccination failure and covid-19 which included Paxlovid.; Sender's Comments: The reported COVID-19 positive after company products immunization is considered ineffective of products, and the Company cannot completely exclude the possible causality between the reported events and the product administration

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230108; Test Name: Siemens Clinitest; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Asthma; Hypertension (Other medical history: Hypertension, asthma)
Andere Medikamente: LIPTOR [ATORVASTATIN]; CHLORTHALIDONE; KCL; VIT C; VITAMIN B12 [VITAMIN B12 NOS]
Allergien: -
Vorherige Impfungen: -

VAERS 2558766

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: WA
Alter: 62,0
Geschlecht: F
Eingang: 12.01.2023
Impfdatum: 12.01.2023
Beginn: 01.01.2023
Tage bis Beginn: -
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Extra dose administered

Symptomtext

Patient was given a 2nd dose of the bivalent vaccine 3 weeks after initial bivalent booster

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: not listed
Andere Medikamente: not listed
Allergien: none
Vorherige Impfungen: -

VAERS 2558763

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: WA
Alter: 64,0
Geschlecht: M
Eingang: 12.01.2023
Impfdatum: 01.01.2023
Beginn: 12.01.2023
Tage bis Beginn: 11,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

due to communication gap patient was given a 2nd dose of bivalent vaccine 3 weeks after

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: not listed
Andere Medikamente: not available to provider
Allergien: none
Vorherige Impfungen: -

VAERS 2558733

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: GA
Alter: 61,0
Geschlecht: F
Eingang: 12.01.2023
Impfdatum: 12.01.2023
Beginn: 12.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

given bivalent vaccine before primary series

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2557763

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MI
Alter: 11,0
Geschlecht: F
Eingang: 11.01.2023
Impfdatum: 11.01.2023
Beginn: 11.01.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product administered to patient of inappropriate age

Symptomtext

Patient was given a Pfizer 12+ Bivalent booster. Patient waited in the exam room for 20 minutes+ after receiving this vaccine. Provider was notified, attempted to contact patient's guardian to notify - left a voicemail for them to please contact our office. Occurrence report and VAERS complteted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2557601

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CO
Alter: 46,0
Geschlecht: F
Eingang: 11.01.2023
Impfdatum: 10.01.2023
Beginn: 10.01.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered

Symptomtext

This patient received a bivalent Pfizer dose on 10/4/2022. The MA on 1/10/23 gave another bivalent Pfizer dose which was incorrect. This patient should NOT have received the 1/10/23 dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2557578

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: TX
Alter: 29,0
Geschlecht: M
Eingang: 11.01.2023
Impfdatum: 30.12.2022
Beginn: 30.12.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

Error: Dose in Series Given Too Early-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2555970

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: TX
Alter: 18,0
Geschlecht: M
Eingang: 10.01.2023
Impfdatum: 02.12.2022
Beginn: 02.12.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

Patient given bivalent booster by pharmacist instead of primary vaccine series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: N/lA
Aktuelle Erkrankungen: none.
Vorgeschichte: obesity
Andere Medikamente: None.
Allergien: NKDA or other allergies.
Vorherige Impfungen: -

VAERS 2555058

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: MA
Alter: 59,0
Geschlecht: M
Eingang: 10.01.2023
Impfdatum: 28.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 60-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 59 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 15Apr2022 as dose 4 (booster), single (Lot number: FL3197) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient did not take any other medication within 2 weeks. It was reported that the patient received treatment of Paxlovid from 21Dec2022 to 26Dec2022, for treatment of COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2552778

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 64,0
Geschlecht: M
Eingang: 07.01.2023
Impfdatum: 11.10.2022
Beginn: 31.12.2022
Tage bis Beginn: 81,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

This is a spontaneous report received from a non-contactable reported A 64-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 64 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 31Jan2021 as dose 1, single (Lot number: EL3247) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "COVID" (unspecified if ongoing), notes: if COVID prior vaccination: Yes. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 31Dec2022, outcome "unknown" and all described as "+ Ag test 31Dec2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (31Dec2022) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221231; Test Name: home AG; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (if COVID prior vaccination: Yes)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2552777

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: MA
Alter: 42,0
Geschlecht: M
Eingang: 07.01.2023
Impfdatum: 29.09.2022
Beginn: 25.12.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

This is a spontaneous report received from a contactable reporter A 42-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 42 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 26Jan2021 as dose 1, single (Lot number: EL3247), on 18Feb2021 as dose 2, single (Lot number: EL3247) and on 10Oct2021 as dose 3 (booster), single (Lot number: FF2589) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLUCELVAX QUADRIVALENT taken for immunisation, on 09Sep2022 as dose number unknown, single. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 25Dec2022, outcome "unknown" and all described as "severe flu-like symptoms / Home test COVID +". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (28Dec2022) Positive, notes: Home test covid +. Therapeutic measures were not taken as a result of vaccination failure, covid-19. Clinical course: The patient experienced severe flu-like symptoms on 25Dec2022 and had a home test covid positive (+) on 28Dec2022. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the available information in the case, the causal association between the events and the suspect drug BNT162B2 cannot be excluded.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221228; Test Name: COVID Test; Test Result: Positive ; Comments: Home test covid +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2552608

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: OH
Alter: 18,0
Geschlecht: F
Eingang: 06.01.2023
Impfdatum: 09.12.2022
Beginn: 09.12.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

The patient received the Pfizer bivalent booster vaccine but had never received any doses of a primary series. No adverse events were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Blisovi FE 21 1mg-20mcg
Allergien: Amoxicillin, penicillin
Vorherige Impfungen: -

VAERS 2551929

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: -
Geschlecht: M
Eingang: 06.01.2023
Impfdatum: 22.09.2022
Beginn: 26.12.2022
Tage bis Beginn: 95,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

26Dec2022 mild symptom and positive test 27Dec2022; 26Dec2022 mild symptom and positive test 27Dec2022; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). A 60-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 as dose 5 (booster), single (Lot number: GJ6742) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications: Other vaccine in four weeks was reported", vaccination date on 15Sep2022, lot number: 942381. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Dec2022, outcome "unknown" and all described as "26Dec2022 mild symptom and positive test 27Dec2022". The events "26dec2022 mild symptom and positive test 27dec2022" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27Dec2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19, treatment included PAXLOVID. No follow-up attempts are possible. No further information is expected.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), to the events drug ineffective (LOE) and covid-19 cannot be ruled out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221227; Test Name: Test; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2551925

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: MA
Alter: 49,0
Geschlecht: F
Eingang: 06.01.2023
Impfdatum: 28.09.2022
Beginn: 02.01.2023
Tage bis Beginn: 96,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

COVID +; COVID +; This is a spontaneous report received from a contactable reporter(s) (Nurse). A 50-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 49 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLUCELVAX QUADRIVALENT taken for immunisation, on 28Sep2022 as dose 4, single. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 02Jan2023, outcome "not recovered" and all described as "COVID +". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Jan2023) Positive. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19. Prior to vaccination, the patient was not diagnosed as COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine (as reported). List of any other medications the patient received within 2 weeks of vaccination was reported as unknown. On 02Jan2023, the patient began to have mild symptoms. No follow-up attempts are possible. No further information is expected.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the Drug ineffective (LOE) and COVID-19 cannot be ruled out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20230102; Test Name: Nasal Swab; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: FLUCELVAX QUADRIVALENT
Allergien: -
Vorherige Impfungen: -

VAERS 2551921

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: -
Alter: 40,0
Geschlecht: F
Eingang: 06.01.2023
Impfdatum: 28.09.2022
Beginn: 23.12.2022
Tage bis Beginn: 86,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

got COVID; got COVID; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). A 41-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 40 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 23Dec2022, outcome "unknown" and all described as "got COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Dec2022) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: 4 COVID doses and last was bivalent and got COVID on 23Dec2022 then plus Ag 24Dec2022 after gym mild symptoms cough and congestion. COVID prior vaccination was not Unknown. Patient tested COVID post vaccination. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the available information in the case, the causal association between the events and the suspect drug BNT162B2 cannot be excluded.,Linked Report(s) : US-PFIZER INC-202300004020 same patient/reporter/dose, different dose/event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221224; Test Name: Ag; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2551789

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge GJ6742

gering

Staat: KY
Alter: 96,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 20.12.2022
Beginn: 21.12.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dysphagia Face oedema Full blood count Metabolic function test Oedema peripheral Urine analysis

Symptomtext

Resident began to have facial edema and bilateral edema to upper extremities. Resident also began having difficulty with swallowing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dysphagia
Hospital-Tage: -
Labordaten: CBC/CMP/Urinalysis
Aktuelle Erkrankungen: none
Vorgeschichte: Type 2 Diabete Mellitus Hypertension Hyperlipidemia Atrial fibrillation Dementia Anxiety disorder Long term use of Anticoagulants Vitamin D deficiency Colostomy Anemia Major depressive disorder GERD History of Venous Thrombosis and embolism Colostomy status Ischiorectal abcess
Andere Medikamente: Acetaminophen 325mg tablet Amlodipine 5mg tablet Atorvastatin 19mg tablet Bisoprolol Fumarate 5 mg tablet HCTZ 12.5mg tablet Miralax 17gm daily Potassium Chloride 20meq tablet Vitamin D3 2,000 IU tablet
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2551628

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge gj6742

gering

Staat: WI
Alter: 24,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 05.01.2023
Beginn: 05.01.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

physician ordered covid vaccine medical assistant wasn't aware patient had never received primary dose so the booster vaccine was given and not the first dose patient is aware and understanding clinic manager was notified and she contacted pharmacist which stated this could be used as her primary dose

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: hyperthyroidism, obesity, hsv , chronic nonintractable headache, hidradenitis axillaris
Vorgeschichte: -
Andere Medikamente: baclofen 10mg
Allergien: none
Vorherige Impfungen: -

VAERS 2551279

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: TX
Alter: 29,0
Geschlecht: M
Eingang: 05.01.2023
Impfdatum: 29.12.2022
Beginn: 30.12.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Lymphadenopathy

Symptomtext

Systemic: Lymph Node Swelling-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lymphadenopathy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2550987

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CT
Alter: 65,0
Geschlecht: F
Eingang: 05.01.2023
Impfdatum: 12.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 66-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Oct2022 as dose 5 (booster), single (Lot number: GJ6742) at the age of 65 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 01Mar2021 as dose 1, single (Lot number: EL3247), on 24Mar2021 as dose 2, single (Lot number: EP6955), on 13Oct2021 as dose 3 (booster), single (Lot number: EW0217) and on 27Apr2022 as dose 4 (booster), single (Lot number: FL3197) for covid-19 immunisation. The patient's relevant medical history included: "osteoporosis" (unspecified if ongoing); "obesity" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "past mini-stroke" (unspecified if ongoing); "Known allergies: sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30Dec2022) Negative, notes: Negative antigen test on 30Dec2022; (01Jan2023) Positive, notes: Antigen test positive again on 01Jan2023; (2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 (PAXLOVID Treatment).

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 2022; Test Name: antigen test; Test Result: Positive ; Test Date: 20221230; Test Name: antigen test; Test Result: Negative ; Comments: Negative antigen test on 30Dec2022; Test Date: 20230101; Test Name: antigen test; Test Result: Positive ; Comments: Antigen test positive again on 01Jan2023
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hypothyroidism; Obesity; Osteoporosis; Stroke; Sulfonamide allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2550832

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 10,0
Geschlecht: M
Eingang: 05.01.2023
Impfdatum: 23.12.2022
Beginn: 23.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product administered to patient of inappropriate age

Symptomtext

Wrong vaccine indicated for patient's age was given to the patient. Patient's mother was informed but stated that patient was fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2549625

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: PA
Alter: 48,0
Geschlecht: M
Eingang: 04.01.2023
Impfdatum: 28.09.2022
Beginn: 26.12.2022
Tage bis Beginn: 89,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

Tested positive for Covid after experiencing mild flu-like symptoms; Tested positive for Covid after experiencing mild flu-like symptoms; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from product quality group. The reporter is the patient. A 48-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 4 (booster), single (Lot number: GJ6742) at the age of 48 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 24Feb2021 as dose 1, single (Lot number: EL3247), in left arm, on 18Mar2021 as dose 2, single (Lot number: EN6203), in left arm and on 07Dec2021 as dose 3 (booster), single (Lot number: FF8839), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 26Dec2022, outcome "recovering" and all described as "Tested positive for Covid after experiencing mild flu-like symptoms". Prior to vaccination, no Covid-19 was reported. Post vaccination, Covid-19 was tested positive. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (26Dec2022) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221226; Test Name: COVID-19 test; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2548777

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 66,0
Geschlecht: F
Eingang: 03.01.2023
Impfdatum: 30.12.2022
Beginn: 30.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Wrong product administered

Symptomtext

Error: Wrong Vaccine/Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2547698

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MA
Alter: 28,0
Geschlecht: F
Eingang: 31.12.2022
Impfdatum: 28.12.2022
Beginn: 28.12.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Error: Dose in Series Given Too Early-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2547650

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 73,0
Geschlecht: F
Eingang: 30.12.2022
Impfdatum: 30.12.2022
Beginn: 30.12.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose normal Hypoglycaemia

Symptomtext

most likely not an adverse to the vaccine however, patient did experience a hypglcyemic event afer a covid vaccine with pfizer bivalant booster.Patient had in implanted glucometer on her left arm that read on the low 50s following a the vaccine. On site RN contacted on call MD and he advised to give a glucose tab.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood glucose normal
Hospital-Tage: -
Labordaten: Glucometer
Aktuelle Erkrankungen: INTERMITTENT ASTHMA GERD (GASTROESOPHAGEAL REFLUX DISEASE) HTN (HYPERTENSION) DM 2 W MIXED HYPERLIPIDEMIA SEVERE OBESITY ATRIAL FIBRILLATION, PAROXYSMAL ATHEROSCLEROSIS OF AORTA DM 2 W BILAT PROLIFERATIVE RETINOPATHY OSTEOPENIA LONG TERM NON WARFARIN ORAL ANTICOAGULANT THERAPY PROTHROMBOTIC STATE. CKD STAGE 3A (GFR 45-59)
Vorgeschichte: INTERMITTENT ASTHMA GERD (GASTROESOPHAGEAL REFLUX DISEASE) HTN (HYPERTENSION) DM 2 W MIXED HYPERLIPIDEMIA SEVERE OBESITY ATRIAL FIBRILLATION, PAROXYSMAL ATHEROSCLEROSIS OF AORTA DM 2 W BILAT PROLIFERATIVE RETINOPATHY OSTEOPENIA LONG TERM NON WARFARIN ORAL ANTICOAGULANT THERAPY PROTHROMBOTIC STATE. CKD STAGE 3A (GFR 45-59)
Andere Medikamente: Acetaminophen-Codeine (TYLENOL #3) 300-30 mg Oral Tab Dabigatran Etexilate (Pradaxa) 150 mg Oral Cap Losartan (COZAAR) 50 mg Oral Tab Pantoprazole (PROTONIX) 20 mg Oral TBEC DR Tab Pravastatin (PRAVACHOL) 40 mg Oral Tab Insulin NPH Human (H
Allergien: lisinopril
Vorherige Impfungen: -

VAERS 2545275

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: AZ
Alter: 34,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 23.12.2022
Beginn: 01.12.2022
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

Patient received bivalent COVID-19 Pfizer vaccination as the primary series. Patient was not previously vaccinated with monovalent vaccination. Patient advised that bivalent dose can be counted as a primary series dose and to continue with the recommended vaccination schedule (i.e., complete the primary series with a monovalent Pfizer-BioNTech vaccine, then administer a bivalent booster dose at least 2 months after completion of the primary series).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Not Known
Vorgeschichte: Not Known
Andere Medikamente: Atorvastatin 20mg, Omeprazole Dr 40mg, Montelukast 10mg, Sumatriptan 50 MG, Escitalopram 20mg, Cyclobenzaprine 10mg, Pregabalin 75mg, Breo Ellipta 200-25 mcg, Topiramate 200mg, Buspirone 10mg. Seroquel 25mg, Butalbital-Acetamn-Caf 50-325-40
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2544628

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: KY
Alter: 11,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 28.12.2022
Beginn: 28.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Patient was given 12+ year old dose instead of pediatric booster (5-11 year old booster). No specific reactions reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2543129

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: -
Alter: 31,0
Geschlecht: F
Eingang: 26.12.2022
Impfdatum: 26.12.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event

Symptomtext

There are no adverse events reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2541430

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 43,0
Geschlecht: M
Eingang: 22.12.2022
Impfdatum: 22.12.2022
Beginn: 01.12.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

the Vial was opened a day before but no Date or time was placed on the Vial. not sure if patient would need an additional vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2540917

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 1,8
Geschlecht: F
Eingang: 22.12.2022
Impfdatum: 17.12.2022
Beginn: 17.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bronchiolitis Cough Immunisation reaction Incorrect dose administered Influenza

Symptomtext

21month old patient was admitted for bronchiolitis due to influzenza virus on 12/16/22. On 12/17/22, patient inadvertently received Pfizer bivalent booster for 12+year old patients. Spoke with mother on 12/22/22 through interpreter that patient experienced stronger side effects post vaccination but is doing better now with only a lingering cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bronchiolitis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2539620

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 13,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 20.12.2022
Beginn: 20.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Emotional distress Underdose

Symptomtext

Pt with history of "fear of needles". Vaccinator went to administer the vaccine and administered 1/3 of the vaccine until the pt pulled away and become inconsolable. Pharmacist made aware and pt parent education given that pt must return another time or to their clinician for revaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Emotional distress
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2537908

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MA
Alter: 36,0
Geschlecht: M
Eingang: 20.12.2022
Impfdatum: 14.12.2022
Beginn: 15.12.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered Interchange of vaccine products

Symptomtext

Patient had rec'd one dose of Monovalent Moderna. Patient was then given Pfizer Bivalent dose. Did not complete primary series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Right hand pain and tendonitis
Vorgeschichte: Essential HTN
Andere Medikamente: Naproxen, Norvasc, Tylenol
Allergien: NKA; NKDA
Vorherige Impfungen: -

VAERS 2537323

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: NJ
Alter: 67,0
Geschlecht: M
Eingang: 19.12.2022
Impfdatum: 19.12.2022
Beginn: 19.12.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered No adverse event

Symptomtext

Patient had present to the pharmacy to receive his 2nd dose of the monovalent Pfizer Covid-19 vaccine 12yrs +, but was accidentally administered the Pfizer bivalent vaccine product 12yrs+. Error was not realized until patient had left the pharmacy, patient was contacted and notified of error, and he reported no adverse reaction or symptoms. Was notified to reach out to pharmacy or healthcare provider in the event of any symptoms or adverse reactions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2536012

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 17.12.2022
Impfdatum: 12.12.2022
Beginn: 12.12.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product preparation issue

Symptomtext

Error: Incorrect Reconstitution-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product preparation issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2535999

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: TX
Alter: 25,0
Geschlecht: M
Eingang: 17.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

Error: Dose in Series Given Too Early-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2530369

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MI
Alter: 68,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 09.12.2022
Beginn: 09.12.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered No adverse event

Symptomtext

Participant received Moderna Primary Series #1 on 12/29/21. Pfizer Bivalent was administered employee on 12/09/22. Participant did not have any adverse effects with immunization.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: COVID + 11/07/22
Vorgeschichte: Fibromyalgia M79.7 Chronic atrial fibrillation, unspecified I48.20 Person injured in unsp motor-vehicle accident, traffic, subs V89.2XXD Other fatigue R53.83 Dizziness and giddiness R42 Syncope and collapse R55 Tobacco use Z72.0 Tobacco abuse counseling Z71.6 Bipolar disorder, current episode depressed, mild F31.31 Contact w and exposure to oth viral communicable diseases Z20.828 Hyperglycemia, unspecified R73.9 Driver injured in collision w unsp mv nontraf, init V49.00XA Encounter for screening for cardiovascular disorders Z13.6 Hypertensive heart disease with heart failure I11.0 Long term (current) use of opiate analgesic Z79.891 Long term (current) use of oral hypoglycemic drugs Z79.84 Athscl heart disease of native cor art w unsp ang pctrs I25.119 Personal history of pneumonia (recurrent) Z87.01 Hypersomnia, unspecified G47.10 Cerebral infarction, unspecified I63.9 Encounter for dental exam and cleaning w/o abnormal findings Z01.20 Cardiac murmur, unspecified R01.1 Nicotine dependence, cigarettes, uncomplicated F17.210 Unspecified ptosis of bilateral eyelids H02.403 Hypomagnesemia E83.42 Other chest pain R07.89 Melena K92.1 Enlarged lymph nodes, unspecified R59.9 Nontoxic single thyroid nodule E04.1 Solitary pulmonary nodule R91.1 Long term (current) use of anticoagulants Z79.01 Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits Z86.73 Other sequelae of cerebral infarction I69.398 Presence of other cardiac implants and grafts Z95.818 Anxiety disorder, unspecified F41.9 Athscl heart disease of native coronary artery w/o ang pctrs I25.10 Chronic obstructive pulmonary disease, unspecified J44.9 Essential (primary) hypertension I10 Gastro-esophageal reflux disease without esophagitis K21.9 Heart failure, unspecified I50.9 Hyperlipidemia, unspecified E78.5 Insomnia, unspecified G47.00 Migraine, unsp, not intractable, without status migrainosus G43.909 Nicotine dependence, unspecified, uncomplicated F17.200 Old myocardial infarction I25.2 Other chronic pain G89.29 Polyosteoarthritis, unspecified M15.9 Restless legs syndrome G25.81 Type 2 diabetes mellitus with diabetic neuropathy, unsp E11.40 Unspecified age-related cataract H25.9 Vitamin D deficiency, unspecified E55.9
Andere Medikamente: Abilify 5 mg tablet Take 1 Tablet by mouth once a day Route: by mouth Acetaminophen Extra Strength 500 mg tablet - Expired Take 2 Tablet by mouth twice a day PRN as needed Route: by mouth As Needed - as needed Advair HFA 115-21 mcg/actuat
Allergien: quinine zolpidem
Vorherige Impfungen: -

VAERS 2530140

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: IL
Alter: 66,0
Geschlecht: M
Eingang: 13.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

none

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: unknown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2530120

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: IL
Alter: 63,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Wrong product administered

Symptomtext

Pt had Pfizer Covid vaccines in the past. I reviewed her vaccine card with her. I discussed Pfizer bivalent and pointed this out on the literature. Pt verbalized understanding of teaching. I did not see on her paper that she had checked Moderna Bivalent this time instead of the Pfizer Bivalent. Pt received Pfizer Bivalent and I saw the error when charting the lot #. I explained the error. Pt was not happy as she "wanted the superior vaccine" this time instead of Pfizer. I aknowledged my error, apologized, and explained that I would make a VAERS report. Pt waited the observation time of 15 min. No adverse effects from vaccine while in the office.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none known
Vorgeschichte: lung Ca
Andere Medikamente: unknown
Allergien: nkda
Vorherige Impfungen: -

VAERS 2529893

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: PA
Alter: 78,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 07.12.2022
Beginn: 01.12.2022
Tage bis Beginn: -
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Wrong product administered

Symptomtext

PATIENT HAD ASKED FOR MODERNA AND I GAVE HER PFIZER. SHE WAS HERE WITH HER HUSBAND WHO WAS GETTING PFIZER. I USUALLY SAY THE NAME OF VACCINE BEFORE INJECTING BUT DID NOT DO IT THIS TIME. I SAID IT TO HER HUSBAND AND THIS IS WHEN I REALIZED I HAD GIVEN HER PFIZER. SHE DID NOT HAVE AN ADVERSE REACTION AND WAS NOT EVEN UPSET THAT THIS HAD OCCURED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: NONE NEEDED
Aktuelle Erkrankungen: NONE
Vorgeschichte: HIGH BLOOD PRESSURE, HIGH CHOLESTEROL
Andere Medikamente: METOPROLOL ER 50, ATORVASTATIN 10 MG ESTRADIOL CR
Allergien: NO KNOWN ALLERGIES
Vorherige Impfungen: -

VAERS 2529102

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: ND
Alter: 15,0
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 07.12.2022
Beginn: 07.12.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered No adverse event

Symptomtext

Inadvertantly gave the Bivalent Covid vaccine instead of the monovalent Covid vaccine. There was no "adverse" event. No signs/symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: albuterol HFA inhaler Duac Retin-A Minocin Melatonin Multi-vitamin Vitamin D3
Allergien: none
Vorherige Impfungen: -

VAERS 2528630

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: NY
Alter: 87,0
Geschlecht: F
Eingang: 10.12.2022
Impfdatum: 10.12.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong product administered

Symptomtext

Patient supposed to receive flu shot , but received covid shot. This had hapenned because she identified herself as a different person.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: heart disease
Andere Medikamente: n/a
Allergien: penicillin
Vorherige Impfungen: -

VAERS 2528359

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: PA
Alter: 85,0
Geschlecht: M
Eingang: 10.12.2022
Impfdatum: 06.12.2022
Beginn: 06.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong product administered

Symptomtext

Error: Wrong Vaccine/Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2528253

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: PA
Alter: 55,0
Geschlecht: F
Eingang: 10.12.2022
Impfdatum: 28.09.2022
Beginn: 04.12.2022
Tage bis Beginn: 67,0
Dosis: 5
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

tested postive with home test kit; tested postive with home test kit; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from product quality group. The reporter is the patient. A 55-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 at 09:15 as dose 5 (booster), single (Lot number: GJ6742) at the age of 55 years intramuscular, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 25Feb2021 as dose 1, single (Lot number: EL3247), on 18Mar2021 as dose 2, single (Lot number: EN6200), on 01Nov2021 as dose 3 (booster), single (Lot number: FF8839) and on 04Apr2022 as dose 4 (booster), single (Lot number: FL3197), all intramuscular for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 28Sep2022 as dose number unknown, single (Batch/Lot number: unknown), in left arm for immunisation. The patient's relevant medical history included: "cholesterolemia" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 04Dec2022, outcome "recovering" and all described as "tested postive with home test kit". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (04Dec2022) Positive, notes: tested postive with home test kit; (04Dec2022) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19. Clinical course: Patient did not receive other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had been tested for COVID-19. Patient had no known allergies.; Sender's Comments: As per the available information the causality of the events vaccination failure and covid-19 with the suspects can not be ruled out completely.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221204; Test Name: Covid-19 test; Test Result: Positive ; Comments: tested postive with home test kit.; Test Date: 20221204; Test Name: Covid-19 test; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Borderline hypercholesterolemia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2528216

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: 11,0
Geschlecht: M
Eingang: 09.12.2022
Impfdatum: 09.12.2022
Beginn: 09.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Overweight Product administered to patient of inappropriate age

Symptomtext

The patient is 11 years 9 months and was given the incorrect vaccine. He should have received the 5 to 11 year old solution 0f 0.2 ml. Instead he received the 12 t solution of 0.3 ml the child is robust and overweight

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2525553

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: VA
Alter: 61,0
Geschlecht: M
Eingang: 07.12.2022
Impfdatum: 01.12.2022
Beginn: 01.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered Interchange of vaccine products

Symptomtext

PATIENT RECIEVED COVID PFIZER BIVALENT VACCINE ASSUMING IT WAS GOING TO BE IS INITAL DOSE SERIOUS DUE TO THE FACT THAT THIS PRIOR COVID SERIOUS (SPUTNIK V) ARE NOT RECOGNIZED BY THE US.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2525465

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: CA
Alter: -
Geschlecht: F
Eingang: 07.12.2022
Impfdatum: 06.12.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered

Symptomtext

No symptoms per the patient

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2521096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: ND
Alter: 36,0
Geschlecht: F
Eingang: 01.12.2022
Impfdatum: 01.12.2022
Beginn: 01.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Wrong product administered

Symptomtext

Patient reported to clinic to receive flu shot. Front desk staff reported to nurse that client here to receive covid vaccine. Asked if client had any reactions to the previous vaccines, did not specify COVID vaccines. Clients reported no issues with previous shots. Covid bivalent booster given. Client was eligible to receive vaccine, last dose was 12/13/2021. No known adverse side effects from vaccine noted as of yet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2520251

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: NV
Alter: 91,0
Geschlecht: M
Eingang: 30.11.2022
Impfdatum: 29.11.2022
Beginn: 30.11.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered

Symptomtext

Patient's caregiver states that pt had already received the flu vaccine 2 weeks prior. He was given an additional one on this day inadvertently.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: None were given. Patient's MD was notified and waiting on response.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2519199

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge gj6742

gering

Staat: RI
Alter: 50,0
Geschlecht: F
Eingang: 29.11.2022
Impfdatum: 26.11.2022
Beginn: 26.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Musculoskeletal stiffness

Symptomtext

stiffnes in left side of neck

Weitere VAERSDATA-Felder

Praegender Schweregrund: Musculoskeletal stiffness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: levothyroxine
Allergien: penicillin
Vorherige Impfungen: -

VAERS 2517214

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: CT
Alter: 60,0
Geschlecht: M
Eingang: 26.11.2022
Impfdatum: 05.10.2022
Beginn: 21.11.2022
Tage bis Beginn: 47,0
Dosis: 5
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

Contracted Covid 19; Contracted Covid 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 60-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Oct2022 at 11:15 as dose 5 (booster), single (Lot number: GJ6742) at the age of 60 years intramuscular, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 11Mar2021 at 09:00 as dose 1, single (Lot number: EL3247), in left arm, on 01Apr2021 at 09:00 as dose 2, single (Lot number: EP6955), in left arm, on 03Dec2021 at 09:45 as dose 3 (booster), single (Lot number: FH8027), in left arm and on 04May2022 at 11:15 as dose 4 (booster), single (Lot number: FL3197), in left arm, all intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Known Allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]; ESOMEPRAZOLE MAGNESIUM; ESCITALOPRAM. Past drug history included: Ceftin, reaction(s): "Known allergies: ceftin". The following information was reported: VACCINATION FAILURE (medically significant) with onset 21Nov2022, outcome "unknown", COVID-19 (medically significant) with onset 21Nov2022, outcome "recovering" and all described as "Contracted Covid 19". The event "contracted covid 19" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (21Nov2022) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of vaccination failure, covid-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200672278 Same reporter/patient, same drug/different dose, different AE;US-PFIZER INC-202200672278 Same reporter/patient, same drug/different dose, different AE;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221121; Test Name: COVID 19 Antigen Rapid Test; Test Result: Positive ; Comments: Nasal Swab
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Sulfonamide allergy
Andere Medikamente: CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS; ESOMEPRAZOLE MAGNESIUM; ESCITALOPRAM
Allergien: -
Vorherige Impfungen: -

VAERS 2512512

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge gj6742

gering

Staat: PA
Alter: 34,0
Geschlecht: F
Eingang: 20.11.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

Error: Wrong Vaccine/Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2507929

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: MA
Alter: 58,0
Geschlecht: F
Eingang: 15.11.2022
Impfdatum: 28.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 58-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 at 12:30 as dose 5 (booster), single (Lot number: GJ6742) at the age of 58 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 04Mar2021 at 14:30 as dose 1, single (Lot number: EL3247), in left arm, on 25Mar2021 at 14:45 as dose 2, single (Lot number: EL3247), in left arm, on 30Nov2021 at 12:15 as dose 3 (booster), single (Lot number: FF2589), in left arm and on 05Apr2022 at 12:15 as dose 4 (booster), single (Lot number: FL3197), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ESTRADIOL, start date: 15Oct2022; PROGESTERONE, start date: 15Oct2022; BUPROPION HCL ER; SYNTHROID. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19 Virus test; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: ESTRADIOL; PROGESTERONE; BUPROPION HCL ER; SYNTHROID
Allergien: -
Vorherige Impfungen: -

VAERS 2503324

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge GJ6742

gering

Staat: MA
Alter: 25,0
Geschlecht: F
Eingang: 09.11.2022
Impfdatum: 03.11.2022
Beginn: 04.11.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Intermenstrual bleeding

Symptomtext

I've had unusual light menstrual spotting since the day after I got the vaccine to today, almost a week later. Usually I don't have much spotting throughout the month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intermenstrual bleeding
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2476912

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: MA
Alter: -
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 29.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Alanine aminotransferase Alanine aminotransferase increased Aspartate aminotransferase Aspartate aminotransferase increased Blood test

Symptomtext

AST and ALT levels were extremely high. 337 and 139 respectively.; AST and ALT levels were extremely high. 337 and 139 respectively.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 59-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 as dose 5 (booster), single (Lot number: GJ6742) intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Batch/lot number: EL3247, Anatomical Location: Arm Left, Dose Number: 1), for COVID-19 immunization; Bnt162b2 (Batch/lot number: EL3247, Anatomical Location: Arm Left, Dose Number: 2), for COVID-19 immunization; Bnt162b2 (Batch/lot number: FH8030, Anatomical Location: Arm Left, Dose Number: 3), for COVID-19 immunization; Bnt162b2 (Batch/lot number: FN2908, Anatomical Location: Arm Left, Dose Number: 4), for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The following information was reported: ASPARTATE AMINOTRANSFERASE INCREASED (medically significant), ALANINE AMINOTRANSFERASE INCREASED (medically significant) all with onset Oct2022, outcome "recovering" and all described as "AST and ALT levels were extremely high. 337 and 139 respectively.". The events "ast and alt levels were extremely high. 337 and 139 respectively." required physician office visit. The patient underwent the following laboratory tests and procedures: Alanine aminotransferase: (21Apr2022) 14; (Oct2022) 139, notes: extremely high; Aspartate aminotransferase: (21Apr2022) 24; (Oct2022) 337, notes: extremely high; Blood test: (Oct2022) normal. Clinical course: Patient had a normal blood workup done on 06Oct2022 in prep for a physical and her AST and ALT levels were extremely high. 337 and 139 respectively. Prior levels done on 21Apr2022 were 24 and 14 (date of start of reaction/event was also reported as 01Oct2022). Events were reported as non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Alanine aminotransferase
Hospital-Tage: -
Labordaten: Test Date: 20220421; Test Name: ALT; Result Unstructured Data: Test Result:14; Test Date: 202210; Test Name: ALT; Result Unstructured Data: Test Result:139; Comments: extremely high; Test Date: 20220421; Test Name: AST; Result Unstructured Data: Test Result:24; Test Date: 202210; Test Name: AST; Result Unstructured Data: Test Result:337; Comments: extremely high; Test Date: 202210; Test Name: blood workup; Result Unstructured Data: Test Result:normal
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2469425

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ6742

gering

Staat: MA
Alter: 53,0
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Immunisation Off label use Swelling

Symptomtext

Swelling under right armpit; dose number 5; dose number 5; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient. A 53-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 at 11:00 as dose 5 (booster), single (Lot number: GJ6742) at the age of 53 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Penicillin" (unspecified if ongoing), notes: known allergies: Penicillin. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose number: 1, lot number: FL397), for COVID-19 immunization; Bnt162b2 (dose number: 2, lot number: FF2589), for COVID-19 immunization; Bnt162b2 (dose number: 3, lot number: EL3247), for COVID-19 immunization; Bnt162b2 (dose number: 4, lot number: EL3247), for COVID-19 immunization. The following information was reported: OFF LABEL USE (non-serious), IMMUNISATION (non-serious) all with onset 29Sep2022 at 11:00, outcome "unknown" and all described as "dose number 5"; SWELLING (non-serious) with onset 30Sep2022 at 08:00, outcome "not recovered", described as "Swelling under right armpit". Therapeutic measures were not taken as a result of swelling. Additional Information: It was reported that the patient did not have Covid prior vaccination and not tested post vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Immunisation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Penicillin allergy (known allergies: Penicillin)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -